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Abstract 
Lindsey Ann Ingerman: Dynamic Combinatorial Chemistry as a Tool in the Identification 
of Novel Receptors for Biomolecules 
 
(Under the direction of Marcey L. Waters) 
 
 The work presented in this thesis highlights various advances in the field of dynamic 
combinatorial chemistry (DCC), both in the development of new types of dynamic 
libraries and in the investigation of molecular receptors for biomolecules of interest.  
DCC has emerged in recent years as a new strategy for the discovery of host-guest 
systems based on the generation of libraries via reversible chemistry.  The true utility of 
DCC lies in the fact that recognition of a guest molecule causes the equilibrium to shift, 
allowing for amplification and detection of novel receptors.    
 This technology has been utilized most notably for the identification of synthetic 
receptors for protein post-translational modifications, particularly methylated lysines and 
arginines.  These modifications are of great interest due to their crucial role in gene 
expression and cell signaling.  Small molecule receptors have been demonstrated via 
DCC that discriminate for trimethyllysine over the lower methylation states, for example, 
paralleling the affinity and selectivity of the native protein receptor.  This suggests that 
such synthetic receptors have a promising future as affinity reagents for PTMs.  Also of 
interest are methylated nucleotides, and larger peptide based macrocycles have been 
shown to function as selective receptors for 7-methyl guanosine via DCC, revealing the 
importance of the methyl group in strengthening this host-guest interaction. 
 iv 
 In addition to executing molecular recognition studies via DCC, we have expanded 
upon the present collection of building blocks and libraries that have been demonstrated 
previously.  An azobenzene moiety was incorporated into a doubly dynamic library to 
highlight the utility of photocontrolled libraries.  Through templation with a polyproline 
peptide the amplification of an azobenzene containing macrocycle was demonstrated.  
Photoresponsive receptors of this type have the potential to allow for greater control over 
molecular recognition events.  Furthermore, new libraries of peptidic marcocycles were 
demonstrated via thioester exchange.  This work is particularly advantageous in that it is 
feasible to generate large numbers of cyclic peptides efficiently within hours for further 
screening.  The reaction dynamics and the kinetic determinants of macrocycle formation 
were investigated and found to be highly dependant on the peptide building block 
structures. 
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CHAPTER I 
DYNAMIC COMBINATORIAL CHEMISTRY
 
A. Introduction  
 In attempt to mimic the thriving process of natural selection where those deemed 
most “fit” are rewarded with the ability to successfully reproduce, since the mid-1990s 
chemists have been developing their own natural selection process involving both 
selection and amplification, known as dynamic combinatorial chemistry (DCC).  
Dynamic combinatorial chemistry is an attractive alternative to traditional rational design 
in the development of novel receptors, in which molecular recognition guides the 
synthesis of complex host systems from simple building blocks using reversible linkages 
under thermodynamic control (Figure 1.1).1  It takes advantage of the ability of a 
molecular target to template the preferential bond formation of the strongest target 
binders, upon which desired receptors are amplified at the expense of other oligomers.2  
DCC not only allows for the discovery of non-intuitive receptors, but it also provides 
access to structures that may otherwise be unobtainable by traditional synthesis.3   
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Figure 1.1.  Generation and templation of a dynamic combinatorial library (DCL). 
 
 There are several key components of DCC that together allow for a system that can 
facilitate Darwinian like evolution, each of which will be introduced to some degree to 
provide adequate background for the work in this thesis.  First, a set of designed 
monomers which serve as building blocks in the generation of a larger library of 
constituents are needed.  Second, the implementation of reversible chemistry between 
monomers is required to generate a group of library members which are under 
thermodynamic control.  This highlights the primary difference between traditional 
combinatorial chemistry and DCC, as combinatorial chemistry functions under kinetic 
control.  Third, a selection mechanism is necessary, which is most commonly a form of 
molecular recognition or receptor binding, however many other selection methods have 
been demonstrated.  Last, an analytical method is required to identify those compounds 
which are most “fit” and are thus are enhanced via this selection process.    
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B. Reversible exchange reactions 
 While the principal requirement of a reaction used to facilitate exchange between 
building blocks in a dynamic combinatorial library is that it be reversible, there are 
multiple other criteria that must be met in order for the system to serve as an effective 
selection process.1a  To begin, the rate of reversible exchange is important in that it 
should occur on a reasonable time scale.  While this requirement is often a matter of 
convenience, it can also be important when degradation of the target molecule over time 
is an issue.  Next, due to the simultaneous nature of the equilibration and selection 
processes, the reversible reaction must proceed under conditions that are compatible with 
the target of interest, including all functional groups on the molecule.  This becomes 
particularly relevant, and often challenging, in the screening of biomolecules which 
generally require physiological conditions (neutral pH in buffered aqueous solution).  
While the reaction conditions must be compatible with the experimental conditions for 
selection, they must also be fairly mild (for example, ambient temperature and pressure) 
as to not interfere with the non-covalent interactions involved in molecular recognition.  
The reversible reaction must also ensure the solubility of all library members formed at 
equilibrium, as any insoluble species can potentially act as a thermodynamic trap.  Lastly, 
the ability to turn off the exchange reaction and kinetically “freeze” the library 
distribution is essential for analysis of the library distribution and to fully assess the 
degree of amplification.  The isolation and further investigation of identified receptors is 
also only feasible if exchange has been halted.   
 Both a wide range of covalent and noncovalent reversible reactions have been 
demonstrated in the context of dynamic combinatorial libraries.  While reversible 
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covalent bonds often exhibit slower kinetics, they are more widespread due to the fact 
that enhanced compounds can be easily isolated and handled further.  In contrast, 
libraries formed based on noncovalent interactions achieve equilibration rapidly, yet the 
often weak and labile bonds generate products that are difficult to analyze in solution and 
even more problematic to isolate.  Despite this, both hydrogen bonds4 and metal-ligand 
coordination bonds5 have been successfully applied to DCC experiments in numerous 
cases.  While the full scope of potential reversible reactions is exhaustive and beyond the 
scope of this thesis, it is worth addressing those that have received significant attention 
thus far in this field.   
 Nearly all reversible unsymmetrical covalent bonds used in DCC involve carbonyl 
compounds or some derivative thereof (Figure 1.2).  Acyl exchange reactions such as 
trans-esterification, allyl ester exchange, amide exchange, aldol exchange, and thioester 
exchange are all facilitated by the relatively fragile nature of the C(O)-X bonds, which 
can consequently be reversibly broken.  One of the earliest examples where reversible 
transesterification was utilized in DCC studies was reported by Sanders and coworkers, 
where a cholic acid methyl ester derivative was used to form an equilibrating mixture of 
linear and cyclic oligomers in the presence of a potassium methoxide-crown ether 
complex.6  Amide bond exchange, while slightly more challenging due to the stability of 
amide bonds, has also been demonstrated based on approaches which employ 
biocatalysts, such as proteases.7  While important steps have been made towards the use 
of synthetic catalysts for transamidation reactions, the conditions employed are not yet 
compatible with biomolecular recognition.8  Thioester exchange has received attention 
more recently as it proceeds both at room temperature and under neutral conditions, and 
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has been employed in the context of libraries targeting hydrolases9 and in the evaluation 
of the higher order structural stability in polypeptides.10   
O XXO
X
N X
Acyl 
transfer
Acetyl-type
exchange
C=N
exchange
 
Figure 1.2.  Different types of unsymmetrical covalent exchange reactions involving 
carbonyl groups: acyl transfer (X = NHR, OR, SR, CH2R), C=N exchange (X = R, NHR, 
OR), and acetal-type exchange (X = OR, SR, NHR). 
 
 Several studies have also explored exchange reactions that benefit from the labile 
C=N double bond, such as imine, oxime, and hydrazone exchange.  The first 
demonstration of imine exchange in DCC was described by Huc and Lehn in the 
generation of a library targeting the production of carbonic anhydrase inhibitors,11 and 
imine exchange has since remained prevalent in the DCC literature.  Structurally related 
hydrazones and oximes are often viewed as advantageous due to their great hydrolytic 
stability in comparison to imines.  While the application of reversible oxime chemistry in 
the generation of libraries has been somewhat scarce since its first demonstration by 
Eliseev and coworkers in the late 1990s,12 hydrazone exchange has proven to be a quite 
successful and powerful technique in the generation of diverse DCLs.  Numerous 
examples have been presented based on pseudo-mono-and dipeptides in the generation of 
acyl hydrazone libraries,13 many of which have resulted in receptors for cationic 
templates such as quaternary ammoniums14 and alkali cations,15 as well as nucleotide 
bases.16 
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 Transacetalization chemistry based on the well-known formation of cyclic acetals 
from diols and aldehydes has been demonstrated in relatively few studies in comparison 
to acyl and C=N exchange reactions.  An initial example revealed the transacetalation 
between a D-threitol derivative and a diacetal to generate a very complex mixture of 
cyclic and linear compounds.17  Acetal exchange between formaldehyde acetals to 
explore cyclophane formation via DCC has also been presented,18 while more recently 
the production of a cyclic polyether DCL was reported resulting in the amplification of 
small macrocyclic library members by ammonium ions.19 
 Beyond the use of reversible reactions involving carbonyl compounds, numerous 
other covalent bonds have been utilized in the context of DCLs, most of which provide 
symmetrical linkages as opposed to the unsymmetrical covalent bonds discussed 
previously.  Disulfide exchange is arguably one of the most widespread and promising 
reversible reactions in the generation of DCLs, due to not only its simplicity and 
robustness, but it is also one of the few reactions that is compatible with most 
biomolecules.  Sanders and coworkers reported the first example of a large dynamic 
library of macrocycle disulfides in water formed from a range of aliphatic dithiol building 
blocks, including carbohydrate and amino acid derivatives.20  This reaction is particularly 
relevant to the work in this thesis due to its biocompatibility and will be discussed in 
greater length in chapter two.  Both olefin metathesis and the Diels-Alder reaction are 
included on a very short list of exchange reactions involving carbon-carbon bonds.  Lehn 
and coworkers have demonstrated a Diels-Alder reaction that is designed to be reversible 
under particularly mild conditions.21  With the development of efficient catalysts such as 
Grubbs catalyst, olefin metathesis has become a promising reaction for the preparation of 
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DCLs.  Nicolaou and coworkers used reversible olefin metathesis to prepare a library of 
vancomycin dimers in water, although not initially intended as a DCC experiment per se.  
A significant catalyst dependence has also been demonstrated in the templated synthesis 
of porphyrin boxes from alkene functionalized porphyrin building blocks.22 
 
C. Building block design 
 For the successful use of DCC, particularly in the event of a selection process, there 
are various elements that must be considered in the design and choice of building blocks.   
Specific functionality is required to facilitate an identified reversible reaction, and the 
reactive functionality can be incorporated either once or twice in each monomer, 
depending on whether a library of linear dimeric species or cyclic oligomers are desired.  
The presence of two reactive groups is generally advantageous in that it results in an 
increase in the structural diversity of the library, which is particularly crucial in the 
search for molecular receptors.  The generation of species of varying size is feasible, 
albeit often at an entropic cost for the larger oligomers, however the placement of the 
reactive groups within each monomer is quite important in dictating the formation of 
linear versus cyclic oligomers.   
 The structural diversity desired is often tied to the extent of flexibility incorporated 
into each designed monomer.  When monomers are quite rigid they have a tendency to 
self-sort, particularly when they differ from each other significantly in terms of size and 
“bite angle” (Figure 1.3).1a  In this case, heterodimers tend to be destabilized through ring 
strain and therefore represent only minor species within the mixture.  A degree of 
flexibility within each monomer can allow for a library of increased diversity, even in the 
 8 
investigation of a single building block library.  Furthermore, diversity can be increased 
by the incorporation of a small, flexible unit, which can bridge monomers that would 
otherwise not cyclize or be quite strained. 
 
Figure 1.3.  The tendency of rigid building blocks to self-sort. 
 
 A consideration of solubility and molecular weight are also worth nothing in the 
design of monomers.  While often difficult to predict, all species formed in a particular 
library must maintain complete solubility throughout library equilibration to ensure a 
complete analysis.  This becomes particularly problematic upon the generation of larger 
library members, as the appropriate solubility of each monomer does not ensure that each 
macrocycle formed will remain soluble.  The solubility must also be maintained in a 
solvent system that is appropriate for each application, be it templation or otherwise.  In 
the case of templation studies, the hosts and guests must sustain complete solubility as 
individual components and upon binding.  In regards to molecular weight, a unique mass 
is desired for each monomer, as most libraries are analyzed by mass spectrometry which 
can not differentiate between structural differences.  However, in some cases this can be 
circumvented as a result of different UV absorption spectra of mass degenerate 
monomers. 
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D. Experimental considerations 
 As in most reactions, upon choosing reagents and conditions under which the reaction 
is performed, the main consideration that remains is the concentration of the reagents.  In 
the case of DCC, the building block concentrations tend to be quite influential on the 
composition of the resulting library.  This is a key parameter because it influences the 
rates of the exchange reactions, as well as the oligomer to polymer ratio.  It has been 
proposed previously that there exists a critical concentration below which the equilibrium 
composition of the system consists entirely of small macrocycles.23  This concentration 
dependence should be evaluated in the context of each library in order to generate 
macrocycles of appropriate size and diversity.   
 In addition, in the pursuit of molecular recognition studies, the template concentration 
is also crucial, particularly in relation to that of the building blocks.  While the most ideal 
concentrations are often dependent of the level of affinity for a particular template, initial 
screens are often conducted at template concentrations equal to or above that of the 
building blocks in order to enforce binding.  In cases where the enhancement of a 
multitude receptors is observed, lowering the template concentration should serve to 
amplify only those best receptors.  Furthermore, theoretical studies have reported the 
possible breakdown of the correlation between amplification and binding efficiency at 
certain concentrations as a result of the tendency of a DCL to maximize the binding 
interactions of the entire library.24   When choosing between the amplification of a larger 
number of small, moderate binders versus a smaller number of larger, tighter binders, the 
latter option is not necessarily preferred, often causing the best binders to go unnoticed.25  
However, this is generally observed when an excess of template is used, and dropping the 
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template concentration ensures amplification of those best receptors without a serious 
loss in templating efficiency.  This behavior reflects the truly complex nature of such 
DCL molecular networks. 
 
E. Possible selection methods 
 While initial investigations in this field were focused on library development and the 
underlying reversible chemistry, attention has more recently moved toward evaluating 
shifts in product distribution resulting from some type of favorable noncovalent 
interaction.  It is this unique ability of reversible DCLs to efficiently select and amplify a 
species that is most “fit” in the context of the library that highlights the true utility of this 
methodology.  The majority of the selection methods that have been presented to date 
involve the use of templating to select for molecules that act as hosts or receptors for 
particular guests of interest.  While synthetic chemists have proven to be quite good at 
designing elegant syntheses for complex molecular receptors, developing new and 
modified versions of such receptors often involves a lengthy process of design, synthesis, 
evaluation, and often redesign.  By simply designing potential receptor fragments and 
leaving the rest up to the recognition properties of the guest, DCC has allowed for the 
identification and synthesis of quite complex and unpredictable synthetic receptors, with 
often impressive affinity.  This type of selection has been applied to the identification of 
receptors for a wide range of molecules, from biomolecules to metal ions, using a variety 
of reversible chemistries and reaction conditions. 
 Similarly, the selection of new guests or ligands is possible through the introduction 
of a separate host molecule.  This is most applicable in the field of drug discovery, where 
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the use of an enzyme’s active site, for example, can lead to amplification of potential 
inhibitors.  The subtle mechanisms of protein folding, the difficulty in predicting the 
strength of ligand-protein interactions, and the fact that the structure of many proteins is 
not precisely known often hampers the design and discovery of new inhibitors by 
traditional methods.  DCC is particularly attractive in this context in that the exact nature 
of the binding site need not be well understood.  Although the association between the 
ligand and biomolecule is generally entirely noncovalent, a tethering approach has also 
been developed in which a reversible covalent linkage is used to tether the ligand to the 
biomolecule.26  This concept is advantageous in that it facilitates the binding of ligands so 
that low-affinity binders that would otherwise not bind strongly enough can be detected.  
It should be noted that such systems can be somewhat limiting due to the physiological 
conditions and high protein concentrations required. 
 In addition, the selection of the most stable structure within a mixture of structures 
with different conformational properties can also be facilitated via DCC.  Through the 
use of reversible chemistry, folding into secondary and tertiary structures by proteins or 
nucleic acids, as well as polymers or oligomers, can be monitored.  Molecular recognition 
takes place intramolecularly, and there is generally no need for a formal template 
molecule.  Somewhat related is the use of DCC to investigate the stabilization of specific 
library members through intermolecular noncovalent interactions.  In this case the library 
composition is biased toward those species that form stable assemblies or aggregates.  
While this selection method has yet to gain a significant amount of attention, it has much 
potential in the investigation of self-assembling molecules, such as interlocked or 
dendritic molecules, or new materials.   
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F. Analytical methodology 
 One primary advantage to DCC as a combinatorial technique is the simultaneous 
nature of the synthesis and selection processes.  Library analysis via liquid 
chromatography coupled with mass spectrometry has by far evolved as the primary 
method of library analysis, allowing for a full identification of all species in solution, in 
both templated and untemplated reactions.  Often more important than characterizing all 
members of the library, LC-MS allows for the accurate identification of all species 
enhanced due to favorable molecular recognition events (Figure 1.4).  The untemplated 
reaction ideally serves as an internal control for self-selection processes, and allows for a 
direct comparison to a library containing a molecular guest of interest.  Those species 
enhanced become visually apparent via inspection of the chromatography traces, and 
subsequent MS analysis facilitates their immediate identification.  Further MS-MS can 
also be utilized in the analysis of libraries involving sequence isomers and 
regioisomers.27 
 
Figure 1.4.  Representative chromatography traces of an untemplated library distribution 
(left), and a library templated with an external template (right).  Molecular recognition 
events guide the amplification of those most favorable receptors (shown in green). 
 
 While this is quite an effective and efficient method of analysis, particularly with the 
development of new analytical systems which allow for more high throughput analysis, it 
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also presents many challenges, as library mixtures can only become so complex before 
accurate analysis is no longer possible.  When the chromatography becomes quite 
involved, not only is the library composition difficult to ascertain, but the ability to 
identify amplified, active compounds is often lost.  With increasing complexity the 
probability of generating strong binders increases, yet this results in concentrations of 
individual library members that are quite low, often below a reasonable concentration for 
either detection or amplification.  The question of how many compounds a DCL can 
contain while still allowing the amplification of strong binders to useful concentrations is 
still under debate, and theoretical studies have aided in this regard.28  This again 
highlights the importance of careful monomer design, as maximum diversity is desired 
within the limits of the analytical method.  The use of larger solution phase libraries (> 
9000 compounds) have been reported in the successful identification of molecular 
receptors, however most studies continue to make use of relatively simple libraries.29   
 Due to the intrinsic limitations associated with LC-MS analysis, efforts have been put 
forth in the development of alternative analytical techniques, the primary goal of which is 
generally to separate those selected receptors from a complex mixture of species.  One 
way in which this has been achieved is through the immobilization of the template during 
the equilibration processes, allowing for the simultaneous selection, amplification, and 
isolation of favorable receptors, as the selected compounds remain bound to the resin.  
Immobilized receptors, such as the carbohydrate-binding protein concanavalin A, have 
been reported,30 as well as immobilized guest molecules, such as methylated ammonium 
ions31 and cinchona alkaloids.32  In addition, Miller and coworkers have developed the 
technique of resin-bound DCC (RBDCC) in which the library constituents themselves are 
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immobilized, and the detection of selected hits is facilitated by the use of fluorescently 
labeled targets.33  Beyond liquid-solid phase segregation, the use of liquid-liquid phase 
segregation has also be reported using two immiscible solvents to increase the diversity 
and scope of libraries that can be generated and explored via DCC.34  Lastly, as an 
extension to traditional DCL selection methods, Rayner and coworkers have described a 
process that combines DCC and SELEX (for Systematic Evolution of Ligands by 
Exponential enrichment) for the in vitro selection of small molecule conjugated RNA 
aptamers that bind tightly to the TAR (transactivation-responsive) element of HIV-1.35 
 
G. Purpose of this work 
 In recent years, many contributions have been made to the field of DCC and it has 
found application among a variety of disciplines, ranging from drug discovery to material 
science.36  Although the potential utility of DCC is unquestionable, it remains a relatively 
limited and young field, allowing for further contributions in a range of areas, while a 
number of challenges have yet to be addressed.  Although the groundwork has been laid 
in the development of reversible reactions for library generation, new types of reactions 
will continually be of interest, while the use of known reactions under more 
physiological-like conditions is undoubtedly desired for biological applications.  The 
potential to generate new monomers and libraries with novel functionality is unlimited, 
while there are also numerous targets, biological and otherwise, for which DCC may 
provide an effective method in the identification of host molecules.   
 This thesis represents an effort to contribute to the field of DCC in a meaningful and 
diverse way.  It is our goal to design novel monomers with potentially useful 
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functionality, generate new types of libraries for future applications, and to investigate 
the recognition of biologically interesting targets.  The identification of synthetic 
receptors for post-translationally modified amino acids such as methylated lysine and 
arginine, as well as methylated nucleotides, has been investigated due to the critical role 
of each in controlling gene expression.  Our interests in both photochemistry and the 
development of libraries containing more than one reversible reaction prompted an 
investigation of azobenzene containing monomers.  An array of thioester peptide 
monomers were also evaluated for their ability to readily generate libraries of cyclic 
macyrocycles for future DCC assays, while the application of larger peptide monomers 
with known secondary structures have also been investigated in the context of dynamic 
combinatorial libraries.  It is our hope that these studies ultimately play a role in 
expanding the use and application of DCC within the scientific community, while also 
highlighting DCC as a versatile tool in the drug discovery process, particularly in the 
field of epigenetics.    
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CHAPTER II 
SMALL MOLECULE RECEPTORS FOR PROTEIN POST-TRANSLATIONAL 
MODIFICATIONS 
 
(Reproduced, in part, with permission from The Royal Society of Chemistry and 
Ingerman, L. A.; Cuellar, M. E.; Waters, M. L. Chem. Commun. 2010, 46, 1839-1841.) 
 
A. Background and Significance 
 i. Histone post-translational modifications and their role in gene transcription.  
Developing a better understanding of the factors that control gene expression is crucial to 
the study of both development and disease, and consequently, epigenetics has emerged as 
a major challenge and field of study.1  In studying the control of genetic information, it 
has become clear that post-translational modifications (PTMs), particularly those of 
histone proteins, are intimately involved in gene regulation.  These modifications 
encompass a range of structural changes to natural amino acids, including methylation, 
acylation, phosphorylation, ubiquitination, and glycosylation, among others, and they 
have equally diverse functions.  Post-translational modifications have been seen to play a 
critical role in the regulation of signaling pathways and in tagging proteins for 
degradation, while they can also act as chemical switches to induce or repress protein-
protein interactions.2     
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 Histone proteins are largely considered to be the framework for packaging genetic 
material.  Within the nucleus, DNA is wrapped around histone proteins to form 
nucleosomes, which are then further condensed to give chromatin (Figure 2.1).  
Chromatin can exist as tightly packed inactive genetic material, known as 
heterochromatin, or switch to actively transcribed genetic material in a lightly packed 
state, or euchromatin.   
a)     b)  
Figure 2.1.  a) Packaging of DNA within the nucleus (Adapted from a National Human 
Genome Research Institute Image).  b) The atomic structure of the nucleosome core (pdb 
1eqz), with each strand of DNA shown in a different shade of blue, surrounding the 
histone octamer. 
 
 There are eight histone proteins which assemble to form an octamer, composed of 
two H2A-H2B heterodimers and two H3-H4 heterodimers.3  While DNA is wrapped 
around the core of this octamer, each histone protein contains disordered termini which 
protrude from the nucleosome.  By extending beyond the nucleosome, these unstructured 
peptide tails are readily available for enzymatic modification (Figure 2.2).  Lysine and 
serine residues in particular are abundant throughout the histone tail sequences, resulting 
in highly methylated, acylated, and phosphorylated proteins.   
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Figure 2.2.  The types of post-translational modifications observed on the core histones, 
comprised of a tetramer of H3 (green) and H4 (yellow) and two dimers of H2A (red) and 
H2B (beige).  The modifications are shown, including methylated lysine and arginine 
(blue circle), acetylated lysine (pink hexagon), phosphorylated serine (pink square), and 
ubiquitinated lysine (pink star).4 
 
 While it was initially proposed that these histone modifications exerted their 
biological function by significantly altering the nucleosome structure, it has since been 
realized that they instead act as markers for the initiation or repression of specific 
interactions or for the precise recruitment of non-histone proteins, dictating the higher-
order chromatin structure in which DNA is packaged and resulting in gene expression or 
gene silencing depending on the type and location of the PTM.5  While lysine acylation is 
commonly associated with transcriptional activation, as it is thought to negate the 
favorable electrostatic interaction between lysine and the phosphate backbone of DNA 
resulting in the loosening of chromatin, lysine methylation often initiates the recruitment 
of other proteins through specific binding interactions with the modified tail, resulting in 
further chromatin condensation.6  Lysine methylation is especially important for 
chromatin function due to its stability and direct contribution to heritable patterns of gene 
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expression.  Although various PTMs have been documented for over forty years, it has 
only been within the past decade or so that the impact of certain modifications on gene 
transcription have emerged.   
 Solving the puzzle of histone PTMs is complicated by the fact that the same chemical 
modification occurring at different positions within a single protein can have different 
effects on gene expression.  This is particularly apparent with methylation.  For example, 
within the histone 3 tail, methylation of lysine 4, 36, or 79 results in activation of 
transcription, whereas methylation of lysine 9 or 27 results in transcriptional repression.   
This situation is further complicated by the fact that both arginine and lysine can be 
variably methylated.  Histone methyltransferases can add up to three methyl groups to a 
single lysine side chain, while arginine can exist as either monomethyl or dimethyl 
arginine (Figure 2.3).  Some enzymes specifically produce symmetric dimethylarginine 
(sRMe2), while others produce asymmetric dimethylarginine (aRMe2).  It has become 
clear that both the position of the residue and the degree of methylation together dictate 
the transcriptional outcome of the modification.7 
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Figure 2.3.  Methylated lysine and arginine PTMs. 
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 ii.  The histone code.  With the investigation of these modifications and their specific 
functions in isolation, it soon became apparent that there is a form of communication 
between PTMs which allows them to work together in a very elaborate signaling 
pathway.  This idea that distinct histone modifications, on one or more tails, act 
sequentially or in combination to form a code that is read by other proteins to bring about 
distinct downstream events has since been deemed the “histone code.”8  Thus, it is 
considered to be the effect of multiple modifications that together control gene 
transcription.   
 Mechanistically it can be envision that this communication between modifications 
may occur at several different levels.  First, the presence of multiple modifications 
(particularly those resulting in an increase or decrease of charge such as phosphorylation 
and acetylation, respectively) are thought to amplify the readout of signaling pathways, 
causing greater changes in the overall charge density of histone tails, and leading to a 
greater change in the extent of chromatin condensation (or decondensation).  Second, it is 
possible that the covalent modification of a histone tail by one enzyme influences the rate 
or efficiency with which a second enzyme follows.  Many sites of modification are close 
enough within the histone tail to influence, either positively or negatively, the ability of 
enzymes to further modify the protein.  An enzyme may recognize its substrate more 
effectively in the context of other modifications, while the catalytic activity of an enzyme 
may also be compromised by prior modification of its substrate.  Thirdly, the recruitment 
of PTM binding proteins may be affected by the presence of multiple modifications, in 
some cases creating a stronger association, and in others working in tandem to recruit 
unique biological complexes.  PTMs have also been identified which work together as 
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switches to control gene transcription, whereby adjacent PTMs establish a switch 
mechanism to regulate protein-protein interactions.  One such example is seen with 
phosphorylation of serine 10 of the H3 protein, which disrupts the binding interaction 
between the neighboring methylated lysine 9 and heterochromatin protein 1 (HP1) 
(Figure 2.4).9  By ejecting the HP1 protein, this PTM switch serves to reverse the effects 
of histone methylation and in turn reactive transcription.  Furthermore, the reversibility of 
these modifications allows for an extremely intricate control of gene transcription.  
 
Figure 2.4.  Phosphorylation as a PTM switch in the H3 tail, serving to reverse the 
transcriptional outcome of lysine methylation. 
 
 iii.  Post-translational modification binding domains.  Although the mechanisms 
by which cells decipher a PTM-mediated histone code are far from understood, the 
emerging school of thought is that histone PTMs are read by protein receptors, or effector 
proteins, which facilitate downstream events via the recruitment and/or stabilization of 
chromatin-templated machinery.10  Many epigenetic readers have been identified that 
bind to specific PTMs of interest, and these have played a key role in furthering our 
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understanding of how histone PTMs regulate biological functions.11  These conserved 
protein domains bind histone PTMs in a way that is dependent on both the type of 
modification and the position within the histone sequence.  The identification of binding 
modules for methylated lysines has been largely successful, and are known to include 
chromodomains, Tudor domains, MBT-repeats, WD40-repeats, and PHD fingers, 
whereas protein receptors for methylated arginines in histone proteins have yet to be 
identified.12  The identification of such methylated arginine reader proteins remains a 
challenge, as does the broader goal of uncovering the relationship between PTM binding 
proteins and human disease.   
 Unlike the elimination of charge upon lysine acetylation, all methylated forms of 
lysine are cationic at physiological pH, with trimethyllysine containing a fixed positive 
charge.  As the number of lysine methyl groups increase, the hydrophobicity and the 
distribution of positive charge of the methylammonium group increases, while 
concomitantly it’s ability to serve as a hydrogen bond donor decreases.  As a result, each 
PTM requires a protein partner that can adapt to these inherent physical properties, in 
turn leading to a great deal of specificity.   
 The recognition of these modifications results largely from contacts made between 
the methylammonium group and aromatic residues in the protein receptor, forming an 
aromatic “cage” about the PTM (Figure 2.5).  These aromatic cages are generally highly 
specific for a certain methylation state, discriminating between PTMs based on only very 
slight differences in size and shape.  The cages are thought to be preorganized and static 
in nature, showing little or no appreciable structural perturbation upon binding, and 
therefore minimal loss in entropy.  The binding interaction between the 
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methylammonium and the aromatic cage is mediated largely by cation-π interactions, 
while hydrophobic desolvation effects also have an appreciable role.  The cation-π 
interaction is generally thought of as a charge-quadrupole interaction between a 
positively charged species and an aromatic ring, primarily electrostatic in nature.  More 
specifically, as the quadrupole moment places partial negative charge above each face of 
the aromatic ring, favorable interactions with cations occur perpendicular to the plane of 
the ring.  The role of this interaction in proteins is a topic of great interest, particularly in 
the investigation of protein structures, protein-protein interactions, and protein-ligand 
interactions.13 
a) b)
 
Figure 2.5.  Binding pockets for lysine PTMs.  a) Histone 3 K9Me3 (green) bound to the 
HP1 chromodomain (gray) via cation-π interactions with three aromatic side chains (pdb 
1KNE).  B) Histone 3 K4Me2 (green) bound to the 3-MBT domain (gray) via cation-π 
interactions with three aromatic residues and a hydrogen bond to glutamic acid (blue) 
(pdb 2RHI). 
 
 The magnitude of the cation-π interaction in proteins is dependent on numerous 
factors, including the electron density of the aromatic ring (for example, phenylalanine 
versus tryptophan), the distribution of positive charge across the cation, the degree of 
solvent exposure of the interaction, as well as the contribution of other forces such as van 
der Waals and hydrophobic interactions.  Prior work in the Waters Lab has shown the 
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importance of the charge-quadrupole interaction to KMe3 binding and specificity in the 
context of a β-hairpin model system, as well as in a histone peptide, indicating that the 
driving force for binding is indeed the cation-π interaction as opposed to the hydrophobic 
effect.14  Specifically, replacement of KMe3 in a histone 3 peptide with its neutral 
analogue, tert-butylnorleucine, resulted in binding to the HP1 chromodomain nearly as 
weak as unmethylated lysine, demonstrating the essential nature of the cation-π 
interaction to the recognition of the H3 tail by the HP1 chromodomain with good affinity 
and selectivity.   
 In the recognition of the lower methylation states, hydrogen bonding and steric 
exclusion also become increasingly important.  Nearby acidic residues in the protein are 
also known to form salt bridges with the protonated amines of KMe2 and KMe.  This has 
been demonstrated in the context of a PHD domain by engineering dimethyllysine 
recognition specificity.  While the wild-type PHD finger’s binding preference is for 
histone 3 K4Me3 over K4Me2, the binding preference was reversed for that of KMe2 
over KMe3 through the mutation of a key tyrosine residue to glutamic acid.15  The 
change in selectivity is associated with hydrogen bonding between the KMe2 proton and 
the carboxylate group of the glutamic acid side chain.   
 Furthermore, complexes with a lower methylation state PTM are bound via the 
cavity-insertion recognition mode, where the methylammonium group is inserted into and 
buried deep within a protein cleft.  This allows the protein pocket to bind only those 
PTMs of the appropriate size.12  In contrast, the higher methylation states are known to 
use a surface-groove recognition mode whereby the binding pockets are both wider and 
more accessible.  The methyllysine side chain lies along the protein surface groove and 
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consequently the effector proteins have slightly less stringent preferences for specific 
methylation states. 
 Beyond selectivity for different methylation states, effector proteins display marked 
selectivity for the sequence context within which a PTM is presented.  The PTM 
containing peptides are generally unstructured in the unbound state, but undergo an 
induced-fit conformational change, adopting secondary structure when bound to their 
recognition proteins.  The histone tail peptides tend to adopt a β-sheet conformation, 
pairing through an antiparallel alignment with an exposed face of an existing β-sheet of 
the effector protein, as seen in the case of H3 K4Me3 recognition by the PHD finger of 
NURF.16  Similarly, six residues of the H3 peptide containing K9Me3 insert as a β-strand 
on the surface of the protein receptor, HP1 chromodomain, and complete a β-sandwich 
overall fold.17  While backbone hydrogen bonds between residues adjacent to the PTM 
and the effector protein are formed, strengthening the interaction, the sequence selectivity 
is largely due to complementary side chain interactions between the two domains.  The 
steric compatibility, intermolecular hydrogen-bonding, and electrostatic interactions of 
the surrounding residues all play a role in determining the binding affinity and specificity.   
A significant protein-protein interaction induced by lysine methylation most relevant 
to the work presented in this thesis is the binding of histone 3 K9Me3 to the HP1 
chromodomain, which results in gene silencing (Figure 2.6).  It is thought that the 
function of the chromatin binding is to passively stabilize a dense conformation of the 
chromatin fiber associated with gene repression.18  The binding affinities have been 
reported to be in the micromolar range for both H3 K9Me3 and H3 K9Me2, ranging from 
2.5 to 10 µM for K9Me3 and from 7 to 15 µM for K9Me2, while there was no observable 
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binding for the corresponding unmethylated peptide.14,17  The chromodomain adopts an 
incomplete β-barrrel secondary structure, with the methyllysine binding pocket 
positioned at one end.  The aromatic binding cage is made up of three aromatic residues, 
two tyrosines and a tryptophan, to form a conserved aromatic pocket into which the 
methylammonium group inserts itself.  Mutation of any of these aromatic residues 
drastically reduces affinity for the methylated histone tail.  Furthermore, residues 5-10 of 
the histone tail (QTARK9S) interact with the chromodomain by an induced-fit 
sandwiching between terminal β-strands, completing a five-stranded antiparallel β-sheet.  
Mutation studies of residues in both the peptide and protein have confirmed the 
contribution of intermolecular contacts along the extended surface groove to both binding 
affinity and selectivity.19   
 
Figure 2.6.  Crystal Structure of the HP1 chromodomain (yellow surface) in complex 
with Lys9Me3 H3 tail residues 5 through 10 (gray stick). 
 
To discuss all of the remaining lysine methyl binding domains would be exhaustive 
and beyond the scope of this thesis, however there are two general classes of protein folds 
that bind methyllysine with aromatic cages, sharing several molecular recognition 
features: members of the Royal superfamily of folds (chromodomains, Tudor domains, 
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MBT domains, and others) and PHD fingers.  While some proteins, such as the HP1 
chromodomain or the Polycomb (PC) protein, contain a chromodomain that allows them 
to specifically recognize the appropriate repressive methylation mark (H3 K9 and H3 
K27 respectively), others such as the chromodomain helicase DNA-binding protein 1 
(CHD1) uses its chromodomain to bind the activating methylated H3 K4.20  Therefore, 
the ultimate function of the methylated lysine PTM is a reflection of the type of effector 
protein it has evolved to interact with in a highly specific manner, either an activator or a 
repressor of transcription. 
 While much attention has been focused on the methylation of lysines, arginine 
methylation has similarly been identified as a key player in the regulation of cellular 
processes.21  While knowledge of methylarginine effector proteins is presently limited, as 
no structure of a reader bound to this PTM is available, there is much evidence for 
methylated arginine acting as a mediator of protein-protein interactions.22  Similarly to 
methylated lysine, it is expected that the recognition of methylated arginine may often 
depend on its interaction with aromatic rings.  There is much precedence for the stacking 
of arginine with aromatic residues, as cation-π interactions are generally observed 
between the guanidine sidechain and tyrosine, tryptophan, and phenylalanine.23  
Arginine’s ability to stack with aromatic residues, even more so than lysine, is due to it’s 
ability to interact via a combination of cation-π and π-π stacking interactions, lending 
itself to both favorable dispersion and electrostatic forces without a significant 
desolvation penalty.  Methylation of arginine therefore is expected to magnify this Arg-π 
interaction, with a further increase in hydrophobicity.  Prior work in the Waters lab has 
investigated the interaction between tryptophan and aRMe2 and sRMe2 in the context of 
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a β-hairpin peptide, showing that methylation of arginine significantly enhances peptide 
stability while maintaining the stacked geometry.24  This suggests that this enhanced 
interaction may be a key driving force in the mediation of protein-protein interactions.  
 There is substantial evidence that the SMN Tudor domain, which is linked to spinal 
muscular atrophy, recognizes the arginine-glycine rich C-terminal tails of spliceosomal 
Sm proteins, and that this binding is mediated by symmetrical dimethylation of arginine 
side chains.25  It is proposed that this interaction is facilitated by positioning the 
symmetrical dimethylarginine side chain near a cluster of conserved aromatic residues, 
forming a typical cage-like mode of recognition.  Although knowledge of methylarginine 
effector proteins is limited, some arginine residues have been identified that influence 
other PTMs and other PTM-protein interactions.  The methylation of histone 4 Arg3 has 
been seen to facilitate histone 4 acetylation, enhancing the activation of transcription by 
nuclear hormone receptors.26  Reports have also suggested that asymmetric dimethylation 
of arginine at histone 3 Arg2 antagonizes methylation at Lys4, likely due to the fact that 
an unmodified H3Arg2 is essential for binding of the lysine methyltransferase, and 
effective binding of the methyltransferase is required for H3 Lys4 methylation.27  It is 
clear that like other PTMs, methylated arginine residues also participate in a form of 
crosstalk with other modifications, determining the final outcome of recognition events 
and in turn regulating the complicated cascade controlling gene transcription. 
 iv.  Current methods for identifying post-translational modifications.  Although 
much progress has been made, efforts to map out histone modifications, as well as study 
their functional interplay and subsequent biological outcomes has to some degree been 
limited by the analytical techniques available to do so.  First, antibodies have been used 
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in a variety of analyses, particularly Western blots, which have evolved as a widespread 
and easy method of analyzing protein modifications.  Although they can easily be used 
on large mixtures of proteins, antibody-based analyses are met with their own set of 
caveats.  Due to the sequence specificity of antibodies, antibody-based analyses rely on 
prior knowledge of the type and position of specific protein modifications, as well as the 
availability of high-quality antibodies.28  This clearly prevents the use of antibodies in the 
discovery of novel sites of modification.  Furthermore, issues of antibody production, 
unwanted cross-reactivity, epitope occlusion, and the inability to detect patterns of 
modifications to investigate the histone code also plague such antibody-based analyses.29     
 Mass spectrometry has become a versatile and indispensable tool in proteomics, 
allowing for determination of the mass-to-charge ratio of protein ions, while tandem MS 
(MS/MS) enables smaller peptides to be sequenced and PTMs to be identified and 
characterized.  Some of the challenges associated with MS based analyses include the 
mass degeneracy of specific modifications, the low occupancy at many sites (for 
example, the presence of only 5% of modified protein may suffice to activate a signaling 
pathway), the reversibility of some modifications, and the difficulty of purification and 
sample preparation.30  Despite these limitations, many histone PTMs have been identified 
by mass spectrometry, and new details of the histone code are continually being reported 
due to the effectiveness of MS analysis.31 
 Most common is a “bottom-up” type of MS analysis which involves the digestion of 
histone proteins into short peptides, enabling sequencing analysis and characterization of 
the individual fragments (Figure 2.7b).  While this method allows for determination of 
the exact location of the PTM, it becomes difficult to determine which peptides 
 33 
originated from the same molecule in a complex mixture, and information about 
interdependence of modifications is lost.32  In contrast, “top-down” analysis allows for 
the identification of the number of modifications with an intact protein, without providing 
information on the location of such modifications (Figure 2.7a).  Several more recent 
techniques such as electron capture dissociation have proved particularly useful, 
especially in the context of histone PTMs, allowing for the sequencing of intact 
proteins.33  Kelleher and coworkers, among others, have used this technique quite 
successfully in the characterization of histone PTMs on all four core human histones.34 
 
Figure 2.7.  a) “Top-down” and b) “bottom-up” approaches to identifying PTMs via 
mass spectrometry. 
  
 Recently, DNA aptamers have also been used to develop protein affinity reagents for 
acylated lysine PTMs, as aptamers have received much attention as possible alternatives 
to traditional antibodies.35  Aptamers are pieces of single-stranded DNA or RNA that fold 
into three-dimensional structures with binding sites that are complementary in shape and 
charge to the target antigens, and because these molecules can be produced in vitro, their 
recognition and binding properties can be tailored to specific targets of interest.  
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Although aptamers serve as a new molecular tool for the recognition of PTMs, like 
antibodies, they require a prior knowledge of the target and are sequence dependant.   
 v.  Goal of this work. The development of small molecules which mimic PTM 
effector proteins is a field which up to this point has remained largely unexplored, as 
utilizing synthetic receptors for molecular recognition often presents the challenge of 
poor selectivity.  Furthermore, synthetic modification for optimization is often quite 
difficult and labor intensive.  However, synthetic receptors have some significant 
potential advantages, including better reproducibility, lower cost, lower molecular 
weight, and the possibility of being used within cells.  Small molecule receptors are also 
much more likely to bind PTMs in a sequence independent fashion due to their size, 
unlike most known protein receptors.  The only report of a synthetic molecule that 
distinguishes between post-translational modifications was presented very recently, 
making use of the well-known ammonium ion binder p-sulfonatocalix[4]arene to 
selectively recognize trimethyllysine.36    
Given the importance of mapping out PTMs in attempt to unravel the histone code 
and better understand their pivotal responsibility in controlling gene expression, non-
sequence selective small molecule receptors have the potential to serve as novel reagents 
in the discovery of new sites of methylation within proteins.  The work described in this 
chapter uses dynamic combinatorial chemistry to provide a high-throughput method for 
the identification of small molecule receptors for methylated lysines and arginines.  
While we are not looking to achieve selectivity for a PTM solely within the context of its 
native sequence, identifying receptors which can distinguish between the different lysine 
and arginine methylation states is of great importance.  DCC allows for screening of the 
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same library against all lysine and arginine methylation states, providing a rapid approach 
to screen for selectivity for the different PTMs.  We report here the identification of 
multiple synthetic receptors selective for various methylated PTMs, one of which 
recognizes trimethyllysine with both comparable affinity and selectivity as the native 
HP1 chromodomain. 
 
B. Library design and precedence for using dynamic combinatorial chemistry for 
the recognition of ammonium cations. 
 Dynamic combinatorial chemistry is an attractive alternative to the rational design of 
synthetic receptors in that it allows molecular recognition to guide the synthesis of 
complex host systems from simple building blocks.37  These building blocks are linked 
reversibly under thermodynamic control to produce an equilibrium mixture of potential 
receptors.  In the presence of a molecular target, favorable host-guest binding interactions 
drive the synthesis and amplification of the best receptor(s) at the expense of other 
oligomers.  
 Disulfide exchange has become one of the most widely used reactions in dynamic 
combinatorial libraries, and it is particularly suited for this biological application as it 
occurs in aqueous solution at close to neutral pH.  Disulfide exchange is advantageous in 
that disulfides form readily from thiols in the presence of oxygen, it takes place under 
mildly basic conditions in the presence of a catalytic amount of thiol, it can be quenched 
under acidic conditions, and disulfides are stable toward many different functional 
groups.38  During oxidation the mixture contains both disulfides and thiols, allowing for 
equilibration through nucleophilic attack of thiolate anions on the disulfides, displacing a 
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new thiolate anion in the process (Figure 2.8).  The primary downside to disulfide 
exchange is that it occurs relatively slowly, sometimes requiring on the order of weeks 
for equilibration to be reached. 
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Figure 2.8.  Reversible disulfide exchange mediated by thiolate anions. 
 
 In choosing a set of dithiol monomers for this application, there were various 
requirements to consider.  First, the facile synthetic introduction of the thiol groups is 
required to facilitate reversible disulfide exchange.  Second, in attempt to mimic the 
recognition of methylated PTMs by aromatic cages in protein receptors, aromatic 
surfaces are needed to allow for potential cation-π and hydrophobic interactions.  Third, 
functional groups such as carboxylates are required to induce solubility in aqueous 
solutions, while carboxylates also have the potential to induce favorable electrostatic 
interactions.  Last, a mixture of structural monomers, some more curved and/or rigid and 
others more linear and/or flexible, are necessary to avoid either self-sorting or extensive 
linear oligomerzaiton of monomers. 
 Building blocks were utilized that contain structural elements of previously reported 
synthetic receptors for specific guests, equipped with appropriate thiol functionality for 
reversible covalent attachment.  The water soluble cyclophane receptor utilized by 
Dougherty and coworkers (Figure 2.9) has been demonstrated as an effective cation 
binder.39  Taking advantage of this known receptor, Sanders and coworkers have made 
use of subunits A and B, which allow for the introduction of two thiol groups on each 
with minimal effects on the overall structure of the receptor.  The cyclophane has also 
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been shown to be tolerant of minor structural variations such as the nature of the phenyl 
spacer, providing evidence that replacing the ether linkage with a disulfide would not 
necessarily destroy binding.40    
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Figure 2.9.  Design of the dithiol building blocks A and B inspired by Dougherty’s 
cyclophane receptors. 
 
 Sanders and coworkers have elegantly demonstrated the use of such dithiol 
monomers in isolation as single component libraries, or in combination, developing 
libraries of higher complexity.  In initial reports investigating the exposure of such 
libraries to cationic guest molecules, it was seen that receptors A2B and A3 were 
significantly amplified in the presence of methylisoquinoline and N-methyl morphine 
respectively (Figure 2.10).41  Methylisoquinoline showed about a four-fold selectivity for 
A2B over A3 (5 µM versus 22 µM), whereas N-methyl morphine showed a twenty-fold 
selectivity for A3 over A2B (39 µM versus 1.9 µM).  Interestingly, the structures of the 
selected receptors differ from the expected tetrameric disulfide analogue of Dougherty’s 
cyclophane receptor.  This may be due to the more flexible nature of the ether linkages as 
compared to their corresponding disulfides, while the increased length and different bond 
angles of the disulfides may cause a difference in binding.  It is also feasible that the 
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smaller binding pockets of the selected disulfide receptors provide higher affinity for the 
ammonium guests.   
 A later report demonstrated the very efficient amplification of tetrameric receptor A4 
by tetramethylammonium in a highly diasteroselective fashion, as dithiol A is synthesized 
and introduced into the library as a racemic mixture.42  Both the affinity and selectivity 
were much greater in this case, as tetramethylammonium binds A4 with a binding 
constant of 250 nm in comparison to 154 µM for A2B and 1.2 mM for A3.  The higher 
affinity is attributed to the fact that A4 can easily fold into a four-stave barrel shape, 
forming a cavity ideally sized to accommodate tetramethylammonium.  It is evident that 
there are some structural similarities between tetramethylammonium and trimethyllysine, 
and we envisioned that libraries containing similar building blocks could also be used to 
effectively develop small molecule receptors for methylated PTMs. 
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Figure 2.10.  Selective amplification and binding of three different hosts with three 
different quaternary ammonium guests. 
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 Showing an even higher degree of structural similarity to trimethyllysine, the 
biologically relevant template acetylcholine has been more recently investigated in a 
study using a large series of different but structurally related cationic templates.43  In this 
case acetylcholine was seen to bind the corresponding receptors with more modest 
affinity and selectivity (Figure 2.11), nonetheless we saw this as further evidence that 
dynamic combinatorial chemistry would serve as an effective method to identify PTM 
receptors.   
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Figure 2.11. Macryocyclic receptors A2B and A3 amplified by acetylcholine. 
 
 In addition to dithiol monomers A, B, and C, we designed and synthesized a range of 
building blocks to investigate, all containing the basic features of aromatic groups, 
carboxylates, and thiols (Figure 2.12).  Monomer H is the only exception, which we 
envisioned as a possible linker for any macrocycles that would not otherwise be able to 
cyclize.  The size of the aromatic surface was varied in different monomers, along with 
the position of and distance between the two thiols, and the position of the carboxylic 
acid.  Variation of the monomers in a fairly systematic manner allows for optimization of 
 40 
both binding affinity and selectivity, and this is arguably the most notable advantage to 
developing receptors in this fashion, as such a systematic study using traditional 
macrocyclic receptors may present various synthetic challenges.  Generally three to four 
monomers were combined in a single library, with the size of the libraries largely limited 
by the analytical analysis.  The majority of the following discussion is focused on those 
libraries in which the equilibrium was significantly perturbed in the presence of post-
translational modifications due to the recognition of the PTMs by specific receptors. 
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Figure 2.12.  Monomers used in DCLs. 
 
C. Selective recognition of trimethyllysine: receptors rac-A2B and meso-A2B 
 i. Results and discussion 
  a. Design and synthesis of guests and monomers.  Based on the successful use 
of monomers A-C in the recognition of ammonium cations previously, a library that we 
sought to investigate early on was that containing those same three monomers.  
Monomers A, B, and C were synthesized as shown in Schemes 2.1, 2.2, and 2.3 
respectively, according to literature procedures, with slight modifications in the case of 
monomer C.43,44 
 41 
O
O
OH
HO
NaBH4
aq Na2CO3
OH
HO
O
O
N S
NS
DABCO,
DMF, 0°C!RT
S
Cl N
diphenyl ether,
230°C
S
S
N O
NO
SH
HS
O
O
HO
OH
S
S
O
O
O
O
N
O
O
N
CO2MeMeO2C
diphenyl ether,
190°C
1) KOH (in diethylene 
glycol), 125°C
2) 10% HCl, H2O
1 2
5 4
3
A  
Scheme 2.1.  Synthesis of monomer A. 
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Scheme 2.2.  Synthesis of monomer B. 
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Scheme 2.3.  Synthesis of monomer C. 
 
 Monomer A was synthesized as a racemic mixture, where the key step is a Diels-
Alder reaction between the protected precursor 4 and dimethylacetylenedicarboxylate.  
For the majority of the dithiol monomers, including A and B, starting from aromatic 
alcohols, the thiol groups are introduced through a Newman-Kwart rearrangement on the 
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O-thiocarbamate intermediates (3 and 7).  Monomer C is prepared uniquely through a 
radical bromination followed by introduction of the thiol functionality with thiourea. 
 Dipeptides were designed as PTM templates for initial library screens (Figure 2.13), 
each of which contained a C-terminal glycine and a post-translational modification on the 
N-terminus (Ac-PTM-Gly-NH2).  The peptides were also acylated on the N-terminus to 
avoid any potential non-specific interactions with the free amine.  The peptides were 
synthesized by Fmoc solid phase peptide synthesis, with the LysMe3 guest easily 
obtained via alkylation of LysMe2 with methyl iodide.45  Each peptide was characterized 
by electrospray mass spectrometry.    
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Figure 2.13.  Methylated and unmethylated lysine and arginine dipeptide guests. 
 
  b. Unbiased library templation studies.  Dynamic combinatorial libraries were 
prepared by mixing equimolar amounts of monomers A-C (2.5 mM each) in basic 
solution.  The building blocks were dispersed in water and the pH was adjusted to 8.5 
with NaOH and HCl.  Eight DCLs contained a PTM template at a concentration of 7.5 
mM, while no template was added to the ninth DCL.  The libraries were allowed to 
oxidize in capped HPLC vials at room temperature for about three weeks.  All libraries 
 43 
remained completely soluble with no visible precipitation, which is essential.  The library 
compositions were analyzed by LC-MS at various time points, and all library members 
could be easily identified by negative electrospray ionization.  In some cases, the mass 
degeneracy of multiple macrocycles prevented the complete characterization of all 
species without further MS/MS analysis (for example, A2BC and B6 have identical 
masses).  Upon equilibration the chromatograms were integrated, and in each case the 
peak areas were represented as a percentage of the total chromatogram area.  This aided 
in taking into account slight baseline differences from chromatogram to chromatogram.   
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Figure 2.14.  Dynamic combinatorial library of dithiol monomers resulting in 
amplification of receptors rac-A2B and meso-A2B upon addition of a KMe3 guest. 
 
 In the absence of a guest, two major constituents were present, BC and ABC, as well 
as numerous smaller peaks corresponding to other macrocyclic library members.  
However, the introduction of a trimethyllysine dipeptide resulted in a significant and 
promising shift in the library composition in comparison to the untemplated reaction 
(Figure 2.15).  The amplification of two peaks in the KMe3 templated library were 
clearly observed, both corresponding to the trimeric macrocycles rac- and meso-A2B 
(Figure 2.14).  The two isomers were found to exist in a ratio of about 5.5:1 in the 
untemplated library, with rac-A2B as the larger of the two peaks.  The identification of 
rac-A2B as the dominant isomer in an untemplated library was previously described by 
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Sanders and coworkers with the use of a chiral shift reagent to give separate NMR signals 
for the two enantiomers of the racemate without changing the signals for the meso 
isomer, and confirmed in our case by 1H NMR upon isolation of the macrocycles.43 
 
Figure 2.15.  Part of the analytical HPLC trace at 254 nm of a DCL consisting of 
monomers A, B, and C (2.5 mM each), untemplated (blue) and in the presence of Ac-
KMe3-G-NH2 (red). 
 
 Due to our interest in not only identifying a macrocycle that amplifies 
trimethyllysine, but one that is selective as well, the amplification of A2B in the presence 
of lower lysine methylation states was also examined.  It was found that the amplification 
of both A2B diastereomers was dependent on the extent of methylation, with 
amplification increasing with increasing methylation, suggesting significant selectivity 
for higher methylation states (Figure 2.16).  This trend mimics that of the HP1 
chromodomain’s affinity for methylated histone tails, displaying the greatest affinity for 
the trimethylated peptide tail.   
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Figure 2.16.  Analytical HPLC traces at 254 nm of DCLs consisting of monomers A, B, 
and C (2.5 mM each), untemplated (gold) and in the presence methylated lysine 
dipeptides (pink = Lys, green = LysMe, red = LysMe2, blue = LysMe3).  Rac-A2B is 
marked by a grey circle in each, and meso-A2B by a grey star. 
 
 The libraries templated with methylated arginine dipeptides were also investigated to 
determine whether these PTMs were recognized by the same receptors as the methylated 
lysines, or whether the structural differences between the two methylated amino acids are 
significant enough to result in either no amplification or the amplification of different 
receptors.   The chromatograms of the arginine templated libraries revealed amplification 
of both rac- and meso-A2B receptors, however the extent of amplification is modest in 
comparison to that of LysMe3 (Figure 2.17).  Although it is somewhat surprising that the 
same macrocycles are amplified, it seems logical that the three methyl groups on lysine 
would result in a greater number of contacts with the receptor and hence produce greater 
amplification than that of its dimethylated arginine counterparts.   
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Figure 2.17.  Analytical HPLC traces at 254 nm of DCLs consisting of monomers A, B, 
and C (2.5 mM each), untemplated (gold) and in the presence methylated arginine 
dipeptides (pink = Arg, green = ArgMe, red = symmetric ArgMe2, blue = asymmetric 
ArgMe2).  Rac-A2B is marked by a grey circle in each, and meso-A2B by a grey star. 
 
 The library chromatograms were integrated after a month of equilibration, and the 
percent area of each A2B peak was calculated by dividing the raw peak area by the total 
area of the chromatogram, not including the area of the peptide guest peak in the case of 
the templated reactions.  It can be noticed that there is a significant amount of broadening 
in the A2B peaks, and the area of meso-A2B in the untemplated reaction is quite small 
making an extremely accurate integration difficult.  In that regard it must be noted that 
the integration values are used to represent an overall trend as opposed to an absolute 
comparison of binding affinity.  The percent change in each peak area upon amplification 
can be determined with the following equation, as is shown for each case in Figure 2.18. 
% change = [(% area templated - % area untemplated) / % area untemplated] × 100 
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Figure 2.18.  Amplification results of an ABC library templated with all lysine and 
arginine methylation states, represented as a percent change in amplification.  The 
amplification of rac-A2B is shown in red, and that of meso-A2B is shown in orange. 
 
 There are likely several factors that result in the observed selectivity of both A2B 
diastereomers for LysMe3 over lower lysine and arginine methylation states.  First, the 
binding pocket may be too large for the lower methylation states, while the increased 
hydrophobicity and van der Waals interactions of the higher methylation states is more 
amenable to binding an aromatic pocket.  In addition, all other Lys and Arg PTMs can 
form hydrogen bonds with water, and binding to the pocket may therefore require some 
degree of desolvation, which would be unfavorable.  Model systems have also shown that 
cation-π interactions are enhanced with increasing methylation of the ammonium 
group.46  Thus, KMe3 is expected to have a stronger cation-π interaction with A2B than 
the lower methylation states.   
 In looking more specifically at the amplification with methylated arginine guests it 
appears that having two methyl groups in close proximity in the case of asymmetric 
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dimethyl arginine is more favorable than when the two methyl groups are on different 
nitrogens in the case of symmetric dimethyl arginine.  However, symmetric dimethyl 
arginine still shows increased amplification in comparison to its monomethylated 
counterpart indicating that both methyl groups still play a role in binding to A2B.   
  c. Biased library templation studies.  Focusing on the more promising 
recognition of trimethyl lysine, an additional DCL was set up biased towards the 
formation of A2B in which building blocks A and B were mixed in a 2:1 ratio (7.5 mM 
total) and the selectivity of the diastereomeric receptors for the different methylation 
states of lysine was investigated.  By biasing the library towards the formation of A2B, 
these receptors are formed in a much higher concentration than in the unbiased case.  
This not only allows for a better visualization of the amplification, but also a more 
accurate integration of the peak areas.   
 A diverse library was generated in the absence of a template, with A2 and A2B3 as the 
dominant species, and rac-A2B and meso-A2B constituting only 2.4% and 1.1% of the 
total library composition respectively.  Upon templation with LysMe3, both rac-A2B and 
meso-A2B clearly become the largest species in the library.  As expected, the 
amplification of both diastereomers was dependant on the extent of methylation, 
suggesting a significant selectivity for the different methylation states, however little 
diastereoselectivity was observed (Figure 2.19). 
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Figure 2.19.  Part of the analytical HPLC trace at 254 nm of a biased DCL consisting of 
monomers A (5 mM) and B (2.5 mM), untemplated (blue) and in the presence of all 
lysine methylation states, Ac-KMex-G-NH2. 
 
 The amplification was quantified in this case by determining the amplification factor 
for both A2B receptors.  Amplification factors are defined as the concentration of a 
library member in a templated library divided by its concentration in the corresponding 
untemplated library, and can be calculated by dividing the percent areas of the HPLC 
peaks corresponding to a specific compound in the templated and untemplated libraries.  
It must be noted that when no amplification is observed, this results in an amplification 
factor of 1, not 0.  Despite some minor differences, it is evident that the amplification in 
this biased library follows a similar trend as that of the DCL not biased towards the 
desired receptor, showing significant selectivity for trimethyllysine over its dimethylated 
counterpart (Figure 2.20).  While the concentration of both A2B receptors less than 
doubles in the presence of unmethylated lysine, it increases by about 1000 percent when 
templated with LysMe3.  These results provided substantial evidence that rac-A2B and 
meso-A2B were worth pursuing as small molecule receptors for trimethyllysine.   
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Figure 2.20.  Extent of amplification of rac-A2B and meso-A2B with Ac-KMex-G-NH2 
guests relative to the untemplated library. The amplification of rac-A2B is shown in light 
blue, and that of meso-A2B is shown in dark blue. 
 
  d. Investigation of a histone 3 K9Me3 peptide template.  To ensure that these 
amplification results were maintained in the context of naturally methylated histone tail 
peptides, the 8-residue peptides in Figure 2.21 were synthesized.  Similar to the 
dipeptides, they were synthesized by Fmoc solid phase peptide synthesis, with the 
LysMe3 peptide obtained via alkylation of LysMe2.  The sequence contains residues five 
through twelve of the histone 3 tail, with a lysine at position 9 and an arginine at position 
8, both of which can be methylated in nature.  Successful amplification of rac-A2B and 
meso-A2B with these longer peptide guests is important to show that binding to the PTM 
does not occur only in the context of the isolated PTM, and that surrounding residues do 
not interfere with binding.   
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Figure 2.21.  Histone tail peptide guests containing residues 5-12 from the native histone 
3 sequence, and either KMe3 at lysine 9 or RMe2 at arginine 8. 
 
 Biased libraries were set up as described previously, monitored by LC/MS, and rac-
A2B and meso-A2B amplification was quantified (Figure 2.22).  It must be noted that over 
extended periods of time, a small amount of decomposition of these peptides guests was 
sometimes observed under these basic conditions.  Our analysis was performed before 
this became a problem, yet after equilibration had been reached.  Significant 
amplification of both diastereomeric receptors by H3 K9Me3 was observed, with 
amplification factors of about 9 for each, close to that of the KMe3 dipeptide.  This 
confirms that A2B binding is still possible in the context of a histone tail peptide, greatly 
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increasing the significance of this work, as many possible applications for such histone 
tail binding small molecule receptors can be envisioned.  In contrast, amplification in the 
presence of either H3 R8Me2 peptide is minimal, confirming that the previously 
observed selectivity is maintained.  Furthermore, this confirms that A2B does not interact 
significantly with the residues surrounding the PTM to enhance binding beyond what 
would be expected for the PTM residue alone (for example, it could be predicted that 
favorable electrostatic interactions would form between the carboxylates on A2B and the 
adjacent basic lysine residue).   
 
Figure 2.22.  Extent of amplification of rac-A2B and meso-A2B with methylated histone 
tail guests relative to the untemplated library. The amplification of rac-A2B is shown in 
light blue, and that of meso-A2B is shown in dark blue. 
 
  e. Preparative scale biased libraries and isolation of rac-A2B and meso-A2B.  
To pursue further investigation of rac-A2B and meso-A2B as potential trimethyllysine 
small molecule receptors, preparation and isolation of these molecules was required.  
While preparation of the A2B diastereomers by traditional synthetic methods would prove 
daunting, DCC allows for the facile synthesis of these isomers in a fairly straightforward 
manner.  Large scale biased libraries were prepared with a total volume of 10-20 mL and 
a ratio of A : B : guest of 2 : 1 : 3, with a total monomer concentration (A + B) of either 
7.5 or 10 mM.  Due to the known high affinity of A2B for methylisoquinoline (Kd = 5 
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µM) and our ability to prepare it cheaply on a much larger scale than a KMe3 peptide, 
most of these libraries were templated with methylisoquinoline to achieve the highest 
A2B concentration possible.  The successful amplification of both A2B diastereomers by 
methylisoquinoline to a greater extent than LysMe3 was also confirmed on an analytical 
scale.   
 The three solids were combined with the appropriate amount of water, titrated to pH 
8.5 with NaOH and HCl, and let stir in a capped scintillation vial for 1-3 weeks before 
being purified on a semi-preparative HPLC.  While separation of the two isomers was 
easily feasible on an analytical HPLC, co-elution was much more problematic on a semi-
preparative system, and separation of the diastereomers was largely facilitated by the use 
of a column heater.  While the dominant rac-A2B diastereomer was easily purified, a 
second and sometimes third purification was often required to achieve pure meso-A2B.  
The purity of both receptors was confirmed in each case by analytical LC/MS due to their 
different retention times, as both receptors are indistinguishable by mass.  While the 
receptor synthesis is not very laborious upon successful synthesis of the monomer 
building blocks, only milligram quantities (generally < 5 mg) are obtained after 
purification in each case.   
  f. NMR analysis of trimethyllysine binding to rac-A2B.  To confirm that the 
binding event is indeed occurring at the site of modification, we chose to investigate the 
trimethyllysine dipeptide NMR spectra in the absence and presence of rac-A2B.  If rac-
A2B is indeed binding the PTM, an upfield shift of the lysine methyl groups would be 
expected as a result of being buried in the aromatic pocket of the receptor.  The dipeptide 
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1H NMR spectra appeared as expected, and the chemical shifts of the lysine side chain 
protons were confirmed by a TOSCY experiment. 
 Upon introduction of a slight excess of rac-A2B to ensure the majority of the 
trimethyllysine is in the bound state, significant broadening of all peptide proton signals 
was observed, indicating a change in the peptide’s environment.  Furthermore, the methyl 
groups were upfield shifted by 0.826 ppm, indicating that the binding event is indeed 
occurring at the site of modification. When the same experiment was performed at 5°C 
instead of room temperature, a slightly greater upfield shift of 0.976 ppm was observed 
for the methyl groups.  No NMR studies were performed with meso-A2B because of 
limited availability of the compound, largely due to significant co-elution with rac-A2B 
during purification, however a similar upfield shift of the lysine methyl group would be 
expected when bound to meso-A2B.  Overall, these findings confirm that the key binding 
interaction is between the trimethylammonium group and the aromatic pocket, as in the 
histone-chromodomain protein-protein interaction.   
  g. Binding studies by fluorescence anisotropy.  Fluorescence anisotropy was 
used to measure the dissociation constant of rac-A2B and meso-A2B to each methylated 
lysine PTM to determine both an absolute binding affinity and the extent of selectivity 
between the different methylation states.  Histone tail peptides were synthesized similar 
to those used for prior amplification studies, containing residues 5-12 of the histone 3 
protein, and each methylation state at Lys9.  The peptides were appended with an N-
terminal carboxyfluorescein (FAM) for fluorescence detection (Figure 2.23).  The 
binding studies were done at slightly basic pH to ensure complete solubility of A2B, as 
well as to maintain full fluorescein fluorescence, as it is significantly reduced below pH 
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7.47  Fluorescein was chosen as the fluorophore over TAMRA 
(carboxytetramethylrhodamine) in order to minimize any possible binding interactions 
between A2B and the fluorophore, as TAMRA contains two dimethylamine groups 
appended to the ring system in place of the ketone and hydroxy functionalities of 
fluorescein.   
 
Figure 2.23.  Fluorescently labeled histone 3 tail peptides for anisotropy experiments, 
containing and N-terminal fluorescein and a PTM and Lys9 (x = 0, 1, 2, 3). 
 
 In each experiment, while the amount of fluorescent peptide remains constant, the 
concentration of unlabeled receptor concurrently increases.  When the fluorophore is 
excited by polarized light, the loss of polarization in the emitted light can be correlated 
with the mobility of the fluorophore.  Binding of A2B to the PTM-containing peptide 
increases the effective molecular weight of the fluorescent peptide, decreasing the 
effective fluorophore mobility, and therefore increasing the fluorescence anisotropy.  The 
ratio of parallel and perpendicular polarized light emitted upon binding is used to 
determine the anisotropy value, which can in turn be correlated to binding affinity.48   
The anisotropy value is determined based on the equation below, where III and I⊥ are 
fluorescence intensities observed when the emission polarizer is oriented parallel and 
perpendicular to the direction of the polarized excitation, respectively. 
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 The H3 K9Me3 peptide was found to bind both rac- and meso-A2B with binding 
affinities of about 25-30 µM, which is virtually equivalent to the binding affinity of the 
HP1 chromodomain protein receptor (Table 2.1).14,17,19  This comparable affinity to the 
chromodomain is quite promising yet somewhat surprising, as A2B is significantly 
smaller in size than the protein receptor, and as a result does not form additional 
interactions with the adjacent residues of the histone tail.  Moreover, upon investigating 
the binding affinity to the lower lysine methylation states it was determined that H3 
K9Me3 binds to both rac- and meso-A2B with greater than 2-fold selectivity over its 
dimethylated counterpart, exhibiting slightly better selectivity than the native protein.  
While rac-A2B bound H3 K9Me2 with a dissociation constant of 58 µM, meso-A2B 
bound with a similar affinity of 73 µM.  The mono- and umethylated peptides exhibited 
considerably weaker affinity for rac-A2B, with no appreciable binding for the 
unmethylated histone tail.  The binding affinity of the mono- and umethylated peptides to 
meso-A2B was not measured due to a limited amount of meso-A2B, although binding is 
expected to be weak and comparable to that of rac-A2B.  Overall, it is evident that the 
trend in both affinity and selectivity of A2B parallels that of the native protein receptor.   
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Table 2.1.  Dissociation constants for H3 tail peptides with varying methylation states at 
K9 determined by fluorescence anisotropy.a 
 
Peptide 
rac-A2B 
Kd (µM)b 
meso-A2B 
Kd (µM)b 
HP1 chromodomain 
Kd (µM) 
H3 K9Me3 25 ± 3 28 ± 4 10d (21 ± 2 at 25°C)e 
H3 K9Me2 58 ± 10 73 ± 9 15d (39 ± 7 at 25°C)e 
H3 K9Me 166 ± 50 N.A.c 96e 
H3 K9 > 1200 N.A.c > 1000e 
H3 K9Me3 R8G 34 ± 8 N.A.c -- 
 
a Conditions: 27 °C, 10 mM phosphate buffer, pH 8.5.  b Errors are from the fit.  c Not 
available due to limited material (meso-A2B), although binding is expected to be 
comparable to that of rac-A2B.  d Values are taken from Hughes, R. M.; Wiggins, K. R.; 
Khorasanizadeh, S.; Waters, M. L. Proc. Nat. Acad. Sci. USA 2007, 104, 11184-11188; 
Conditions: 15°C in pH 7.5 phosphate buffer.  e Conditions: 25°C in 50 mM potassium 
phosphate buffer, pH 8.0, 25 mM NaCl (Eisert and Waters, unpublished results). 
 
 To confirm that the adjacent basic arginine residue does not contribute significantly to 
binding, a mutant H3 K9Me3 peptide tail with glycine in place of Arg8 was synthesized.  
Fluorescence anisotropy experiments revealed that rac-A2B bound the R8G mutant with 
a dissociation constant of 34 µM, which is comparable to that of the native sequence, 
indicating that Arg8 is not required for binding.  This helps to confirm that A2B binding 
to KMe3 is independent of the sequence surrounding the methylated residue.  
Furthermore, a H3 peptide tail was synthesized where the Arg8 remained intact, however 
the Lys9 was mutated to glycine.  As expected, this mutation resulted in total loss of 
binding to rac-A2B, reinforcing that the methylated lysine is required for binding.   
 To fully evaluate the selectivity of A2B for trimethyllysine over other post-
translational modifications, fluorescent H3 peptide tails were synthesized with 
methylated arginine residues at position 8 and unmethylated lysine at position 9.  Three 
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peptides were synthesized, with aRMe2, sRMe2, or RMe in place of R8, and the binding 
of each to rac-A2B was similarly evaluated by fluorescence anisotropy (Table 2.2).  In 
each case, binding was determined to be much weaker than that of the methylated lysine 
peptides, further establishing the selectivity of A2B for trimethyllysine.  While both 
aRMe2 and sRMe2 bind with similar weak affinities of about 600 µM and 750 µM 
respectively, binding to RMe is substantially weaker, comparable to that of the fully 
unmethylated peptide.  The binding affinities for meso-A2B were not demonstrated, but 
they are expected to be weak as well.  It is clear that in this case, recognition of the 
methylated guanidinium moiety of arginine is significantly different than that of the 
methylated ammonium group of lysine and that based on these fluorescence anisotropy 
binding studies, A2B shows promise as a selective receptor for trimethyllysine with 
affinity paralleling that of the native protein receptor.   
 
Table 2.2.  Dissociation constants for H3 tail peptides with varying methylation states at 
R8 determined by fluorescence anisotropy.a 
 
Peptide rac-A2B Kd (µM)b 
H3 asymmetric R8Me2 601 ± 234 
H3 symmetric R8Me2 754 ± 194 
H3 R8Me > 1700 
 
a Conditions: 27 °C, 10 mM phosphate buffer, pH 8.5.  b Errors are from the fit.   
 
  h. Binding studies by isothermal titration calorimetry.  To supplement the 
fluorescence anisotropy binding data, isothermal titration calorimetry (ITC) was used to 
confirm the binding affinity of rac-A2B and meso-A2B to trimethyllysine.  Similar results 
from these two quite different methods of analysis not only serves to confirm our prior 
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results, but also allows for a more direct comparison to the binding affinities reported 
previously by Sanders and coworkers, as they used ITC to evaluate binding.  In each 
experiment, a H3 K9Me3 peptide is titrated into a solution of either rac-A2B or meso-
A2B in precisely known aliquots, causing heat to be evolved upon binding.  Direct 
measurement of this heat release with each injection is monitored over time, and 
determined by the input of power required to maintain equal temperatures between the 
sample and reference cell.  As successive amounts of the KMe3 peptide are titrated into 
the cell, the quantity of heat released is in direct proportion to the extent of binding.  As 
A2B becomes saturated, the heat signal diminishes until only heats of dilution are 
observed.  A binding curve is then obtained by plotting the heats from each injection 
against the molar ratio of KMe3 and A2B in the cell.   
 New histone 3 peptides were synthesized, containing residues 5-12 from the histone 
tail as well as an N-terminal tryptophan for concentration determination (Figure 2.24).  
The tryptophan was separated from the histone sequence by three glycine spacers to 
prevent any possible interactions between the Trp and either KMe3 or A2B.  This peptide 
also contained Gly8 as opposed to Arg8 as found in the native sequence, although this 
mutation has been shown to have minimal affect on the overall binding affinity.  ITC 
binding curves from the titration of Ac-WGGGQTAGKMe3STG-NH2 into rac- and 
meso-A2B gave dissociation constants of 20 and 13 µM, respectively, confirming that 
these binding events occur with low micromolar affinity and that the two methods of 
analysis are comparable.   
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Figure 2.24.  Histone 3 peptide (Ac-WGGGQTAGKMe3STG-NH2) used as the titrant in 
ITC experiments to confirm A2B binding to KMe3. 
 
  i. Structure-function studies.  DCC experiments provide an ideal system for 
studying the fundamental aspects of molecular recognition, allowing for the systematic 
variation of both the guest and host molecules.  We have shown that varying the 
methylation state of Lys and Arg guests influences the extent of both amplification and 
binding, gaining insight into the features required for the selective recognition of these 
PTMs.  It is also feasible to evaluate how variations in the receptor influence binding and 
selectivity, either positively or negatively, through simple systematic variations of the 
individual monomers.  For example, either the position or spacing of the thiols or the 
position of the carboxylate relative to the thiols in monomer B can be varied to see how 
these changes influence the amplification of PTM peptides (Figure 2.25).   
HS SH
B'
O OHS SH
B
OO
SH
F
OO
SH
vary position 
of carobxylate
vary position 
of thiols
 
Figure 2.25.  Possible variations of monomer B. 
 
 Monomer B’ was first investigated, where the thiols are placed in the 2- and 6-
positions of the ring relative to the carboxylate.  Although monomer B is somewhat free 
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to rotate about the disulfide bonds within the A2B macrocycle, it is feasible that moving 
the position of the carboxylate may influence binding.  If the carboxylate was previously 
on the outer face of the receptor and is moved towards the interior of the binding cavity, 
it is possible that it could facilitate additional favorable electrostatic interactions with 
positively charged methylated lysine guests.  In contrast, there may not be room for the 
carboxylate in the interior of the cavity, preventing such an interaction, or even getting in 
the way of binding.  By screening monomer B’ in a biased library against all of the 
methylated lysine guests, we can gain insight into how this subtle variation influences 
binding. 
 Monomer B’ was synthesized similarly to B, however deprotection of the methyl 
ester was performed first with TMS-I to give 15,49 followed by installation of the thiols 
with KOH (Scheme 2.4).  Initial attempts to simultaneously deprotect both protecting 
groups resulted in incomplete conversion of the methyl ester to the carboxylic acid, so 
this was circumvented with a two-step deprotection.   
HO OH
S
Cl N
+
DABCO
DMF
O O N
S
N
S
S S N
O
N
O
1) KOH (in diethylene 
glycol), 125°C
2) 10% HCl, H2O
HS SH
CO2Me CO2Me CO2Me
CO2H
S S N
O
N
O
CO2H
TMS-I
diphenyl ether
230°C
12 13 14
15B'  
Scheme 2.4.  Synthesis of building block B’. 
 
 Biased analytical DCLs were setup as described previously by mixing building blocks 
A and B’ in a 2:1 ratio (7.5 mM total), and the selectivity of the receptors for different 
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methylation states of lysine and arginine was investigated using dipeptide guests.  Upon 
equilibration, the libraries were analyzed, and the extent of amplification was evaluated 
by LC/MS.  Surprisingly, in the untemplated library only one peak was found 
corresponding to the mass of A2B’, either rac-A2B’ or meso-A2B’, and it was present in a 
substantially higher concentration than either of the A2B isomers in untemplated DCLs, 
indicating a higher thermodynamic stability of A2B’ in comparison to A2B.  This was a 
clear indication that monomers B and B’ do not behave identically in the context of these 
libraries.  Overall, the amplification of two different receptors was observed, A2B’ and 
AB’3, and interestingly, a similar degree of amplification was seen for all lysine 
methylation states as well as for unmethylated lysine (Figure 2.26).  The comparable 
recognition of Lys and LysMe3 by A2B’ and AB’3 indicate that the increased 
hydrophobicity of LysMe3, its ability to form stronger cation-π interactions, and its 
dispersion of positive charge over a great surface area are no longer the dominant 
interactions dictating binding specificity.  Instead, the lack of selectivity observed may be 
the result of additional electrostatic and/or hydrogen bonding interactions with each 
lysine guest due to the position of the carboxylic acid in B’ as compared to B.  In contrast 
to the lysine PTMs, only minimal amplification of A2B’ and AB’3 was observed in the 
presence of monomethylated and asymmetric dimethylated arginine guests. 
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Figure 2.26.  Part of the analytical HPLC trace at 254 nm of a biased DCL consisting of 
monomers A (5 mM) and B’ (2.5 mM), untemplated and in the presence of all lysine 
methylation states (top) and arginine methylation states (bottom). 
 
An AB’3 biased library was also prepared (7.5 mM monomer total) in attempt to 
potentially enhance the amplification of this receptor over A2B’; however it was 
discovered that this ratio of monomers formed to a library dominated by macrocycles 
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containing only B’, forming up to a B’ octamer.  Under these conditions only minimal 
amplification was observed in the presence of KMe3 as seen in Figure 2.27, and this 
clearly demonstrates the drastic influence that the ratio of monomers has on the library 
composition and thus on the extent of amplification observed.   
 
Figure 2.27.  The analytical HPLC trace at 254 nm of an AB’3 biased DCL consisting of 
monomers A (1.9 mM) and B’ (5.9 mM), untemplated (blue) and in the presence LysMe3 
(red). 
 
Due to the fact that the equilibrium of all A2B’ biased libraries with lysine templates 
was shifted entirely towards two amplified macrocycles, A2B’ and AB’3 with only minor 
traces of other macrocycles, it is difficult to conclude under these conditions that 
recognition is entirely unselective.  To further pursue this observation, libraries were 
prepared at one tenth the concentration of the original libraries, (0.5 mM A, 0.25 mM B’, 
0.75 mM guest).  By lowering the monomer concentrations, we hoped to decrease both 
the concentration of A2B’ and AB’3 in the untemplated library as well as the magnitude 
of amplification, increasing the overall selectivity.  A templated library at lower 
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concentrations is also more likely to selectively amplify the better host, which would 
potentially provide insight as to whether A2B’ or AB’3 is the better receptor of the two.   
Analysis of these lower concentration libraries revealed only modest A2B’ selectivity 
for increasing lysine methylation states, with about equal amplification of KMe2 and 
KMe3 (Figure 2.28).  As expected, minimal A2B’ amplification was observed for any of 
the methylated arginine templates.  Both A2B’ and AB’3 receptors remained dominant 
species in the untemplated library resulting in a fairly small percent change in 
concentration upon amplification.  Amplification of AB’3 was not accurately assessed in 
this case, as poor chromatographic resolution did not allow for separation of AB’3 from 
AB’4.  Although it was apparent from the mass spectra of this peak that the ratio of these 
two macrocycles differed in the untemplated and templated libraries, accurate 
integrations were not feasible.  Unbiased libraries with a 1:1 ratio of A:B’ (0.25 mM 
each) were also prepared and analyzed in attempt to achieve further selectivity, however 
these libraries revealed amplification almost identical to that of the biased library.  
Although the absolute binding affinity of these new receptors has not been pursued 
further, as macrocycles which also bind unmethylated lysine are of much less value, this 
simple structure function study through the modification of one functional group on a 
single monomer provided interesting results and further insight as to the factors 
contributing to KMe3 recognition.  The difference in selectivity observed when B is 
replaced with B’ is surprising, and demonstrates that subtle structural changes can have a 
significant effect on binding.   
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Figure 2.28.  Amplification results of the lower concentration A2B’ library (0.75 mM 
total) templated with all lysine and arginine methylation states, represented as a percent 
change in peak area.  
 
 In addition to changing the position of the carboxylate, the position of the thiols can 
also be varied relative to each other and relative to the carboxylate.  We chose to 
investigate monomer F (Figure 2.25), where the thiols are placed in closer proximity on 
adjacent carbons.  A library was prepared with a 1:1:1 ratio of monomers A, F, and H 
(7.5 mM total), with the non-aromatic dithiol monomer H (Figure 2.12) included largely 
to serve as a linker to help cyclize molecules which would otherwise be too strained to 
cyclize.  In contrast to the change in selectivity observed when B is replaced with B’, 
when B is replaced with monomer F the amplification trends seem to mimic that of A2B.  
Two A2F isomers are amplified significantly in the presence of KMe3, and both isomers 
exist in very low concentrations in the untemplated library (Figure 2.29).  The 
amplification of the A2F macrocycle at 8.5 minutes is also greater than it appears, as the 
receptor co-elutes with other macrocycles in the untemplated library only, increasing the 
area of this peak.  Upon templation, these other co-eluting macrocycles are depleted.  
This study clearly shows that while some monomer structural variations result in a fairly 
drastic change in the extent of amplification and selectivity between PTMs, others have 
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little impact on binding.  Many other structural variations of monomer B can be 
envisioned, and there are ongoing investigations in the Waters Lab to pursue such 
structure-function studies further.    
– No Template
– KMe3
– aRMe2
A2F
A2F
 
Figure 2.29.  The analytical HPLC trace at 254 nm of a DCL consisting of monomers A 
(2.5 mM), F (2.5 mM), and H (2.5 mM) untemplated (blue) and in the presence KMe3 
(red) and aRMe2 (green).   
 
 ii.  Conclusions 
  In conclusion, we have identified synthetic receptors for KMe3 that exhibit both 
comparable affinity and selectivity to the native HP1 chromodomain.  The mass of A2B is 
less than 900 Da, as compared to approximately 6300 Da for the HP1 chromodomain and 
about 150 kDa for a typical antibody. The comparable binding affinity to the native 
protein is impressive, particularly given that the synthetic receptor appears to bind only to 
the KMe3 sidechain, whereas the chromodomain binds to the surrounding sequence as 
well.  The observed selectivity for higher methylation states with A2B can be attributed to 
differences in the magnitude of the cation-π interactions, as well as differences in size 
and desolvation penalty. The difference in selectivity observed when B is replaced with 
B’ is surprising, and demonstrates that subtle structural changes can have a significant 
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effect on binding.  Such sequence-independent receptors have the potential to be widely 
used in the investigation of unknown protein Lys methylation sites,50 unlike antibodies 
which are sequence selective.  This work suggests that small molecule receptors 
identified via DCC have a promising future as affinity reagents for PTMs, as they can 
easily be synthetically modified with a fluorophore, cell-penetrating peptide, or other tag.  
  
 iii. Experimental Section 
  a. Monomer Synthesis.  Monomers A, B, and F were synthesized following 
literature procedures.43,51  Monomer H is commercially available.  Monomer C was 
synthesized following a modified procedure of Field and Kirrstetter.44b 
 Methyl 3,5-dimethylbenzoate (10).  To a solution of 3,5-dimethylbenzoic acid 9 (5.0 
g, 33.3 mmol) in 50 mL of methanol, sulfuric acid (10 ml, 184 mmol) was slowly added, 
producing a significant amount of heat.  The solution was then refluxed overnight under 
nitrogen at about 85°C.  The reaction was monitored by TLC (silica gel, 5% MeOH in 
CH2Cl2 with TFA; Rf starting material: 0.5; Rf product: 0.83).  The colorless reaction 
mixture was allowed to cool and the methanol was removed by rotary evaporation.  The 
remaining solution was then poured into a 300 ml beaker of ice water to obtain a white 
precipitate which extracted into ether, washed with NaHCO3, dried with MgSO4.  The 
MgSO4 was removed by filtration and the solvent was evaporated to give a light yellow 
oil.  The product was recrystallized by adding petroleum ether (2-3 ml) to give 5.1 g of a 
clear, colorless solid (31.2 mmol, 94%).  1H NMR (CDCl3, 400 MHz): δ = 7.63 (s, 2H), 
7.18 (s, 1H),  3.90 (s, 3H), 2.34 (s, 6H). 
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 Methyl 3,5-bis(bromomethyl)benzoate (11).  To a solution of methyl 3,5-
dimethylbenzoate 10 (4.4 g, 27.1 mmol) in 60 ml of carbon tetrachloride N-
bromosuccinimde (9.7 g, 54.2 mmol) was added.  Peroxide (0.13 g, 0.54 mmol) was then 
added to the suspension, and it was refluxed for one hour.  The reaction was monitored 
by TLC (silica gel, 10% EtOAc in hexanes; Rf starting material: 0.70; Rf product: 0.35).  
The reaction was cooled and the NBS was removed by filtration.  The solution was then 
washed with water, dried with MgSO4, and the MgSO4 was removed by filtration.  The 
solvent was removed by evaporation, and the product was precipitated overnight in 
petroleum ether in the fridge.  If necessary the crude product can be recrystallized in ether 
to give pure white crystals (12.2 mmol, 45%).  1H NMR (CDCl3, 400 MHz): δ = 7.99 (d, 
2H), 7.60 (t, 1H), 4.48 (s, 4H), 3.92 (s, 3H). 
 3,5-bis(mercaptomethyl)benzoic acid (C).  A solution of methyl 3,5-
bis(bromomethyl)benzoate 11 (0.74 g, 2.3 mmol) and thiourea ( 0.46 g, 6.0 mmol) in 10 
ml of 95% ethanol was refluxed for 6 hours under nitrogen, after which no starting 
material remained as observed by TLC (10% EtOAc in hexanes).   To the reaction 9.7 
mL of 1M NaOH was added, and the solution was refluxed overnight.  The reaction was 
cooled and acidified with 10% HCl while stirring to give a cloudy white solution.  The 
solution was filtered to give a white, fluffy solid (1.8 mmol, 78%).  1H NMR ((CD3)2CO), 
400 MHz): δ = 7.90 (d, 2H), 7.61 (t, 1H), 3.84 (d, 4H), 2.31 (t, 2H, SH). 
 2,6-Bis(dimethylthiocarbamoyloxy)benzoic acid methyl ester (13).  Methyl 2,6-
dihydroxybenzoate 12 (2.0 g, 11.9 mmol) was dissolved in anhydrous DMF (8 mL) under 
a nitrogen atmosphere.  The solution was cooled to 0 °C and DABCO (8.0 g, 71.4) was 
added in portions.  To the resulting suspension a solution of N,N-dimethylthiocarbamoyl 
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chloride (8.9 g, 71.4 mmol) in DMF (8 mL) was added dropwise.  In cases where the 
solution was too thick to stir, additional DMF was added.  The suspension was allowed to 
warm to room temperature overnight.  The reaction mixture was poured into water (80 
mL) and stirred before filtering.  The product was washed with water and then ethanol to 
give a pure, white solid (2.8 g, 68%).  1H NMR (CDCl3, 400 MHz): δ = 7.49 (t, 1H), 7.03 
(d, 2H),  3.74 (s, 3H), 3.42 (s, 3H), 3.33 (s, 3H). 
 2,6-Bis(dimethylcarbamoylsulfanyl)benzoic acid methyl ester (14).  O-thiocarbamate 
13 (0.5 g, 1.46 mmol) was suspended in diphenyl either (5 mL) and heated in a sand bath 
to 230-240 °C under a nitrogen atmosphere.  Once the appropriate temperature was 
reached, the reaction was stirred for an additional 3 hours.  The reaction was monitored 
by TLC (EtOAc, Rf starting material: 0.58, Rf product: 0.33).  The reaction mixture was 
allowed to cool and then purified by column chromatography (100% hexane to elute 
phenyl ether, then 1:1 EtOAc;hexane followed by 7:3 EtOAc:hexane).  The solvent was 
evaporated and the compound was dried to give a beige solid 0.35 g, 70%).  1H NMR 
(CDCl3, 400 MHz): δ = 7.60 (d, 2H), 7.45 (t, 1H),  3.88 (s, 3H), 3.02 (broad d, 6H). 
 2,6-Bis(dimethylcarbamoylsulfanyl)benzoic acid (15).49  A mixture of 2,6-
bis(dimethylcarbamoylsulfanyl)benzoic acid methyl ester 14 (0.16 g, 0.47 mmol) and 
Me3SiI (0.36 mL, 2.52 mmol) were refluxed at 105°C overnight.  Once cool, diethyl ether 
(11 mL) was added and washed with 10% NaOH.  The basic aqueous layers were 
combined and 1M HCl was added to acidify the solution.  A white crystal-like solid 
precipitated out and was filtered (0.084 g, 0.26 mmol).  1H NMR (MeOD, 400 MHz): δ = 
7.59 (d, 2H), 7.42 (t, 1H),  3.07 (broad d, 12H).  
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 2,6-Dimercaptobenzoic acid (B’).  Under a nitrogen atmosphere 2,6-
bis(dimethylcarbamoylsulfanyl)benzoic acid 15 (0.037 g, 0.011 mmol) was suspended in 
a 1.75 M solution (0.38 mL) of KOH in diethylene glycol that had been purged with 
argon for 2 hr.  The solution was heated at 105°C for 30 min.  After the solution had 
cooled to room temperature, 2.7 mL of purged water was added followed by rapid 
addition of 10% HCl (0.5 mL).  The product was either filtered when possible and 
washed with hexanes, or diluted further and purified by reverse phase HPLC (0.13 g, 
0.070 mmol).  1H NMR (MeOD, 400 MHz): δ = 7.19 (d, 2H), 7.07 (t, 1H).  
 b. Synthesis of methylated lysine and arginine peptides and fluorescent 
labeling.  All peptide synthesis was performed on a Tetras Peptide Synthesizer using 
Peptides International CLEAR-Amide resin.  Peptides were synthesized on a 0.06 mmol 
scale by standard Fmoc solid phase synthesis.  All amino acids with functionality were 
protected during synthesis.  Coupling reagents were HOBt/HBTU in DMF.  For the 
dipeptides and the histone tail peptides used for templation studies, as well as the histone 
peptides synthesized for ITC experiments, the N-terminus was acylated with a solution of 
5% acetic anhydride and 6% 2,6-lutidine in DMF.  Peptides synthesized for fluorescence 
anisotropy were capped with 2 equivalents of 5(6)-carboxyfluorescein and coupled in the 
dark with standard coupling reagents overnight.  Cleavage was performed by hand with a 
cocktail of 95% TFA/2.5% triisopropylsilane/2.5% H2O for 3 hours.  Peptides were 
purified by semipreparative reversed-phase HPLC on a C18 column at a flow rate of 4 
mL/min.  Peptides were purified with a linear gradient of A and B (A: 95% H2O/5% 
CH3CN with 0.1% TFA, B: 95% CH3CN/5% H2O with 0.1% TFA) and elution was 
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monitored at 214 nm.  Once purified, peptides were lyophilized to powder and 
characterized by ESI-MS.   
 All PTM peptides were synthesized using monomethylated (Fmoc-Lys(Me)(Boc)-
OH, Fmoc-Arg(Me)(Pbf)-OH) and dimethylated (Fmoc-LysMe2-OH, symmetric or 
asymmetric Fmoc-ArgMe2-OH) lysine and arginine residues which are commercially 
available from Anaspec, Bachem, or Novabiochem.  The coupling of methylated amino 
acids was done with 2 equivalents of the unnatural amino acid for 10-12 hours.  The 
trimethyllysine-containing peptides were synthesized by reacting the corresponding 
dimethylated peptides (0.6 mmol scale) prior to cleavage from the resin with MTBD 
(10.8 µL, 0.075 mmol) and methyl iodide (37.4 µL, 0.6 mmol) in DMF (5 mL) for 5 
hours with bubbling N2 in a peptide synthesis flask stoppered with a vented septum.  
After washing the resin with DMF (3x), CH2Cl2 (3x), and drying, the peptides were 
cleaved, purified, and characterized as normal.   
  c. Dynamic combinatorial library screens.  The relevant building blocks were 
individually dissolved in water, adding sufficient 1.0 M aqueous NaOH to fully 
deprotonate the thiols and carboxylic acids on the building blocks, using sonication when 
necessary.  The pH of each solution was then adjusted to 8.5 using 1.0 M aqueous HCl 
and 1.0 M aqueous NaOH.  For example, in the unbiased ABC libraries, aliquots of each 
monomer solution were combined in a 2 mL LC-MS vial to reach a final concentration of 
2.5 mM of each monomer. In the biased A2B and A2B’ libraries, aliquots of each 
monomer solution were combined in a 2 mL LC-MS vial to reach a final concentration of 
5 mM A and 2.5 mM of B or B’ (unless noted otherwise).  When necessary, aliquots of 
peptide guests dissolved in water were added to the reactions to reach a final 
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concentration of 7.5 mM peptide.  The peptide guests were not found to significantly alter 
the reaction pH, however if necessary, the pH was adjusted again after addition of the 
guests.  Any remaining volume was made up with water.  The vials were capped and 
analyzed at various time points. 
  d. Analytical LC/MS.  LC-MS was carried out on an Agilent Rapid Resolution 
LC-MSD system equipped with an online degasser, binary pump, autosampler, heated 
column compartment, and diode array detector.  All separations were performed using 5 
mM NH4OAc H2O-acetonitrile gradients at pH 5 and a Halo C18 column (4.6 × 100 mm, 
2.7 micron).  The MS was performed using a single quad mass spectrometer. Mass 
spectra (ESI-) were acquired in ultrascan mode by using a drying temperature of 350°C, a 
nebulizer pressure of 45 psi, a drying gas flow of 10 L/min, and a capillary voltage of 
3000 V.  The reactions were monitored weekly (3 µL injections) until equilibrium was 
reached after about 3 weeks.  Larger injection volumes (10 µL) were used for the lower 
concentration libraries (0.75 mM total monomer) for adequate MS detection.  The 
chromatography of the ABC DCL was carried out at 50°C with gradient A (Table 2.3).  
The chromatography of library A2B was carried out with gradient B using a gradient 
temperature, going from 50°C to 40°C, left to right.  The chromatography of library A2B’ 
was carried out at 50°C with gradient C.  The peak areas were integrated at 254 nm and 
the amplification factors were calculated (A.F. = % area of A2B in templated DCL / % 
area of A2B in untemplated DCL). 
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Table 2.3.  Analytical LC methods use to analyze DCC libraries ABC (Method A), A2B 
(Method B) and A2B’ (Method C). 
 
Gradient A 
Time (min) %B Flow Rate (mL/min) 
0.00 0.0 1.0 
3.00 30.0 1.0 
7.00 32.3 1.0 
7.30 32.3 1.0 
7.35 32.3 0.6 
9.00 32.3 0.6 
9.10 32.3 1.0 
10.80 34.0 1.0 
10.90 100.0 1.0 
11.90 100.0 1.0 
12.00 0.0 1.0 
13.00 0.0 1.0 
 
Gradient B 
Time (min) %B Flow Rate (mL/min) 
0.00 3.0 1.0 
3.00 30.0 1.0 
8.25 33.0 1.0 
8.30 33.0 1.5 
10.30 34.0 1.5 
12.00 50.0 1.5 
12.10 100.0 1.5 
13.50 100.0 1.5 
14.00 3.0 1.0 
19.00 3.0 1.0 
 
Gradient C 
Time (min) %B Flow Rate (mL/min) 
0.00 15.0 1.5 
2.00 30.0 1.5 
6.00 30.0 1.5 
9.00 50.0 1.5 
9.10 100.0 1.5 
11.00 100.0 1.5 
11.50 15.0 1.5 
16.00 15.0 1.5 
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 e. Synthesis and isolation of rac-A2B and meso-A2B.  Biased libraries were 
prepared on a 20 mL scale (A: 35.6 mg, 0.1 mmol; B: 9.3 mg, 0.05 mmol) templated with 
methylisoquinoline triflate (44.0 mg, 0.15 mmol).  Upon equilibration the libraries were 
neutralized and the receptors were isolated by semi-preparative HPLC.  Approximately 
0.5 mL injections were chromatographed using standard peptide synthesis mobile phases 
A and B (0-50% B 0-5 min, then isocratic at 50% B 5-20 min) with a flow rate of 4.0 
mL/min.  Optimal separation of the two isomers was achieved using a column heater set 
to 40°C.  The two A2B peaks from 11.5 – 12.5 minutes were collected separately (Figure 
2.30) and analyzed for purity by analytical LC-MS (Figure 2.31), as their retention times 
differ by about 0.7 minutes.  Both peaks are indistinguishable by mass (Figure 2.32). 
Purified rac- and meso-A2B were lyophilized to powder and stored under nitrogen, 
however in some cases a second purification was required to achieve pure meso-A2B.   
 
Figure 2.30. Semi-preparative HPLC trace of an A2B biased library. 
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Figure 2.31.  Analytical LC traces of purified rac-A2B (top) and meso-A2B (bottom). 
 
 
Figure 2.32.  Mass spectra of both purified rac-A2B and meso-A2B (-ESI). 
 
f. NMR spectroscopy.  All NMR samples were dissolved in 50 mM borate buffer 
at approximately pD 9 containing 0.05 mM DSS.  To prepare the NMR buffer B4Na2O7 
was dissolved in D2O.  The buffer was either adjusted to pD 9 with acetic acid-d4, or used 
without any further adjustment, giving a pD of 9.25.  An NMR sample of the H-KMe3-G-
NH2 dipeptide was prepared with a concentration of approximately 1 mM.  A second 
sample was prepared containing both rac-A2B (0.85 mM) and KMe3 (0.65 mM), with the 
rac-A2B in excess to ensure all of the trimethyllysine was bound.  Samples were analyzed 
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on a Varian Inova 600-MHz instrument at either 25 °C or 5 °C.  1D NMR spectra were 
collected using 32K data points and 128 scans using a 1-3 second presaturation.  2D 
TOSCY experiments were taken with 16-64 scans in the first dimension and 128-256 
scans in the second dimension.  All spectra were analyzed using standard window 
functions (sinbell and Gaussian with shifting).  Presaturation was used to suppress the 
water resonance.  Lysine assignments were made using standard methods as described by 
Wurthrich.52 
 
Figure 2.33.  1H NMR of H-KMe3-G-NH2 at 25 °C. 
 
Table 2.4.  Proton chemical shift assignments for 1H NMR of H-KMe3-G-NH2. 
Residue α β γ δ ε Me 
KMe3 3.47 1.73, 1.70 1.40 1.81 3.31 3.10 
G 3.93      
 
Me3 
DSS 
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Figure 2.34.  1H NMR of H-KMe3-G-NH2 bound to rac-A2B at 25 °C.  The lysine 
methyl groups are broadened and shift upfield to 2.27 ppm.  The signals at 2.21, 1.89, and 
1.25 are due to additional DSS protons and the signal at 3.34 is residual methanol.   
 
 g. A2B extinction coefficient determination.  For all studies investigating the 
affinity of A2B (NMR, anisotropy, ITC), the concentration of A2B was determined by 
either mass or UV-Vis.  For the cases in which UV-Vis was used, an extinction 
coefficient was first determined for the receptor.  Due to limited amounts of material of 
A2B, an extinction coefficient was determined for both A and B individually and used in 
an additive manner to determine that of the receptor.  Stock solutions of a known 
concentration (between 5 and 10 mM) were prepared for each monomer in aqueous 
solution titrated to pH 8.5 with 1 M NaOH (with sonication if needed to help dissolve 
solid).  The stock solutions sat for 1-3 weeks to form various single building block 
macrocycles, eliminating most free thiolate anions, and therefore more closely 
resembling the UV-Vis spectra of the monomers within the A2B macrocycle.   
DSS 
Me3 
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 Various successive dilutions of each monomer were made and the UV-Vis spectra 
was taken at each concentration four times and averaged.  The spectra were taken on a 
Thermo Scientific NanoDrop Spectrophotometer, using 2 µl for each measurement.  The 
absorbance at 315 nm was plotted against concentration with the slope set to zero, and 
based on Beer’s Law, the slope was calculated to determine the extinction coefficient of 
each monomer.  This was repeated 2 to 3 times for each monomer, with some slight 
variance between experiments, and the slopes giving the highest R2 values were used to 
determine the extinction coefficients.  For monomer B the extinction coefficient was 
determined to be 1463 M-1cm-1 based on the average of two separate runs giving slopes 
of 1477 M-1cm-1 and 1448 M-1cm-1 (Figure 2.35).  For monomer A (racemic mixture), the 
extinction coefficient was determined to 1441 M-1cm-1 (Figure 2.36).  Therefore, the 
extinction coefficient for A2B, assuming the absorbance of both rac and meso isomers is 
indistinguishable, was determined to be 4345 M-1cm-1.   
 
Figure 2.35.  Determination of the extinction coefficient of monomer B. 
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Figure 2.36.  Determination of the extinction coefficient of monomer A. 
 
 h. Fluorescence anisotropy binding experiments.  Binding assays were 
performed with purified rac- or meso-A2B and fluorescein labeled histone 3 peptides.  
Peptides were dissolved in buffer (10 mM phosphate pH 8.5), and 100 µM solutions were 
prepared as determined by UV-Vis at 492 nm (ε = 78,000 M-1cm-1).  Stock solutions of 
A2B were prepared, with the solution concentrations determined by either mass or UV-
Vis at 315 nm (ε = 4345 M-1cm-1) on a NanoDrop Spectrophotometer.  Assays were 
prepared in 384-well plates (Corning) with a total volume of 50 µL per well, containing 
20 µM labeled peptide and increasing concentrations of A2B in buffer.  Plates were spun 
down and allowed to incubate for at least 30 minutes before analysis.  Fluorescence 
anisotropy was measured on a PHERAstar plate reader (BMG Labtech) using FP485, 
520A, and 520B filters at approximately 27°C.  The anisotropy data was plotted as a 
function A2B concentration and each plot was fitted in KaleidaGraph to the following 
equation:53 
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where r is fluorescence anisotropy, ro is the initial anisotropy value, r∞ is the maximum 
anisotropy value, a is the peptide concentration, x is the concentration of A2B, and kd is 
the dissociation constant.  All measurements were taken in duplicate or triplicate. 
 
Figure 2.37.  Fluorescence anisotropy of rac-A2B with H3 KMe3. 
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Figure 2.38.  Fluorescence anisotropy of rac-A2B with H3 KMe2. 
 
 
Figure 2.39.  Fluorescence anisotropy of rac-A2B with H3 KMe. 
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Figure 2.40.  Fluorescence anisotropy of rac-A2B with H3 K. 
 
 
Figure 2.41.  Fluorescence anisotropy of meso-A2B with H3 KMe3. 
 
 84 
 
Figure 2.42.  Fluorescence anisotropy of meso-A2B with H3 KMe2. 
 
 
Figure 2.43.  Fluorescence anisotropy of rac-A2B with H3 KMe3 where Arg8 has been 
mutated to Gly8. 
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Figure 2.44.  Fluorescence anisotropy of rac-A2B with H3 aRMe2. 
 
 
Figure 2.45.  Fluorescence anisotropy of rac-A2B with H3 sRMe2. 
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Figure 2.46.  Fluorescence anisotropy of rac-A2B with H3 RMe. 
 
 i. Isothermal titration calorimetry binding experiments.  Isothermal titration 
calorimetry measurements were conducted using an ITC200 from MicroCal, LLC to 
verify the binding data obtained by fluorescence anisotropy.  Solutions were degassed for 
10 minutes under vacuum prior to the experiment.  The titrant used to determine the 
binding to KMe3 was a 2.0 mM solution of the H3 tail peptide          
Ac-WGGGQTAGKMe3STG-NH2 (in 10 mM phosphate buffer, pH 8.5), containing a Trp 
for concentration determination which was separated from the natural sequence by 3 
glycine spacers.  This peptide also contained Gly8 as opposed to Arg8 which is found in 
the native sequence.  It has been shown that this mutation has minimal affect on the 
overall binding affinity.  The cell was filled with a 0.2 mM solution of either rac- or 
meso-A2B (in 10 mM phosphate buffer, pH 8.5).  A single 0.2 µL peptide aliquot 
followed by 38 aliquots of 1 µL were titrated into the calorimetric cell every 2.5 minutes 
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with mechanical stirring.  All measurements were carried out at 26°C.  The titration data 
was analyzed using the Origin software by non-linear least squares fitting the heats of 
binding as a function of the peptide:A2B molar ratio to a one site binding model.  It was 
found by ITC that rac-A2B binds KMe3 with a Kd of 20.0 µM, whereas meso-A2B binds 
KMe3 with a Kd of 12.8 µM (Figures 2.47 and 2.48). 
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Figure 2.47.  ITC binding curve from the titration of Ac-WGGGQTAGKMe3STG-NH2 
into rac-A2B, giving a Kd of 20.0 µM. 
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Figure 2.48.  ITC binding curve from the titration of Ac-WGGGQTAGKMe3STG-NH2 
into meso-A2B, giving a Kd of 12.8 µM. 
 
D. Selective recognition of trimethyllysine and dimethyllysine: receptor BD2 
 i. Results and discussion 
  a. Naphthalene based monomers.  To add a level of diversity to the monomers 
examined up to this point, we chose to explore dithiol building blocks with a naphthalene 
core in the investigation of new methylated PTM receptors.  Naphthalenes provide a 
larger aromatic surface area than phenyl groups for interaction with PTMs, and are 
equally well known for their ability to form cation-π interactions.13a  Furthermore, the 
same synthetic steps can be used for the synthesis of such dithiol monomers due to the 
availability of dihydroxynapthoic acids.  This allows for the straightforward synthesis of 
monomer D (Scheme 2.5).54  The thiols were installed in the 3 and 5 position of the 
naphthalene ring to favor the formation of cyclic macrocycles over linear oligomers.  By 
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having one thiol on each aromatic ring this also takes advantage of the entire naphthalene 
surface, whereas if the thiols were placed on a single ring the monomer may be expected 
to behave similarly to phenyl based monomer B or F. 
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Scheme 2.5.  Synthesis of monomer D. 
 
  b. Unbiased library templation studies.  To investigate this naphthalene 
building block in the context of a DCL, libraries were prepared by mixing equimolar 
amounts of monomers B, C, D, and H (2.5 mM each) in basic solution.  The building 
blocks were dispersed in water and the pH was adjusted to 8.5 with NaOH and HCl.  In 
attempt to identify selective high affinity PTM receptors, all PTM dipeptide templates 
were screened in eight DCLs at a concentration of 10 mM, while no template was added 
to the ninth DCL.  The libraries were allowed to oxidize in capped HPLC vials at room 
temperature for about three weeks.  All libraries remained completely soluble with no 
visible precipitation, which is essential.  The library compositions were analyzed by LC-
MS at various time points, and all library members could be identified by negative 
electrospray ionization.  In some cases, the mass degeneracy of multiple macrocycles 
prevented the complete characterization of all species without further MS/MS analysis 
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(for example, B2CE and D3 have identical masses).  Upon reaching equilibrium the 
chromatograms were integrated, and in each case the peak areas were represented as a 
percentage of the total chromatogram area.  This aided in taking into account slight 
baseline differences from chromatogram to chromatogram.   
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Figure 2.49.  Dynamic combinatorial library of dithiol monomers resulting in 
amplification of receptor BD2 upon addition of a KMe3 guest. 
 
 In the absence of guest there are multiple major constituents present, BC, CD, and 
CD2, as well as numerous smaller peaks corresponding to other macrocyclic library 
members (Figure 2.50).  However, the introduction of a trimethyllysine dipeptide resulted 
in a clear, significant shift in the library composition in comparison to the untemplated 
reaction.  The amplification of a single receptor in the KMe3 templated library was 
clearly observed, corresponding to the trimeric macrocycle BD2 (Figure 2.49).  It must be 
noted that in initial experiments, unacylated dipeptide guests with a free amine on the N-
terminus were used for library screens, however it was later shown that amplification of 
the BD2 receptor was conserved with the corresponding acylated peptide guests.   
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Figure 2.50.  The analytical HPLC trace at 254 nm of a DCL consisting of monomers B, 
C, D, and H (2.5 mM each), untemplated (black) and in the presence of H-KMe3-G-NH2 
(blue). 
 
 Next, the selectivity for KMe3 over the lower lysine methylation states and all of the 
arginine methylation states was examined.  The library chromatograms were integrated 
upon equilibration, and the percent area of the BD2 peak in each library was calculated by 
dividing the raw area of the peak by the total area of the chromatogram, not including the 
area of the peptide guest peak in the case of the templated reactions.  While the 
amplification of BD2 followed the same general trend as that of A2B in that amplification 
increased with increasing methylation, it was found that BD2 showed very similar affinity 
for both KMe2 and KMe3 (Figure 2.51), with a preference for both di- and 
trimethyllysine over monomethyl lysine.  While the comparison of two different libraries 
is not necessarily an accurate one due to the different equilibria at play, it can be noted 
that the amplification of BD2 in the presence of KMe3 is about half that of A2B.  This 
may however be due to the higher concentration of BD2 in the untemplated library in 
comparison to the concentration rac- and meso-A2B in the untemplated DCLs. 
Untemplated 
H-Lys(Me)3-Gly-NH2 BD2 
CD 
BC 
D2 
B3 
BD2H 
CH + 
B2H 
CD2 
B2CH 
or D3 
BCD 
BD2 
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 The analysis of the arginine templated libraries revealed amplification of BD2 in the 
presence of both sRMe2 and aRMe2, however the extent of amplification is modest in 
comparison to that of KMe3 and KMe2.  Interestingly, BD2 shows only a minimal 
preference for aRMe2 over sRMe2 and is essentially unable to discriminate between the 
two PTMs, however binding to both dimethylated arginines is preferred over 
monomethylated arginine, following the trend that favorable binding interactions are 
facilitated by increasing methylation.  While the higher lysine methylation states are 
clearly more favorable than higher arginine methylation states, BD2 does not appear to be 
able to distinguish between monomethyllysine and monomethylarginine, which is 
somewhat surprising due to the significant structural differences between these PTMs.   
 
Figure 2.51.  Amplification of BD2 in a BCDH library templated with all lysine and 
arginine methylation states, represented as a percent change in peak area (where % 
change = [(% area templated - % area untemplated) / % area untemplated] × 100). 
  
 As in the case with A2B, there are likely several factors that result in the observed 
selectivity of BD2 for KMe3 and KMe2 over lower lysine and arginine methylation 
states.  The binding pocket may be too large for the lower methylation states, yet it 
 93 
appears to accommodate both KMe2 and KMe3 equally well.  The increased 
hydrophobicity of the higher methylation states is also more amenable to binding an 
aromatic pocket.  A desolvation penalty may also play a role in the observed selectivity.  
However, the addition of a third methyl group does not appear to introduce any additional 
favorable hydrophobic interactions from that of its dimethyl analogue, nor does 
trimethyllysine’s ability to form a stronger cation-π interaction seem to come into play 
significantly in this case.  It is likely that multiple factors, some of which enhance the 
recognition of KMe2 and others which reduce the affinity for KMe3, work in 
combination to afford BD2’s seemingly equal affinity for both PTMs.  While BD2 still 
shows promise as a small molecule receptor for KMe3 and KMe2, the factors 
contributing to its recognition of methylated PTMs appear to impart less selectivity than 
that of A2B. 
 c. Biased library templation studies.  Focusing on the promising recognition of di- 
and trimethyllysine, additional DCL screens were set up biased towards the formation of 
BD2 in which building blocks B and D were mixed in a 1:2 ratio (7.5 mM total), 
facilitating the formation of BD2 in a higher concentration.  As expected, a number of 
macrocycles were generated in the absence of a template, however upon templation with 
both Lys Me2 and LysMe3 the equilibrium was drastically shifted to form almost 
exclusively BD2 (Figure 2.52).  This high concentration of BD2 indicates a quite high 
thermodynamic stability of this receptor in the presence of both KMe2 and KMe3. 
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Figure 2.52.  Part of the analytical HPLC trace at 254 nm of a biased DCL consisting of 
monomers D (5 mM) and B (2.5 mM) in the presence of Ac-KMe3-G-NH2. 
 
 It is evident that the amplification in this biased library follows a similar trend as that 
of the prior screen, showing significant selectivity for di- and trimethyl lysine over mono- 
and unmethylated lysine (Figure 2.53).  While the concentration of BD2 less than doubles 
in the presence of LysMe and Lys, it increases 400-500 percent when templated with 
both LysMe2 and LysMe3.   
   
Figure 2.53.  The extent of amplification of BD2 with H-KMex-G-NH2 guests in a biased 
library relative to the untemplated library (the BD2 HPLC peak at 254 nm on the left, and 
the calculated percent change on the right).   
 
  d. Investigation of a histone 3 K9Me3 peptide template.  To ensure that these 
amplification results were maintained in the context of the naturally methylated histone 
Lys(Me)3 
Lys(Me)2 
Lys(Me) 
Lys 
No Guest 
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peptide and not substantially influenced by surrounding residues, a biased library 
templated with the 8 residue H3 Lys9Me3 (Figure 2.21) was prepared as described 
previously and monitored by LC/MS.  Significant amplification of BD2 by H3 Lys9Me3 
was observed and determined to be even slightly greater than that of the LysMe3 
dipeptide by about 10% (Figure 2.54).  This confirms that BD2 still binds LysMe3 in the 
context of a histone tail peptide, potentially with even slightly higher affinity.  BD2 
amplification in the presence of a histone LysMe2 peptide was not investigated, although 
based on the above results it is assumed that amplification of LysMe2 in the context of a 
longer histone tail peptide would be equal to that of the dipeptide.   
 
Figure 2.54.  The analytical HPLC trace at 254 nm of a biased DCL consisting of 
monomers D (5 mM) and B (2.5 mM), untemplated (black) and in the presence of H3 
LysMe3 (7.5 mM, blue). 
 
  e. Preparative scale biased libraries and isolation of BD2.  To pursue further 
studies with BD2 involving both its characterization and application as a di- and 
trimethyllysine small molecule receptor, preparation and isolation of BD2 was required.  
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Large scale biased libraries were prepared with a total volume of 20 mL and a ratio of B : 
D : guest of 1 : 2 : 3, with a total monomer concentration (B + D) of 7.5 mM.  Due to the 
approximately equal affinity of BD2 for both di- and trimethyllysine, these larger scale 
libraries were templated with a dimethyl lysine dipeptide due to the simpler synthesis of 
this peptide.  The three solids were combined with the appropriate amount of water, 
titrated to pH 8.5 with NaOH and HCl, and let stir in a capped scintillation vial for 1-3 
weeks before being purified on a semi-preparative HPLC.  The purity was confirmed in 
each case by LC/MS.  Relative to the synthesis and purification of rac- and meso-A2B, 
the preparation of BD2 afforded considerably higher yields, due to both the much higher 
concentration of BD2 in the templated library as well as the isolation of only a single 
isomer.    
 f. Characterization of BD2.  While there is clearly more than one possible 
structural isomer of BD2, the amplification of only a single isomer in the presence of 
methylated PTMs was observed.  This is in direct contrast to the non-diastereoselective 
amplification of both rac- and meso-A2B by LysMe3.  This indicates significant 
structural differences between the three possible BD2 isomers, two of which are 
symmetric and one of which is asymmetric (Figure 2.55).  More interesting is the fact 
that one isomer is significantly more thermodynamically stable than the others, as a 
statistical ratio of the three isomers is not observed in the untemplated library.  Instead, 
only one peak corresponding to the mass of BD2 is observed in a significant quantity, and 
this may indeed be the reason that only a single BD2 macrocycle is amplified.   
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Figure 2.55.  The potential structural isomers of BD2, two of which are symmetric (a and 
b) while the third is asymmetric (c). 
 
It was initially suspected that the three isomers were co-eluting during library analysis 
due to their similarities in structure, polarity, and hydrophobicity.  However during 
efforts to improve the chromatographic separation, there was no evidence of a second 
BD2 isomer.  The purified receptor was then analyzed by NMR to gain further insight as 
to it’s purity and structure.  The 1D 1H NMR of the receptor revealed 6 sharp proton 
signals, with one very broad signal.  The simplicity of the NMR spectra indicated that the 
purified receptor was not only a single isomer, but one of the two symmetric isomers, as 
13 distinct signals would be expected for the asymmetric isomer.   
All protons were assigned through 2D TOSCY and NOESY experiments, with proton 
F determined to be the broadened signal.  While the signals for protons A-E and G get 
sharper above room temperature, the broadening of proton F increases.  However, at 5 °C 
the signal for proton F gets slightly sharper.  It is thus predicted that this proton typically 
undergoes a significant amount of rotation resulting in a broadened signal, and that this 
rotation is restricted to some degree at lower temperatures.  While 1D experiments were 
successfully run above room temperature at both 40 °C and 60 °C, it must be noted that 
longer 2D experiments at 60 °C provided sufficient time and energy for the disulfide 
bonds to break, resulting in re-equilibration of the library as determined by subsequent 
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LC/MS analysis of the NMR sample.  The exact temperature at which this re-
equilibration begins to occur was not investigated further.  2D NOESY experiments did 
not provide sufficient evidence to determine which of the two BD2 symmetric isomers 
was being amplified (Figure 2.55a and 2.55b), and while this information is interesting 
and would provide a more complete characterization, it does not largely impact the 
significance of this work.   
 g. NMR analysis of trimethyllysine binding to BD2.  In addition to the 
characterization of BD2, NMR was also used to investigate the recognition of a 
trimethyllysine dipeptide by BD2.  Three samples were prepared and analyzed under 
identical conditions: a) BD2 only, b) H-KMe3-G-NH2 dipeptide only, and c) H-KMe3-G-
NH2 bound to BD2.  Upon the introduction of BD2, significant broadening of all KMe3 
proton signals was observed, indicating a change in the peptide’s environment.  A similar 
broadening of the BD2 proton signals was also observed upon binding.  Furthermore, all 
lysine side chain protons were upfield shifted upon binding, with the extent of shifting 
increasing moving away from the peptide backbone and closer to the site of methylation.  
The larger shifts are indicative of a greater degree of interaction with BD2.  A similar 
extent of shifting was observed for the δ, ε, and methyl protons, indicating that the 
receptor is not only interacting with the methylammonium group, but is also in close 
contact with both the δ and ε methylene protons (Figure 2.56).  This is not entirely 
surprising, as it has previously been shown that a LysMe3 residue in a β-hairpin peptide 
interacts preferentially with the face of a tryptophan ring through both its polarized ε 
methylene and its methylammonium group.55  It is possible that the naphthalene rings of 
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BD2 are interacting with the KMe3 sidechain in a similar fashion as the indole ring of 
Trp.   
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Figure 2.56.  Upfield side-chain chemical shifts of H-KMe3-G-NH2 upon binding to BD2 
at both 25 °C and 5 °C.  Conditions: 50 mM borate pD 9.0 with 10% acetonitrile-d3, 
referenced to DSS.  
 
 Both the temperature and the solvent system seem to have a significant affect on the 
extent of LysMe3 upfield shifting, and therefore the degree of interaction of the two 
molecules.  The LysMe3 protons are all upfield shifted more drastically at 5 °C.  This 
may indicate that the guest is in a bound state a larger percent of the time at 5 °C, 
assuming the conversion between the bound and unbound state is fast on the NMR 
timescale.  In regards to the solvent system, the amount of an added co-solvent appears to 
influence the degree of upfield shifting.  In figure 2.56 the LysMe3 upfield shifts upon 
binding in 10% acetonitrile-d3 in borate buffer are presented.  If the ratio of acetonitrile to 
aqueous buffer is increased to 1:2 only minimal upfield shifting of the LysMe3 protons is 
observed.  However, in aqueous buffer only, a 0.86 ppm upfield shift of the methyl 
groups was observed at 25 °C, in comparison to about 0.5 ppm at 25 °C in 10% 
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acetonitrile.  Based on such observations, it is evident that the introduction of an organic 
solvent has a negative influence on binding, as the driving force for KMe3 binding to 
BD2 is likely less when the unbound KMe3 exists in a more hydrophobic environment.   
 h. BD2 aggregation by NMR and fluorescence.  Based on evidence that BD2 
functions as a methylated lysine small molecule receptor, we sought to investigate the 
binding affinity of BD2 to LysMe3 and LysMe2.  This was first attempted by an NMR 
titration, and while an accurate binding constant was not determined, this study 
contributed to our overall understanding of this PTM receptor.  With the LysMe3 
dipeptide concentration constant, BD2 was titrated into solution to give concentrations 
ranging from 20 µM to 2.8 mM.  While it was anticipated that plotting the upfield 
chemical shift of the lysine methyl groups against the concentration of BD2 would 
provide an appropriate binding curve, it was the BD2 spectra at varying concentrations 
that proved to be more informative.   
As the concentration of BD2 increased, even well beyond the point where BD2 was 
saturated with LysMe3, the proton signals continued to shift upfield indicating some 
degree of aggregation of BD2 (Figure 2.57).  The stacking of naphthalene moieties is a 
common phenomenon that is highly concentration dependent, which explains the more 
drastic shifts observed with larger jumps in concentration.  The BD2 proton signals 
remain well resolved at low concentrations, however at higher concentrations a 
significant broadening effect is observed, likely due to a much greater extent of 
intermolecular stacking between naphthalene units.  Interestingly, while protons A-E 
were continually upfield shifted with increasing BD2 concentrations, the signal for proton 
G was not shifted throughout the titration.  It is therefore thought that the phenyl ring of 
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monomer B does not participate in any intermolecular interactions or contribute 
significantly to aggregation.  Based on the apparent self-association of this receptor, the 
determination of an accurate binding constant by NMR and other methods has proved to 
be challenging, and while BD2 undoubtedly binds LysMe2 and LysMe3 selectively over 
other lysine and arginine methylation states, the absolute affinity and selectivity has yet 
to be quantified.  
 
Figure 2.57.  1H NMR of BD2 at varying concentrations (100 µM top, 600 µM middle, 
and 2.0 mM bottom) in the presence of H-KMe3-G-NH2 (100 µM).  The chemical shift of 
proton G (red line) remains unchanged, whereas protons A-E (gray lines) shift upfield.   
 
To further investigate this aggregation phenomenon, the fluorescence properties of 
BD2 were explored.  Naphthalene molecules are known to fluoresce from about 300-330 
G 
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nm; however, any aggregation of these molecules would be expected to result in a “self-
quenching” of the naphthalene fluorescence to some degree.  Similarly, naphthalene is 
capable of exhibiting excimer fluorescence at longer wavelength regions around 390 nm, 
in addition to the monomer fluorescence at a shorter wavelength.56  Excimers are short-
lived dimeric species formed from two molecules, at least one of which is in an excited 
state.  Generally as the monomer fluorescence decreases, the excimer fluorescence 
increases, and vise versa.  Upon excitation of a high concentration solution of BD2 (1 
mM) at 240 nm, there was no observable fluorescence of the individual receptors at 
shorter wavelengths, as it is presumably all quenched as a result of BD2 aggregation 
(Figure 2.58).  Interestingly, at this concentration fluorescence is observed at higher 
wavelengths, indicative of stacking of the naphthalene moieties, and thus the formation of 
excimers.   
 
Figure 2.58.  Fluorescence spectra of a 1 mM solution of BD2 upon excitation at 240 nm. 
 
At lower concentrations of BD2 (20 µM), some degree of fluorescence is observed in 
the shorter wavelength region around 310 nm, as aggregation is likely occurring to a 
much lesser degree at this concentration (Figure 2.59).  Upon the addition of an excess of 
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a KMe3 dipeptide, this fluorescence increases.  This indicates that BD2 is indeed 
interacting with the trimethyllysine peptide, and in doing so is breaking up some of the 
BD2 aggregates and decreasing the degree of fluorescence quenching.  Overall, the BD2 
fluorescence spectra support the NMR data, confirming a significant degree of 
aggregation of BD2.   
 
Figure 2.59.  Fluorescence spectra of a 20 µM solution of BD2 upon excitation at 278 nm 
(pink), and in the presence of 60 µM KMe3 (orange). 
 
  i. Structure-function studies.  To evaluate the specificity of the interaction 
between BD2 and KMe3 and KMe2 in comparison to other structurally similar receptors, 
simple systematic structural variations were made to both monomers B and D.  How 
these changes in monomer structure influence the enhancement of BD2 and thus the 
function of these receptors in various libraries templated with methylated PTMs was then 
investigated.  One structural isomer of each monomer was investigated.  Monomer E 
(Figure 2.12) was investigated as a variation of D, where the positions of the thiols were 
changed from the 3- and 5-positions of the naphthalene ring to the 3- and 7-positions.  In 
monomer E the thiols are now placed further apart and on opposite sides of the 
 104 
naphthalene moiety in comparison to D.  The synthesis of monomer E is identical to that 
of D, starting with 3,7-dihydroxynapthoic acid.  In addition, monomer B’, where the 
thiols are placed in the 2- and 6-positions of the ring relative to the carboxylate, was 
investigated as a variation of monomer B.  By screening monomers E and B’ in DCLs 
against methylated PTM guests, we can gain insight into how these subtle variation 
influences binding. 
 In the investigation of monomer E, all methylated lysine and arginine dipeptide 
guests were screened in unbiased DCLs containing monomers B, C, E, and H (2.5 mM 
each).  After over a week, no significant amplification was observed in any of the 
templated libraries, with macrocycle BC as the dominant species in each case.  
Interestingly, there was also evidence of the formation of linear oligomer chains of E.  
Due to the spacing of the thiols in E it is not entirely surprising that monomer D lends 
itself more towards the formation of cyclic macrocycles, whereas E favors linear 
oligomers.  This reiterates the importance of the placement of reactive functional groups 
within monomers, as functional groups closer together tend to favor cycle macrocycles 
whereas those placed on opposite sides are more likely to form linear oligomer chains in 
the absence of binding interactions.  It is clear that despite their structural similarities, 
replacing monomer D with E has a drastic effect on both the composition of the DCLs 
formed as well as the templation of a potential PTM receptor.  While a DCL containing 
monomers B, C, D, and H resulted in a range of amplification in the presence of all 
methylated PTMs, in a similar DCL containing monomers B, C, E, and H no significant 
amplification was observed.   
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 In the investigation of monomer B’, biased analytical DCLs were setup by mixing 
building blocks D and B’ in a 2:1 ratio (7.5 mM total), and the recognition of the 
different methylated PTMs by macrocycles in the DCL was evaluated.  As in the case of 
the A2B’ DCLs, the library composition of these libraries was largely affected by this 
structural change.  Very minor amplification of peaks corresponding to B’D3, B’2D2, and 
B’4D2 was observed in the presence of both symmetric and asymmetric ArgMe2, 
however biasing the libraries towards these receptors did not enhance amplification, 
indicating extremely weak binding.   
 In contrast to the observed amplification of BD2, there does not appear to be 
favorable recognition of either LysMe2 or LysMe3 by B’D2 (Figure 2.60).  This may be 
partially due to the fact that B’D2 is by far the dominant macrocycle in both templated 
and untemplated libraries, indicating a high thermodynamic stability of this macrocycle 
prior to binding.  The thermodynamic stability of B’D2 is significantly higher than that of 
BD2, as BD2 exists in much lower concentrations in untemplated libraries, again 
displaying the drastic change in library composition upon the introduction of slight 
structural modifications.  In attempt to reduce the effective concentration of B’D2 in the 
untemplated library, the ratio of B’:D was varied systematically from 1:2 to 1:1, 2:1, and 
4:1 to bias it away from B’D2.  While increasing the ratio of B’:D reduced the 
concentration of B’D2 to some degree, this was accompanied by a concomitant increase 
in the concentration of macrocycles B’5 - B’8 with still no significant B’D2 amplification.  
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Figure 2.60.  Part of the analytical HPLC trace at 254 nm of a biased DCL consisting of 
monomers D (5 mM) and B’ (2.5 mM), untemplated and in the presence of methylated 
lysine and arginine (7.5 mM) dipeptides. 
 
ii. Conclusions 
  In conclusion, we report the identification of a synthetic receptor, BD2, which 
selectively recognizes both KMe2 and KMe3 over mono- and umethylated lysine, as well 
as all arginine methylation states.  This small molecule receptor was identified through 
dynamic combinatorial chemistry, displaying the novelty and utility of this technique in 
the discovery of synthetic receptors for post-translational modifications.  While BD2 is 
selective for both KMe2 and KMe3 PTMs, it is likely that similar factors contribute to the 
selectivity of this naphthalene based receptor as those contributing to the selective 
recognition of KMe3 by A2B.  The observed selectivity for higher methylation states can 
be largely attributed to differences in the magnitude of the cation-π interactions, as well 
as differences in size and desolvation penalty.  The difference in amplification observed 
when B and D are replaced with structural variants is interesting, and demonstrates that 
 107 
subtle structural changes can have a significant effect on recognition and function.  
Although BD2 shows promise as a small molecule receptor for KMe2 and KMe3, an 
absolute affinity for either PTM has not been determined due to the observed aggregation 
of this receptor.  However, it is conceivable that this could indeed be achieved with 
further studies if the concentration of BD2 remains below that of where aggregation 
begins to occur.  Similarly, this receptor also has the potential to be useful in a variety of 
applications in the investigation of unknown protein lysine methylation states when 
concentrations are required where aggregation is not problematic. 
 
iii. Experimental Section. 
  a. Dynamic combinatorial library screens.  Library screens were conducted 
similarly to those described previously.  The relevant building blocks were individually 
dissolved in water with sufficient 1.0 M aqueous NaOH to bring them into solution, and 
the pH of each solution was then adjusted to 8.5.  In the unbiased BCDH libraries, 
aliquots of each monomer solution were combined in a 2 mL LC-MS vial to reach a final 
concentration of 2.5 mM of each monomer (10 mM total). In the biased BD2 libraries, 
aliquots of each monomer solution were combined to reach a final concentration of 5 mM 
D and 2.5 mM of B (7.5 mM total).  When necessary, aliquots of peptide guests dissolved 
in water were added to the reactions to reach a final concentration of either 10 mM for 
the BCDH libraries or 7.5 mM for the BD2 libraries.  The vials were capped and analyzed 
at various time points. 
  b. Analytical LC/MS.  LC-MS was carried out on either a Waters Acquity LC-
MSD system or a Agilent Rapid Resolution LC-MSD system, equipped with an online 
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degasser, binary pump, autosampler, heated column compartment, and diode array 
detector.  All separations were performed using 5 mM NH4OAc H2O-acetonitrile 
gradients at pH 5.  The MS was performed using a single quad mass spectrometer and all 
peaks were identified by negative electrospray ionization.  The reactions were monitored 
weekly (2 µL or 10 µL injections depending on total monomer concentration) until 
equilibrium was reached after about 3 weeks.  On the Waters Acquity system the 
chromatography of the BCDH and BD2 DCLs was carried out at 40°C with gradient D 
(Table 2.5).  On the Agilient Rapid Resolution system the chromatography of the BD2 
DCLs was carried out at 50°C with gradient E, and the chromatography of the B’D2 
DCLs was carried out with gradient F using a gradient temperature, going from 50°C to 
40°C, left to right (Halo C18 column, 4.6 × 100 mm, 2.7 micron).  The peak areas were 
integrated at 254 nm. 
 
Table 2.5.  Analytical LC methods use to analyze BCDH and BD2 DCC libraries on the 
Waters Acquity system (Method D) and the BD2 libraries (Method E) and B’D2 libraries 
(Method F) on the Agilent Rapid Resolution 
 
Gradient D (Waters Acquity) 
Time (min) %B Flow Rate (mL/min) 
0.00 0.0 0.4 
1.00 20.0 0.4 
3.00 29.0 0.4 
9.00 44.0 0.4 
9.10 100.0 0.4 
10.00 100.0 0.4 
10.0 0.0 0.4 
12.00 0.0 0.4 
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Gradient E (Agilent Rapid Resolution) 
Time (min) %B Flow Rate (mL/min) 
0.00 3.0 1.0 
2.00 30.0 1.0 
9.00 48.0 1.0 
10.00 100.0 1.0 
12.00 100.0 1.0 
12.50 3.0 1.0 
16.00 3.0 1.0 
 
Gradient F (Agilent Rapid Resolution) 
Time (min) %B Flow Rate (mL/min) 
0.00 3.0 1.0 
3.00 30.0 1.0 
8.25 30.0 1.0 
10.00 40.0 1.0 
10.10 100.0 1.0 
12.00 100.0 1.0 
12.10 3.0 1.0 
16.00 3.0 1.0 
 
 c. Synthesis and isolation of BD2.  Biased libraries were prepared on a 19.3 mL 
scale (B: 9.0 mg, 0.048 mmol; D: 22.8 mg, 0.097 mmol) templated with a H-KMe2-G-
NH2 (33.4 mg, 0.145 mmol).  Upon equilibration the libraries were neutralized and the 
receptors were isolated by semi-preparative HPLC (Figure 2.61).  Approximately 0.5 mL 
injections were chromatographed using standard peptide synthesis mobile phases A and 
B (0-55% B 0-5 min, then 55-100% B 5-30 min) with a flow rate of 4.0 mL/min.  The 
BD2 peak was collected and analyzed for purity by analytical LC-MS (Figure 2.62). 
Purified BD2 was lyophilized to powder and stored under nitrogen. 
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Figure 2.61. Semi-preparative HPLC trace of a BD2 biased library. 
 
 
Figure 2.62.  Mass spectra of purified BD2 (-ESI). 
 
 d. NMR spectroscopy.  All NMR samples were prepared and analyzed on a 
Varian Inova 600-MHz instrument similarly to those described previously, unless noted 
otherwise.  For characterization, a BD2 sample (approximately 2 mM) was prepared in 
67% 50 mM borate buffer at approximately pD 9 containing 0.05 mM DSS and 33% 
acetonitrile-d3.  There appeared to be significantly less aggregation at such high 
concentrations with the addition of a co-solvent such as acetonitrile.  1D spectra were 
collected at 5 °C, 25 °C, and 40 °C using 32K data points and 16-32 scans with a 1-3 
second presaturation. All 2D NMR experiments used pulse sequences from the 
Chempack software including TOSCY and NOESY.  TOSCY experiments were taken 
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with 16 scans in the first dimension and 128 scans in the second dimension.  NOESY 
experiments were taken with 32 scans in the first dimension and 256 scans in the second 
dimension, with a mixing time of 0.8 seconds.  A number of cross peaks were identified 
in both TOSCY and NOESY experiments allowing for the assignment of all protons 
(Figure 2.66). 
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Figure 2.63.  1H NMR of BD2 at 40 °C in borate buffer with 1/3 acetonitrile-d3 (left) and 
the assigned protons in both possible symmetric isomers (right).   
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Figure 2.64.  1H NMR of BD2 at 25 °C in borate buffer with 1/3 acetonitrile-d3. 
 
 
Figure 2.65.  1H NMR of BD2 at 5 °C in borate buffer with 1/3 acetonitrile-d3. 
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Figure 2.66.  BD2 TOSCY cross peaks (left) and NOESY cross peaks (right).  The cross 
peak between protons F and G is weaker in both cases, as indicated by a dashed arrow. 
 
 To examine LysMe3 binding to BD2, 1D NMR spectra of three samples were 
collected as described above.  Two samples, one containing BD2 and the other H-KMe3-
G-NH2, were prepared in 50 mM borate pD 9.0 with 10% acetonitrile-d3, each with a 
concentration of approximately 4 mM (600 µl).  Upon collection of 1D spectra for both 
samples at 25 °C and 5 °C, 10 µl of a 261 mM H-KMe3-G-NH2 stock solution was added 
to the BD2 sample to give approximately equal concentrations of both receptor and guest, 
and new spectra were collected with 64 scans.  Due to a significant number of buffer 
impurities, a spectra of the buffer alone was collected to ensure everything in the spectra 
could be properly accounted for.   
 114 
 
Figure 2.67.  1H NMR of H-KMe3-G-NH2 at 25 °C. 
 
Table 2.6.  Proton chemical shift assignments for 1H NMR of H-KMe3-G-NH2 at 25 °C. 
Residue α β γ δ ε Me 
KMe3 3.435 1.706, 1.646 1.390 1.792 3.289 3.080 
G 3.917      
 
ACN-d3 
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Figure 2.68.  1H NMR of H-KMe3-G-NH2 with BD2 at 25 °C. 
 
Table 2.7.  Proton chemical shift assignments for 1H NMR of H-KMe3-G-NH2 bound to 
BD2 at 25 °C. 
Residue α β γ δ ε Me 
KMe3 3.370 1.524, 1.449 1.078 1.290 2.781 2.597 
G 3.918      
 
ACN-d3 
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Figure 2.69.  1H NMR of H-KMe3-G-NH2 at 5 °C. 
 
Table 2.8.  Proton chemical shift assignments for 1H NMR of H-KMe3-G-NH2 at 5 °C. 
Residue α β γ δ ε Me 
KMe3 3.446 1.704, 1.660 1.384 1.798 3.302 3.088 
G 3.918      
 
ACN-d3 
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Figure 2.70.  1H NMR of H-KMe3-G-NH2 with BD2 at 5 °C. 
 
Table 2.9.  Proton chemical shift assignments for 1H NMR of H-KMe3-G-NH2 bound to 
BD2 at 5 °C. 
Residue α β γ δ ε Me 
KMe3 3.421 1.445, 1.382 0.910 1.013 2.502 2.331 
G 3.920      
 
 For the NMR titration experiment, a 100 µM sample of H-KMe3-G-NH2 was 
prepared in 50 mM borate pD 9.0 with 10% acetonitrile-d3.  A 12 mM stock solution of 
BD2 was also prepared in 50 mM borate pD 9.0 with 10% acetonitrile-d3, and 1 to 30 µl 
aliquots were titrated into the KMe3 sample.  1D NMR spectra were collected before the 
addition of BD2 and with each successive addition at 25 °C using 64 scans.  The 
concentration of BD2 in each spectrum was calculated by taking into account the sample 
volume increase with each addition.  The spectra at BD2 concentrations of 100 µM, 600 
ACN-d3 
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µM, and 2.0 mM are shown in figure 2.57, where a significant upfield shift of protons A-
E of the naphthalene moieties is observed due to aggregation of BD2.   
  e. Fluorescence aggregation studies.  BD2 samples were prepared in 10 mM 
borate buffer, pH 9, at varying concentrations, and when applicable, a 3-fold excess of H-
KMe3-G-NH2 was added.  Both BD2 and KMe3 concentrations were determined by mass.  
Fluorescence scans were obtained at 25 °C in a 1 cm pathlength quartz microcuvette, 
using and excitation wavelength of either 240 nm or 278 nm and collecting an emission 
spectra from either 260-470 nm or 300-350 nm respectively.   
 
E. Selective recognition of asymmetric dimethylarginine and trimethyllysine: 
receptor A2D 
 i. Results and discussion 
  a. Unbiased library templation studies.  Monomers A, B, and D can all be 
deemed “successful” building blocks, in that they have each been shown to contribute to 
the recognition of methylated PTMs, reacting with each other through disulfide exchange 
to construct the small molecule receptors rac-A2B, meso-A2B, and BD2.  On the contrary, 
monomers C, E, G, and H have been included in library screens, but have yet to be 
incorporated into a receptor that is significantly amplified in the presence of a methylated 
PTM.  To determine whether any new receptors could be identified which incorporate all 
three of these “successful” building blocks in the generation of more potent, more 
selective PTM receptors, monomers A, B, and D were investigated in a single DCL.
 While this ABD DCL has the potential to form and amplify novel PTM receptors, 
amplification of the previously identified receptors, rac-A2B, meso-A2B, and BD2, should 
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also be expected to different extents depending on the PTM template.  This could serve as 
a competition assay to some degree, yet it must be recognized that having multiple 
receptors amplified and therefore multiple equilibria at play in a single library 
complicates the system.  As a result of this competition between receptors for specific 
building blocks, the efficiency of amplification in this case may not correlate directly 
with the strength of binding.57  This breakdown in the correlation between amplification 
and binding efficiency occurs largely as a result of the tendency of DCLs to maximize the 
binding interactions of the entire library.58  Amplification of a specific receptor may be 
less for one PTM than another, not necessarily because binding is weaker, but because a 
tighter binder has significantly depleted the supply of a required building block, for 
example.  In addition, competition between macrocycles for specific building blocks can 
also result in a competitive advantage for those library members that are not dependent 
on those building blocks.59  
 The three building blocks were combined in equal amounts (2.5 mM each) at pH 8.5 
(Figure 2.71).  Initially, only the higher methylation state templates, KMe3, sRMe2, and 
aRMe2, were investigated, and thus three DCLs contained a PTM template at a 
concentration of 7.5 mM, while no template was added to the fourth DCL.  The libraries 
were allowed to oxidize in capped HPLC vials at room temperature, and their 
compositions were analyzed by LC-MS at various time points. 
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Figure 2.71.  Unbiased DCL of dithiol monomers A, B, and D resulting in amplification 
of receptors rac-A2B, meso-A2B, BD2, and A2D upon addition of a KMe3 or RMe2 
dipeptide guests. 
 
 Initial library analysis revealed far more complex chromatograms relative to the 
previous library screens, with significantly more co-elution of library members.  This 
highlights the limits associated with LC/MS as a detection method for amplification in 
dynamic combinatorial libraries, as libraries can very quickly become too complex for 
adequate resolution.  Initially analyzed under conditions that were optimized for 
resolution of the library as a whole, in the absence of guest, numerous major constituents 
were detected, as well as many smaller peaks.  Upon introducing a trimethyllysine 
dipeptide, the amplification of multiple peaks was observed, dominantly rac-A2B, meso-
A2B, and BD2, as was to be expected (Figure 2.72).  Receptor BD2 co-elutes with 
macrocycle A2B3 in both templated and untemplated libraries, and therefore the exact 
extent of amplification is difficult to ascertain.  In addition, the more subtle amplification 
of a fourth new receptor was observed, identified as A2D.  Interestingly, the formation 
and amplification of only a single A2D isomer was observed.   
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 In comparing the amplification in this ABD DCL in the presence of KMe3 to that of 
aRMe2, as predicted, receptors rac-A2B, meso-A2B, and BD2 were all amplified to a 
lesser extent by aRMe2.  In contrast, however, A2D appeared to be amplified to a 
significantly greater extent when the library was templated with aRMe2 (Figure 2.72).  
This is the first time that a dimethylated Arg PTM was found to amplify a potential 
receptor to a greater extent than KMe3.  By replacing the phenyl based monomer B with 
the naphthalene containing monomer D in A2B, it could be envisioned that the size of the 
binding pocket is increasing, in turn creating a tighter lock-and-key fit between A2D and 
aRMe2 than was possible with A2B.  While this amplification could indeed be the result 
of tighter binding to aRMe2, the degree of A2D amplification in both cases may also be 
influenced by the extent of competition for building blocks A and D with the other 
amplified receptors.   
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Figure 2.72.  The analytical HPLC trace at 254 nm of a DCL consisting of monomers A, 
B, and D (2.5 mM each), untemplated (blue) and in the presence of KMe3 (top, red) and 
aRMe2 (bottom, red). 
 
 As there is some degree of co-elution of A2D and A2BD, the LC/MS analysis 
conditions were optimized for baseline resolution of A2D with little concern as to the 
resolution of the rest of the library.  By doing so, a more accurate picture of the extent of 
amplification was obtained.  While a close to undetectable concentration of A2D was 
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present in the untemplated library, curtailing the integration accuracy and therefore the 
calculated percent change, a clear amplification trend was observed.  Both dimethyl 
arginine PTMs amplified A2D to a greater extent than LysMe3, with more favorable 
recognition of aRMe2 than sRMe2 (Figure 2.73).   
A
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— sRMe2
— aRMe2
    
Figure 2.73.  The extent of amplification of A2D in an ABD library with PTM dipeptide 
guests (the A2D HPLC peak at 254 nm on the left, and the calculated percent change on 
the right).   
  
  b. Biased library templation studies.  While the ABD library results take into 
account multiple equilibria and are influenced by the competition between four receptors 
for certain building blocks, a biased library with only monomers A and D should allow 
for a more accurate evaluation of the recognition of methylated PTMs by A2D.  A DCL 
was set up biased towards the formation of A2D in which building blocks A and D were 
mixed in a 2:1 ratio (7.5 mM total).  At this point the selectivity of A2D for the lower 
methylation states of lysine and arginine was also investigated, as the unmethylated 
lysine and arginine control peptides had not yet been evaluated.  By biasing the library 
towards the formation of A2D, this receptor is also formed to a larger extent, allowing for 
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a better visualization of the amplification as well as a more accurate integration of the 
peak areas.   
 A diverse library was generated in the absence of a template, with A2D constituting 
only 3.3% of the total library composition.  Upon templation with asymmetric RMe2, 
A2D is strongly amplified and clearly becomes the largest species in the library (Figure 
2.74).  The amplification by symmetric RMe2 and RMe however is quite weak in 
comparison, showing a similar affinity of A2D for both sRMe2 and RMe.  This implies 
that A2D exhibits quite impressive selectivity for aRMe2 over sRMe2.  It is likely that 
only one methyl group of sRMe2 significantly contributes to binding, resulting in 
comparable amplification in the presence of both sRMe2 and RMe.  It is possible that the 
pocket of A2D is not large enough to accommodate sRMe2, whereas it fits much more 
tightly around aRMe2 where both methyl groups are in close proximity and can therefore 
make favorable contacts with the receptor.   
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Figure 2.74.  The analytical HPLC trace at 254 nm of a biased DCL consisting of 
monomers A (5 mM) and D (2.5 mM), untemplated (gold) and in the presence of KMe2 
(magenta), KMe3 (green), sRMe2 (red), and aRMe2 (blue). 
 
 
Figure 2.75.  Amplification results of an A2D biased library templated with all lysine and 
arginine dipeptide guests.  The extent of amplification of A2D (blue) and both A3 isomers 
(red and yellow) is shown.    
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 In the presence of KMe3, A2D is now amplified to a greater extent in the biased 
library relative to the unbiased ABD library.  As a result of the high affinity of KMe3 for 
both A2B and BD2, it is likely that in the unbiased library both of these receptors were 
out-competing A2D for the required monomers, resulting in a smaller observed 
amplification of A2D.  Asymmetric RMe2, however, binds A2B and BD2 with very weak 
affinity, and therefore this competitive effect was minimal in comparison and a less 
drastic change in amplification between the unbiased and biased libraries was observed.  
The amplification of A2D was dependant on the extent of lysine methylation, increasing 
with increasing methylation, suggesting a significant selectivity for KMe3 over both 
KMe2 and KMe (Figure 2.75).  This increased affinity for KMe3 is likely due to its larger 
surface area, greater hydrophobicity, lack of desolvation penalty, and ability to form 
stronger cation-π interactions. 
 In addition to the amplification of A2D, upon templation with KMe3 a similar degree 
of amplification of A3 was also observed in this library.  Although to a much lesser 
magnitude, this is also observed with KMe2.  Macrocycle A3 exists as two diastereomers, 
the major being the diastereomer in which the subunits have different chiralities, and the 
minor being the diastereomer in which all three subunits have the same chirality, as 
reported previously.43  This again results in a competitive equilibrium in these lysine 
PTM templated libraries, as both receptors A2D and A3 are in competition for monomer 
A, which may in turn breakdown the correlation between amplification and binding 
efficiency.  As this is not the case for the aRMe2 containing DCL, it is again difficult to 
directly compare the amplification of A2D by KMe3 versus aRMe2.   
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 The observed amplification of A3 can also be used to make predictions about the 
affinity of A2D for KMe3.  In re-evaluating the A2B biased libraries templated with 
KMe3, only a trivial amount of amplification of both A3 diastereomers is detected, 
indicating that both A2B receptors are the more “fit” receptors.  This is based on the idea 
that strong binders survive and are amplified while the weaker ones perish, and it is this 
principle that is considered to be the foundation of DCC.57  The amplification of A2D 
does not dominate over the amplification of the A3 isomers to the same degree, signifying 
that A2D and A3 are both weaker KMe3 binders than rac-A2B or meso-A2B.  The extent 
to which A2D binds more weakly than A2B, however, cannot be determined from these 
experiments.  
 c. Preparative scale biased libraries and isolation of A2D.  To pursue further 
studies of A2D regarding its affinity and selectivity for aRMe2, preparation and isolation 
of this macrocycle was required.  Large scale biased libraries were prepared with a total 
volume of 10-20 mL and a ratio of A : D : guest of 2 : 1 : 3, with a total monomer 
concentration (A + B) of either 7.5 or 10 mM.  Previously the affinity of A2D for 
methylisoquinoline in comparison to aRMe2 was investigated on an analytical scale, and 
it was determined that methylisoquinoline was a superior template resulting in a higher 
concentration of A2D.  Consequently, due to A2D’s apparent high affinity for 
methylisoquinoline and our ability to prepare it cheaply on a much larger scale than an 
aRMe2 peptide, these libraries were templated with methylisoquinoline.  The three solids 
were combined with the appropriate amount of water, titrated to pH 8.5 with NaOH and 
HCl, and let stir in a capped scintillation vial for 1-3 weeks before being purified on a 
semi-preparative HPLC.  The purity was confirmed in each case by LC/MS.  Relative to 
 128 
the synthesis and purification of rac- and meso-A2B, the preparation of A2D afforded 
higher yields, comparable to that of BD2, still in low milligram quantities. 
  d. Characterization of A2D.  Since monomer A is used as a racemic mixture and 
monomer D lacks a plane of symmetry (unlike monomer B), there are two sets of 
possible A2D diastereomers (Figure 2.76).  In contrast to the amplification of both A2B 
stereoisomers, the amplification of only a single A2D diastereomer in the presence of 
methylated PTMs was observed, showing a surprisingly high degree of selectivity and 
indicating significant structural differences between the A2D isomers.  It can also be 
assumed that one isomer is significantly more thermodynamically stable than the others 
due to the fact that in the untemplated library a statistical ratio of the isomers is not 
observed.  Instead, one peak corresponding to the mass of A2D is significantly more 
dominant, and often the only A2D peak in high enough concentration to be detected by 
MS.  It has yet to be determined if the amplification of a single isomer is truly due to the 
fact that only one isomer is structurally capable of binding aRMe2 and therefore gets 
amplified, or if the other isomers are not present at all at thermal equilibrium or exist in 
such low concentrations that they go unnoticed. 
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Figure 2.76.  Isomers of A2D. 
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The purified A2D receptor was analyzed by NMR to gain further insight as to the 
macrocycle’s purity and structure.  Twenty-one distinct signals were expected for a single 
A2D isomer, which is what was revealed in the 1D spectra, confirming that only a single 
isomer was present in solution.  Low temperature experiments proved crucial to achieve 
sufficient resolution to distinguish all 21 protons.   Furthermore, changes in the 
concentration of A2D did not result in any noticeable changes in the proton chemical 
shifts, eliminating the possibility of A2D aggregation as a potential problem for future 
studies.   
In combination with the 1D spectra, NOESY, TOSCY, and COSY experiments 
revealed a great deal of information about the conformation of the A2D receptor.  Most 
notable were the chemical shifts of protons 2 and 3 of monomer D, shifted up to 
approximately 3.1 ppm and 2.9 ppm respectively (Figure 2.77).  This is almost 5 ppm 
further upfield from where these proton signals appear in the spectra of the monomer in 
isolation, indicating a significant interaction with the remainder of the macrocycle.  It is 
proposed that this portion of the naphthalene moiety is pointing towards the inside of the 
receptor cavity, sandwiched between both A molecules and packing into the hydrophobic 
pocket.  Although to a lesser extent, protons 1 and 4 also appear upfield from where they 
would be expected, again indicating that monomer D is packing up against the 
hydrophobic portions of both A monomers.  This was confirmed by the presence of 
NOESY cross peaks between both protons 1 and 4 of D and protons 6 and 13 (Figure 
2.78, green arrows).     
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Figure 2.77.  1H NMR of A2D at 5 °C in borate buffer.  The numbered protons 
correspond to those assigned in monomer D.  The blue and orange protons are each from 
an A molecule on the same face of A2D, and are in close proximity (protons 14 – 21, 
figure 2.78), whereas the green and magenta protons are on the other face of A2D and are 
further from each other (protons 6 – 13). 
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Figure 2.78. A2D NOESY cross peaks within each monomer unit and between 
monomers.  Cross peaks are observed between protons 1 and 6 and 4 and 13 in one 
enantiomer (of the RR,SS/SS,RR pair), and between 1 and 13 and 4 and 6 in the other. 
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Furthermore, A2D is predicted to be the RR,SS/SS,RR enantiomers (Figure 2.76).  
This is due to the presence of cross peaks between four monomer A aromatic doublets all 
in close proximity on one face of the molecule (for example 14, 15, 20, and 21), as 
indicated by the NOESY spectra (Figure 2.78, red arrows).  A cross peak is also present 
between protons 17 and 18 further confirming this hypothesis.  While both A monomers 
appear to be in close proximity on one face of the molecule, as one can “walk” in a 
complete circle from proton 14 to proton 21 in the NOESY spectra, the other sides of 
both A molecules appear to be further apart from each other (protons 6-14), creating 
somewhat of a binding cleft.  These NMR experiments provide substantial evidence that 
A2D is forming a good binding cavity for methylated PTMs, however it is not known to 
what degree A2D maintains this structure upon binding.    
  e. NMR analysis of asymmetric dimethyl arginine binding to A2D.  NMR was 
also used to investigate the recognition of asymmetric ArgMe2 by A2D.  The acylated 
Ac-aRMe2-G-NH2 dipeptide was first characterized at 5 °C in aqueous buffer.  
Subsequently, the peptide was analyzed under the same conditions in the presence of an 
excess of A2D to ensure that all of the aRMe2 peptide was bound.  In addition to 
noticeable broadening of both the A2D and peptide signals upon binding, a clear shift of 
the dipeptide protons was observed, confirming that the methylated arginine is indeed 
bound to the hydrophobic cleft of A2D.  While the largest upfield shift was observed for 
the two methyl groups which are indistinguishable by NMR, the extent of shifting 
decreases moving down the Arg side chain towards the peptide backbone (Figure 2.79).  
The methyl groups are upfield shifted 0.914 ppm, which is quite comparable to the shifts 
observed in the recognition of KMe3 by A2B and BD2.   
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Figure 2.79.  Upfield side-chain chemical shifts of Ac-aRMe2-G-NH2 upon binding to 
A2D at 5 °C.  Conditions: 50 mM borate pD 9.0, referenced to DSS.  
 
 For comparison, the extent of shifting of the KMe3 methyl groups upon binding A2D 
was assessed.  If both aRMe2 and KMe3 are binding in a comparable fashion, it would be 
expected that the methyl groups of both PTMs would be affected similarly.  At 5 °C, the 
three methyl groups on lysine were found to shift 0.985 ppm, which is very similar to the 
observed shift of the arginine methyl groups.  These results confirm that the key binding 
interaction in both cases is between the methylammonium group and the aromatic pocket 
of A2D. 
  f. Binding studies by fluorescence quenching. In order to evaluate the affinity of 
A2D for the different methylated PTMs, as well as the extent of selectivity, for example 
between aRMe2 and sRMe2 or between aRMe2 and KMe3, binding studies were 
conducted.  The determination of binding constants for A2D will allow for an interesting 
comparison between A2D and A2B, and reveal more information regarding the effect of 
replacing the phenyl ring in A2B with the naphthalene moiety in A2D.  Binding studies 
were initially attempted via fluorescence anisotropy to allow for a direct comparison to 
the affinities determined for A2B.  The histone tail peptides previously synthesized 
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containing residues 5-12 of the histone 3 tail and a methylated residue at either Arg8 or 
Lys9, as well as an N-terminal carboxyfluorescein were used to measure binding.  The 
binding studies were performed under similar conditions as those for A2B. 
 In addition to measuring the fluorescence anisotropy for each experiment, a simple 
fluorescence intensity reading was performed on each sample containing both fluorescent 
peptide and a known concentration of A2D.  As the amount of peptide remains constant in 
each, this fluorescence reading is expected to remain unchanged throughout the 
experiment, despite the increasing concentration of A2D.  This indicates that A2D is not 
interacting directly with the fluorophore to cause any form of undesired fluorescence 
quenching, and therefore the anisotropy readings are based solely on the variations in 
parallel and perpendicular fluorescence due to changes in fluorescein rotation upon 
binding.   
 In initial experiments with different PTM peptides in which the level of fluorescein 
fluorescence is evaluated throughout the experiment, a change in fluorescence was 
observed.  This change was generally a drop in fluorescence intensity with increasing 
concentrations of A2D, indicating some degree of fluorescein quenching by A2D.  While 
naphthalenes have been shown to quench the fluorescence of other naphthalene 
molecules in the case of BD2, it should not be entirely surprising that monomer D would 
also serve as a quencher of other fluorophores such as fluorescein.  Due to the fact that 
the extent of fluorescence quenching varied from one PTM peptide to another, this 
revealed that this was not a systematic interaction.  As a result, the anisotropy binding 
data was being affected dissimilarly for the different PTM peptides, and this no longer 
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allowed for an accurate evaluation and comparison of the binding affinities via 
fluorescence anisotropy.   
Interestingly, the degree of fluorescein quenching was greatest for the H3 peptides 
containing either aRMe2 or KMe3, whereas the peptides containing lower methylation 
states exhibit little to no fluorescence quenching.  Based on prior studies, both aRMe2 
and KMe3 are expected to bind A2D most tightly, and this implies that the extent of 
quenching is related to the PTM binding affinity.  Most likely, the binding event occurs 
first which puts the naphthalene in close proximity to the fluorescein, and the 
fluorescence is quenched as a result.  If the quenching were not binding induced, the 
same degree of quenching would be expected for all PTM peptides, regardless of their 
affinity for A2D. 
Since the degree of quenching is a reflection of binding affinity, this allowed for 
binding to be quantified by fluorescein quenching.  The fluorescence intensity of an H3 
control peptide with both Arg8 and Lys9 mutated to Gly was first measured in a similar 
fashion in the presence of increasing concentrations of A2D.  In each case the 
fluorescence of this control peptide, which does not bind and therefore exhibits no 
quenching, was subtracted from that of each PTM peptide fluorescence to ensure that the 
fluorescence change analyzed was that solely due to A2D binding to the PTM of interest.  
The change in fluorescein fluorescence for peptides containing all methylation states at 
either Arg8 or Lys9 was evaluated.   
The H3 aRMe2 peptide was found to bind A2D with a binding affinity of 38 µM, 
which is slightly weaker than the affinity determined for the binding of A2B with KMe3, 
yet is still comparable to the affinity of many natural PTM protein receptors.  Equally 
 135 
significant is the observed selectivity, as A2D was found to bind the H3 aRMe2 peptide 
with greater than 6-fold selectivity over its symmetric RMe2 counterpart (Kd = 236 µM).  
The ability of A2D to discriminate between these closely related PTMs is quite 
promising, enhancing the potential usefulness of this small molecule receptor.  It is clear 
that either the difference in size of these two RMe2 PTMs, or the localization of both 
methyl groups on a single nitrogen in aRMe2 play a significant role in enabling A2D to 
differentiate between the two modifications.  The H3 RMe peptide exhibited even weaker 
affinity, while no appreciable binding was observed for the unmethylated histone tail.   
 
Table 2.10.  Dissociation constants for H3 tail peptides with varying methylation states at 
R8 and K9 as determined by fluorescence quenching.a 
 
Peptide 
A2D 
Kd (µM)b 
H3 asymmetric R8Me2 38 ± 8 
H3 symmetric R8Me2 236 ± 39 
H3 R8Me 474 ± 79 
H3 K9Me3 40 ± 7 
H3 K9Me2 95 ± 11 
H3 K9Me 663 ± 234 
H3 R8K9 No Binding 
 
a Conditions: 27 °C, 10 mM phosphate buffer, pH 8.5.  b Errors are from the fit.   
 
 Interestingly, the binding affinity of A2D for KMe3 was found to be quite comparable 
to that of aRMe2, showing little distinction between the two quite different modifications.  
Despite their similarity in binding affinity, it is likely that various favorable interactions 
are contributing to a different degree in each case, however producing a similar end 
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result.  For example, KMe3 likely results in a stronger cation-π interaction with the 
receptor, whereas aRMe2 may result in a tighter lock-and-key type fit with A2D.  This 
comparable affinity would not have otherwise been realized based on the A2D 
amplification data alone, which is likely a result of the competitive amplification of A3 in 
the case of KMe3, without which the amplification of both aRMe2 and KMe3 may have 
been comparable.  This highlights the possible breakdown of the correlation between 
amplification and binding efficiency as a result of complex competing equilibrium in a 
single DCL, and the tendency of DCLs to maximize the binding interactions of the entire 
library.  Similarly, A2D was found to bind KMe2 with a dissociation constant of 95 µM, 
which is again higher than may have been predicted based on amplification data alone 
due to the competitive binding with A3.  The affinity continues to drop with decreasing 
lysine methylation, mimicking the binding trend of both A2B and native protein 
receptors.   
 
ii. Conclusions 
  In addition to the identification of receptors for the higher methylation states of 
lysine, we have now identified a small molecule receptor exhibiting equally promising 
affinity for asymmetric RMe2.  Although little is known regarding the affinity of aRMe2 
protein binding domains, it can be predicted that the affinity of A2D will not only parallel 
that of protein receptors, but also allow for its use in a variety of biological applications.  
As methylated arginine PTMs and their corresponding protein receptors remain less well 
understood, such small molecule receptors are especially attractive in both the 
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investigation of known sites of arginine methylation as well as the identification of new 
sites of methylation.  
 In comparing A2D to both rac- and meso-A2B, it is clear that replacing one monomer 
makes a substantial impact on the receptor’s recognition capabilities.  A2D not only 
recognizes aRMe2 with about 16-fold greater affinity than rac-A2B, but its affinity for all 
methylated lysine PTMs is slightly diminished due to the change in receptor structure, 
while its affinity for all methylated arginine PTMs is slightly enhanced.  Although these 
small molecule receptors do not display an absolute selectivity for a single PTM, they 
exhibit a degree of selectivity that has not been demonstrated previously with small 
molecule PTM receptors.  Furthermore, they display a level of affinity and selectivity that 
would be challenging to predict and achieve a priori, demonstrating the overall utility of 
DCC as a high-throughput method for developing such PTM receptors for biological 
applications.   
 
iii. Experimental Section 
  a. Dynamic combinatorial library screens.  Overall, library screens were 
conducted similarly to those described previously.  The relevant building blocks were 
individually dissolved in water with sufficient 1.0 M aqueous NaOH to bring them into 
solution, and the pH of each solution was then adjusted to 8.5.  In the unbiased ABD 
libraries, aliquots of each monomer solution were combined in a 2 mL LC-MS vial to 
reach a final concentration of 2.5 mM of each monomer (7.5 mM total). In the biased 
A2D libraries, aliquots of each monomer solution were combined in a 2 mL LC-MS vial 
to reach a final concentration of 5 mM A and 2.5 mM of D.  When necessary, aliquots of 
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peptide guests dissolved in water were added to the reactions to reach a final 
concentration of 7.5 mM peptide.  The vials were capped and analyzed at various time 
points. 
  b. Analytical LC/MS.  LC-MS was carried out on an Agilent Rapid Resolution 
LC-MSD system equipped with an online degasser, binary pump, autosampler, heated 
column compartment, and diode array detector.  All separations were performed using 5 
mM NH4OAc H2O-acetonitrile gradients at pH 5 and a Halo C18 column (4.6 × 100 mm, 
2.7 micron).  The MS was performed using a single quadrupole mass spectrometer via 
negative electrospray ionization.  The reactions were monitored weekly (3 µL injections) 
until equilibrium was reached.  The chromatography of both ABD and A2D DCLs were 
carried out with gradient G (Table 2.11), using a gradient temperature, going from 40°C 
to 50°C, left to right.  The peak areas were integrated at 254 nm and the percent change in 
concentration and/or amplification factors were calculated. 
 
Table 2.11.  Analytical LC methods use to analyze DCC libraries ABD and A2D 
(Method G). 
 
Gradient G 
Time (min) %B Flow Rate (mL/min) 
0.00 3.0 1.0 
3.00 30.0 1.0 
8.00 33.0 1.0 
10.30 34.0 1.25 
12.00 50.0 1.25 
13.00 100.0 1.25 
15.00 100.0 1.0 
15.10 3.0 1.0 
20.00 3.0 1.0 
 
 c. Synthesis and isolation of A2D.  Biased libraries were prepared on a 15 mL 
scale (A: 35.6 mg, 0.1 mmol, 6.67 mM; D: 11.8 mg, 0.05 mmol, 3.33 mM) templated 
 139 
with methylisoquinoline triflate (44.0 mg, 0.15 mmol, 10 mM).  Upon equilibration the 
libraries were neutralized and the receptors were isolated by semi-preparative HPLC.  
Approximately 0.5 mL injections were chromatographed using standard peptide synthesis 
mobile phases A and B (0-50% B 0-5 min, then 50-75% B 5-20 min) with a flow rate of 
4.0 mL/min.  A sharper A2D peak was achieved with a column heater set to 40°C, but this 
was not necessary for separation from the library.  The A2D peak at 13.5 minutes was 
collected (Figure 2.80) and analyzed for purity by analytical LC-MS (Figure 2.81).  
Purified A2D was lyophilized to powder and stored under nitrogen.  
 
 
 
Figure 2.80. Semi-preparative HPLC trace of an A2D biased library at 254 nm. 
 
 
Figure 2.81.  Mass spectra of purified A2D (-ESI). 
 
    Template 
A2D 100% B 
flush 
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 d. NMR spectroscopy.  All 1D and 2D NMR samples were prepared and 
analyzed on a Varian Inova 600-MHz instrument similarly to those described previously, 
unless noted otherwise.  For characterization, a 600 µM A2D sample was prepared in 50 
mM borate buffer at pD 9.25 containing 0.05 mM DSS (Figure 2.77).  The 1D spectrum 
of A2D was collected at 5 °C using 32K data points and 900 scans with a 3 second 
presaturation.  1H NMR (600 MHz): δ = 8.20 (s, 1H), 8.18 (s, 1H), 8.07 (s, 1H), 8.04 (d, 
1H), 7.99 (s, 1H), 7.97 (d, 1H), 7.81 (d, 1H), 7.73 (s, 1H), 7.61 (d, 1H), 7.05 (d, 1H), 6.82 
(s, 1H), 6.46 (d, 1H), 5.95 (s, 1H), 5.75 (d, 1H), 5.72 (s, 1H), 5.58 (s, 1H), 5.34 (d, 1H), 
5.30 (s, 1H), 5.22 (s, 1H), 3.10 (dd, 1H), 2.93 (d, 1H).  2D NMR experiments used for 
structural analysis included COSY, TOSCY, and NOESY experiments. 
 To examine asymmetric RMe2 binding to A2D, two samples, one with Ac-aRMe2-G-
NH2 (0.65 mM) only, and the other Ac-aRMe2-G-NH2 (0.65 mM) bound to A2D (1.0 
mM), were prepared in 50 mM borate buffer pD 9.25.  1D spectra were collected for each 
5 °C with 32K data points and 64 scans.  All arginine protons were assigned using 
standard methods.  An identical experiment was performed with Ac-KMe3-G-NH2 (0.65 
mM) in the absence and presence of A2D (1.0 mM).  
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Figure 2.82.  1H NMR of Ac-aRMe2-G-NH2 at 5 °C. 
 
Table 2.12.  Proton chemical shift assignments for 1H NMR of Ac-aRMe2-G-NH2 at 5 
°C. 
Residue α β γ δ Me2 
aRMe2 4.264 1.869, 1.768 1.674 3.263 2.996 
G 3.901     
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Figure 2.83.  1H NMR of H-KMe3-G-NH2 with A2D at 5 °C. 
 
Table 2.13.  Proton chemical shift assignments for 1H NMR of Ac-aRMe2-G-NH2 bound 
to A2D at 5 °C. 
Residue α β γ δ Me2 
aRMe2 4.266 1.746, 1.629 1.440 2.850 2.082 
G 3.936     
 
  e. Fluorescence quenching binding experiments.  Binding assays were 
performed with purified A2D and fluorescein labeled histone 3 peptides.  Peptides were 
dissolved in buffer (10 mM phosphate pH 8.5), and 25 µM solutions were prepared as 
determined by UV-Vis at 492 nm (ε = 78,000 M-1cm-1).  A 0.25 mM stock solution of 
A2D was prepared, with the solution concentration determined by mass.  Assays were 
prepared in 96-well half-area plates with a total volume of 50 µL per well, containing 5 
µM labeled peptide and increasing concentrations of A2D (from 0 µM to 195 µM) in 
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buffer.  Plates were spun down and allowed to incubate for at least 30 minutes before 
analysis.  Fluorescence scans were measured on a PHERAstar plate reader (BMG 
Labtech) at approximately 27°C, using an excitation wavelength of 485 nm and an 
emission wavelength of 520 nm (Figure 2.84).   
 In each case the fluorescence scans for the control peptide, containing glycine at Arg8 
and Lys9, were subtracted from the raw quenching data for each PTM experiment before 
fitting the data.  Fluorescence titrations were plotted as a function of A2D concentration 
and fit to the following equation for 1:1 binding in KaleidaGraph, where I is the observed 
fluorescence intensity, Io is the initial fluorescence intensity of the peptide, I∞ is the 
fluorescence intensity at binding saturation, [L] is the concentration of the added 
receptor, and Kd is the dissociation constant.  All measurements were taken in duplicate 
or triplicate.   
I = (Io + I∞([L]/Kd)) / (1 + ([L]/Kd)) 
 
 
Figure 2.84.  Representative uncorrected fluorescence intensity data prior to subtraction 
of the Gly8-Gly9 control peptide (Ac-QTAGGSTG-NH2).  Fluorescence titration of G8-
G9 (red), sRMe2 (orange), KMe2 (yellow), KMe3 (green), and aRMe2 (blue) with A2D. 
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Figure 2.85.  Fluorescence titration of H3 aRMe2 with A2D.  The data is corrected by 
subtracting the fluorescence of the H3 Ac-QTAGGSTG-NH2 control peptide.   
 
 
Figure 2.86.  Fluorescence titration of H3 sRMe2 with A2D.  The data is corrected by 
subtracting the fluorescence of the H3 Ac-QTAGGSTG-NH2 control peptide. 
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Figure 2.87.  Fluorescence titration of H3 RMe with A2D.  The data is corrected by 
subtracting the fluorescence of the H3 Ac-QTAGGSTG-NH2 control peptide. 
 
 
Figure 2.88.  Fluorescence titration of H3 KMe3 with A2D.  The data is corrected by 
subtracting the fluorescence of the H3 Ac-QTAGGSTG-NH2 control peptide. 
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Figure 2.89.  Fluorescence titration of H3 KMe2 with A2D.  The data is corrected by 
subtracting the fluorescence of the H3 Ac-QTAGGSTG-NH2 control peptide. 
 
 
Figure 2.90.  Fluorescence titration of H3 KMe with A2D.  The data is corrected by 
subtracting the fluorescence of the H3 Ac-QTAGGSTG-NH2 control peptide. 
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Figure 2.91.  Fluorescence titration of H3 RK with A2D.  The data is corrected by 
subtracting the fluorescence of the H3 Ac-QTAGGSTG-NH2 control peptide. 
 
F. Use of small molecule post-translational modification receptors in peptide 
microarrays 
 i. Background and Significance 
  The small molecules described above are quite unusual as PTM binding domains, 
not only due to their small size in comparison to typical protein binders and antibodies, 
but largely due to their ability to bind in a non-sequence selective fashion.  Consequently, 
these molecules have the potential to serve as novel tools in the identification of sites of 
lysine and arginine methylation in proteins that have yet to be identified.  To achieve this 
goal, the ability of these receptors to identify known sites of methylation within proteins 
must first be demonstrated.  Ideally a screening approach would be used in a high-
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throughput manner, making use of peptide arrays to readily identify PTM containing 
histone tails that a specific small molecule receptor interacts with.   
 To investigate binding in a microarray format we have established a collaboration 
with Dr. Brian Strahl’s group in the Department of Biochemistry and Biophysics in the 
UNC School of Medicine.  With their knowledge in the field of histone peptide 
microarrays, we hope to develop and establish methodology for screening histone 
peptides for their affinity for small molecule receptors such as A2B and A2D.  The Strahl 
lab is developing the technology for such microarrays, in which histone PTM peptides are 
spotted in a grid format on a glass plate (Figure 2.92).  Various histone sequences are 
individually synthesized containing different known PTMs, including all methylation 
states of both lysine and arginine.  Each peptide is appended with a terminal biotin, which 
can subsequently be conjugated to a glass plate via a biotin-streptavidin interaction.  
Upon incubation with a known binder for a specific PTM, such as a protein or antibody 
as is being investigated by the Strahl lab, or a small molecule receptor in our case, the 
relative affinity of that binder for all the PTM containing peptides can be evaluated.  
Typically, after incubation with an effector protein, for example, the plate is then 
incubated with a fluorophore-containing antibody which recognizes and binds any 
proteins bound to the plate via interaction with a PTM peptide.  A primary and then 
fluorophore-containing secondary antibody is sometimes used, while alternatively the 
direct fluorescent labeling of the PTM receptor is also possible.  After various washes the 
fluorescence intensity of the plate can be visualized and quantified to some degree at each 
spot.  While a bright spot is indicative of a tightly bound receptor, no signal is expected 
for the PTMs which do not bind the given receptor.  This allows for the general 
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evaluation of both PTM affinity and selectivity, and can be used to assess PTM binding 
in a sequence selective or non-selective fashion, as well as screening for the effect of 
additional nearby PTMs.   
 
Figure 2.92.  Peptide microarray assays.  An array of histone peptides with desired 
modifications are conjugated onto the plate and then incubated first with the receptor of 
interest, followed by a fluorescently labeled antibody which recognizes the receptor and 
allows for visualization of the binding interaction.   
 
 While there is much to still be worked out in the implementation of this technology, it 
clearly has the potential to showcase the utility of small molecule PTM receptors.    We 
hope to first demonstrate the affinity of A2B for all KMe3 containing peptides, while also 
achieving a level of detection that clearly discriminates between KMe3 and the lower 
lysine methylation states.  Eventually we hope to be able to use this microarray 
technology for the identification of unknown PTM sites by coating plates with, instead of 
synthetic well-characterized peptides, proteins with unknown PTMs.   
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 ii. Results, discussion, and ongoing work 
  a. Generation 1 affinity labeled A2B receptor: A2(B-flagtag).  To use A2B as a 
PTM binder in the context of the peptide microarrays, the receptor must be selectively 
functionalized via synthetic modification with an affinity tag.  We chose to append a 
FLAG-tag sequence to A2B, as this peptide tag is utilized in many different assays that 
require recognition by an antibody.  The peptide sequence of the FLAG-tag is N-
DYKDDDDK-C.  Due to the five carboxylates of A2B, four of which are equivalent, the 
FLAG-tag peptide was first attached to dithiol B prior to equilibration with monomer A, 
so that the receptor would be selectively labeled at a single position.  Dithiol monomer 
flagtag-B was synthesized via solid-phase synthesis of the eight residue peptide, with 
three glycine spacers to introduce some additional space between the unnatural receptor 
and the antibody recognition site (Scheme 2.6).  The peptide was capped with a trityl-
protected monomer B prior to deprotection and cleavage, and finally purified by HPLC.   
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Scheme 2.6.  Synthesis of dithiol monomer flagtag-B via solid phase peptide synthesis. 
 
 Monomer flagtag-B was first investigated in the context of a DCC library.  In the 
presence of two equivalents of A as well as a KMe3 dipeptide template, the FLAG-tag 
peptide had no discernable influence on the amplification of the A2(B-flagtag) receptor 
(Figure 2.93).  Both rac- and meso-A2(B-flagtag) were amplified in a similar ratio as rac- 
and meso-A2B.  On a larger preparative scale, monomer A was equilibrated with flagtag-
B in a biased library and templated with methylisoquinoline to generate higher yields of 
the A2(B-flagtag) receptor than would otherwise be possible with KMe3, as shown in 
prior studies.  Both rac-A2(B-flagtag) and meso-A2(B-flagtag) were well resolved and 
easily purified by semi-preparative HPLC.  The ease of purification of the two isomers 
relative to A2B is likely due to the increased hydrophilicity of the peptide-appended 
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receptor.  Overall, this demonstrates the ease with which receptors identified by DCC can 
be synthetically modified, in contrast to traditional receptors.   
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Figure 2.93.  Structure of the affinity labeled A2(B-flagtag) receptor. 
 
  b. Microarray and binding studies with A2(B-flagtag).  In an attempt to apply 
the designed A2(B-flagtag) receptor to the peptide microarrays, the arrays were incubated 
with various concentrations of rac-A2(B-flagtag) ranging from about 25 – 200 µM.  
After subsequent washes, incubation with the appropriate antibodies, and visualization, 
there was no evidence that A2(B-flagtag) was bound to any PTMs on the array in these 
initial attempts.  We postulated various reasons as to why this may have been the case.  
First, only three glycine residues separate the FLAG-tag antibody recognition site from 
the very unnatural A2B aromatic receptor.  It is possible that these two domains are in too 
close proximity, and therefore the presence of A2B disturbs the interaction of the FLAG-
tag antibody with its target sequence, preventing any visualization of A2(B-flagtag) 
binding.  Second, the role of the carboxylic acid of monomer B in the binding of A2B to 
KMe3 and other methylated PTMs has not been investigated, and hence it is not known if 
this free carboxylate contributes to binding.  It is suspected that monomer B is able to 
rotate within the context of the receptor, potentially allowing the carboxylate to interact 
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with the cationic PTMs.  By appending a peptide at this site, this potential beneficial 
electrostatic interaction is no longer feasible, possibly weakening or preventing binding 
to the PTMs.  Third, the rac-A2(B-flagtag) solution was prepared in 10 mM pH 8.5 
phosphate buffer, and the same buffer was used for subsequence plate washes throughout 
the experiment.  While pH 8.5 buffer was used for consistency with prior binding studies, 
there is some question as to the stability of the FLAG-tag antibodies in basic solution.  If 
the antibodies are consequently destabilized or unable to bind the A2(B-flagtag) receptors 
interacting with the plate, this will again prevent any visualization of the PTM-receptor 
binding interaction.  Last, it is also possible that the binding affinity of A2B for KMe3 is 
relatively weak for these assays, and due to the number of successive steps and washes 
the A2(B-flagtag) receptor is being washed off the plate.   
 To investigate the effect of attaching the FLAG-tag peptide to monomer B on 
binding, the affinity of rac-A2(B-flagtag) for an H3 KMe3 peptide was investigated by 
fluorescence anisotropy.  A similar eight residue H3 KMe3 peptide appended with an N-
terminal fluorescein was investigated as in prior A2B binding studies.  The KMe3 peptide 
was found to bind rac-A2(B-flagtag) with a dissociation constant of 52 µM, indicating 
that the FLAG-tag peptide appears to only have a minor influence of binding.  This small 
difference in affinity between rac-A2(B-flagtag) and rac-A2B for KMe3 should not alone 
radically alter the results of the peptide microarrays.  However, it must noted that the 
binding affinity of rac-A2(B-flagtag) for KMe3 was measured under slightly different 
conditions and on a different instrument than prior rac-A2B binding studies.  Therefore 
these two dissociation constants should not necessarily be compared directly, and any 
discrepancy may purely be the result of experimental differences.   
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 To address the issue of antibody recognition of rac-A2(B-flagtag), the fluorescence 
anisotropy experiment was repeated in the presence of the FLAG-tag antibody.  Due to 
the extremely large size of the antibody in comparison to rac-A2(B-flagtag), it was 
expected that upon binding of the antibody bound rac-A2(B-flagtag) to the KMe3 
peptide, the change in fluorescence anisotropy would be much greater than without the 
antibody.  This is due to the fact that the tumbling of the fluorophore should be more 
drastically altered when the peptide is bound to a large antibody-containing complex.  
However, this increase in fluorescence anisotropy signal was not observed upon 
introduction of the antibody, and closely mimicked the extent of change observed in the 
prior experiment.  This indicated that the recognition of the FLAG-tag sequence by its 
appropriate antibody was likely not occurring, potentially due to the close proximity of 
the A2B receptor.  As expected, the presence of the antibody did not affect the measured 
dissociation constant (Kd = 55 µM).   
  c. Generation 2 affinity labeled A2B receptor: (A-flagtag2)2B.  Based on the 
prior observations that the FLAG-tag antibody did not appear to be recognizing A2(B-
flagtag) receptor, that slightly weaker affinity for KMe3 resulted from modification of 
the carboxylate on monomer B, and that no binding was visualized in the initial peptide 
microarray experiments, the affinity labeled A2B receptor was redesigned.  First, the 
length of the spacer between the A2B macrocycle and the FLAG-tag sequence was 
increased.  Four glycine residues were included after the FLAG-tag sequence as opposed 
to three, followed by a diethylene glycol ((PEG)2) spacer, lengthening the total distance 
between the two moieties by an additional 16 atoms.  In addition, the FLAG-tag sequence 
was appended to monomer A instead of monomer B.  The carboxylates on monomer A 
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are in fixed positions on the outside of the receptor, and therefore the mutation of these 
functional groups should have no influence on the receptor’s affinity for methylated 
PTMs.  Due to the equivalency of all four monomer A carboxylates, this will also result 
in four FLAG-tag sequences, and potentially a greater fluorescent signal upon binding to 
fluorescent antibodies (Figure 2.94).   
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Figure 2.94.  Structure of FLAG-tag labeled monomer A (A-flagtag2). 
 
 The (A-flagtag2)2B receptor was prepared similarly to the first generation receptor.  
The peptides were capped with a trityl-protected monomer A, and it was found that the 
loading of the peptide synthesis resin was high enough to allow for each A to couple to 
two peptides.  Upon cleavage and purification, monomer A-flagtag2 was equilibrated 
with monomer B in a biased library and templated with methylisoquinoline.  Frequent 
LC/MS analysis revealed a slower than usual equilibration for this library, indicating that 
the presence of the appended peptides may be affecting the mobility of the monomers.  
After a month, the (A-flagtag2)2B receptors were purified on an analytical HPLC as a 
result of the low volume of the biased library (Figure 2.95).  Due to extremely limited 
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amounts of material, the binding affinity of this receptor for KMe3 has not yet been 
investigated by fluorescence anisotropy.   
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Figure 2.95.  Structure of affinity labeled (A-flagtag2)2B receptor. 
 
 Future work involves testing this newly designed affinity tagged A2B receptor in the 
peptide microarrays.  A close to neutral pH buffer will be used for these experiments to 
ensure stability of the antibodies, and the FLAG-tag peptide should allow the receptor to 
solubilize at neutral pH.  In addition, attempts to directly label the receptor with a 
fluorophore are underway to significantly cut back the number of steps prior to detection, 
diminishing the possibility that the receptor will be washed off following binding.  In this 
case, the FLAG-tag sequence is no longer required for antibody recognition, and 
therefore fluorophores can be attached via the two lysine residues of the FLAG-tag 
sequence through an amide bond.  This fluorophore-labeled receptor will also be 
investigated for its ability to selectively identify KMe3 containing peptides in the 
microarray assay.   
 
 iii. Experimental Section. 
 a. Synthesis of A2(B-flagtag).  Synthesis of the FLAG-tag peptide was performed 
manually using Peptides International CLEAR-Amide resin.  The peptide was 
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synthesized on a 0.2 mmol scale by standard Fmoc solid phase synthesis, with 
HOBt/HBTU coupling reagents in DMF.  Following the synthesis of the FLAG-tag 
sequence, three glycine residues were coupled by standard methods.  The peptide was 
capped with 1.4 equivalents of trityl-protected B (0.134 g, 0.28 mmol) and coupled 
overnight.  Trityl protected monomer B was prepared previously by standard thiol 
protection methods.60  Monomer B (1.8 g, 9.7 mmol) was suspended in 60 mL of TFA 
with Trt-OH (2.5 g, 9.7 mmol) and stirred under nitrogen for 1 hour.  The TFA was 
evaporated and after addition of EtOAc, the product was extracted into 3M NaOH and 
then acidified with 10% HCl.  The precipitate was filtered to give a white solid (5.5 g, 
85%) and used for solid phase peptide synthesis without further purification.  Upon 
coupling of protected monomer B, the peptide was deprotected and cleaved from the 
resin with a cocktail of 95% TFA/1.0% triisopropylsilane/2.0% H2O/2.0% ethanedithiol 
(EDT) for 3 hours.  The peptide was purified by semipreparative reverse-phase HPLC on 
a C18 column set to 35 °C and at a flow rate of 4 mL/min with a linear gradient of 0-60% 
B in 40 minutes.  Once purified, the peptide was lyophilized to powder and characterized 
by ESI-MS ([M+H]+ = 1352.3).   
 An A2(B-flagtag) biased library was prepared on a 3.2 mL scale (A: 6.67 mM, 7.5 
mg, 0.21 mmol; flagtag-B: 3.33 mM, 14.3 mg, 0.11 mmol) templated with 
methylisoquinoline triflate (10 mM, 9.3 mg, 0.32 mmol).  The three solids were 
combined in a small vial and the pH of the solution was adjusted to 8.5 with 1M NaOH.  
Although some fine precipitate was initially visible, upon stirring the solution overnight 
the library solution turned completely soluble.  After 5 days of stirring, the receptors were 
isolated by semi-preparative HPLC.  Approximately 0.4 mL injections were 
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chromatographed using standard peptide synthesis mobile phases A and B (0-80% B 0-40 
min) with a flow rate of 4.0 mL/min and a column temperature of 40 °C.  The two A2(B-
flagtag) peaks at 22.5 and 23 minutes were collected separately (Figure 2.96) and 
analyzed for purity by analytical LC-MS.  Both peaks are indistinguishable by mass 
([M+H]+ = 2057.3, [M+2H]2+ = 1029.1). Purified rac- and meso-A2(B-flagtag) were 
lyophilized to powder and stored under nitrogen.   
 
Figure 2.96. Semi-preparative HPLC trace of an A2(B-flagtag) biased library (black = 
254 nm, blue = 214 nm). 
 
  b. Fluorescence anisotropy binding experiments.  Binding assays were 
performed with purified rac-A2(B-flagtag) and a fluorescein labeled histone 3 K9Me3 
peptide.  The peptide was dissolved in buffer (10 mM phosphate pH 8.5), and a 25 µM 
solution was prepared as determined by UV-Vis at 492 nm (ε = 78,000 M-1cm-1).  A stock 
solution of rac-A2(B-flagtag) was prepared in identical buffer, with the solution 
concentration determined by mass.  Individual solutions were prepared for each 
concentration of rac-A2(B-flagtag) in the first experiment, whereas serial dilutions were 
used to prepare each concentration of rac-A2(B-flagtag) in the second experiment.  
rac-A2(B-flagtag) 
meso-A2(B-flagtag) 
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Preparation by serial dilutions of the rac-A2(B-flagtag) + antibody samples allowed for 
the ratio of rac-A2(B-flagtag) : antibody to remain constant throughout the experiment.  
Assays were prepared in 96-well half-area plates (Corning) with a total volume of 50 µL 
per well, containing 5 µM labeled peptide and increasing concentrations of rac-A2(B-
flagtag) (with or without the FLAG-tag antibody) in buffer.  Plates were spun down and 
allowed to incubate for at least 30 minutes before analysis.  Fluorescence anisotropy was 
measured on a POLARstar plate reader (BMG Labtech) using FP485, 520A, and 520B 
filters at approximately 25°C.  The anisotropy data was plotted as a function A2B 
concentration and each plot was fitted in KaleidaGraph to the following equation: 
 
where r is fluorescence anisotropy, ro is the initial anisotropy value, r∞ is the maximum 
anisotropy value, a is the peptide concentration, x is the concentration of A2B, and kd is 
the dissociation constant.  These measurements were taken in only once. 
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Figure 2.97.  Fluorescence anisotropy of rac-A2(B-flagtag) with H3 KMe3 (m2 = 
dissociation constant). 
 
 
Figure 2.98.  Fluorescence anisotropy of rac-A2(B-flagtag) with H3 KMe3, in the 
presence of the FLAG-tag antibody (m2 = dissociation constant). 
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 c. Synthesis of (A-flagtag2)2B.  Synthesis of the FLAG-tag peptide was 
performed by hand on a 0.1 mmol scale as discussed previously, followed by the 
coupling of four glycine residues.  Two equivalents of Fmoc-NH-(PEG)2-CO2H (0.089 g, 
0.2 mmol) purchased from Novabiochem were coupled overnight to introduce the PEG 
spacer.  The peptide was capped with about 0.2 mmol of trityl-protected A (0.168 g) and 
coupled overnight.  Trityl protected monomer A was prepared previously by standard 
thiol protection methods with Trt-Cl.61  Monomer A (0.11 g, 0.3 mmol) was added to 
trityl chloride (0.18g, 0.65 mmol) in dichloromethane (1.5 mL) and stirred for three 
hours.  The reaction was quenched with 1 mL of water and a precipitate was formed.  The 
water layer was discarded followed by evaporation of the dichloromethane, and any 
residual water was removed by lyophilization.  The resulting tan solid (0.24 g, quant.) 
was used for solid phase peptide synthesis without further purification.  Upon capping 
with protected A, the peptide was deprotected and cleaved from the resin with a cocktail 
of 95% TFA/1.0% triisopropylsilane/2.0% H2O/2.0% ethanedithiol (EDT) for 3 hours.  
The peptide was purified by semipreparative reverse-phase HPLC on a C18 column set to 
35 °C and at a flow rate of 4 mL/min with a linear gradient of 0-60% B in 40 minutes.  
Efforts must be taken to avoid disulfide exchange during purification by keeping the 
crude solution in aqueous acidic media.  In this case, the reducing agent tris(2-
carboxyethyl)phosphine (TCEP) was added to the crude peptide solution to reduce any 
macrocycles formed.  Once purified, the peptide was lyophilized to powder and 
characterized by ESI-MS ([M+2H]2+ = 1603.6, [M+3H]3+ = 1069.4, [M+4H]4+ = 802.3, 
[M+5H]5+ = 642.0).  This synthesis afforded an extremely low yield. 
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 A (A-flagtag2)2B biased library was prepared on a 95 µl scale (A-flagtag2: 5 mM, 1.5 
mg, 0.48 µmol; B: 2.5 mM, 0.044 mg, 0.24 µmol) templated with methylisoquinoline 
triflate (7.5 mM, 0.21 mg, 0.72 µmol).  Monomer A-flagtag2 was dissolved directly into 
50 mM sodium phosphate buffer pH 8.5, and aliquots of B and methylisoquinoline were 
added from larger stock solutions to achieve the desired concentrations.  The solution sat 
in a capped vial and was frequently analyzed by LC/MS (0.2% formic acid aqueous and 
acetonitrile mobile phases; 10-22% B 0-3 minutes, then 22-55% B 3-17 minutes).  After 
over a month of equilibration, the receptors were isolated via automated 6-8 µl injections 
on a Waters Alliance analytical HPLC.  The library was chromatographed using an 
Atlantis C18 column (4.6 × 150 mm, 5 µm) with a flow rate of 1.0 mL/min and a column 
temperature of 35 °C (0.1% TFA aqueous and acetonitrile mobile phases; 10-39% B 1-22 
minutes).  Poor resolution of the two isomers was achieved, however the two (A-
flagtag2)2B peaks at 18 minutes were collected separately (figure 2.98) and analyzed for 
purity by analytical LC-MS.  Both peaks are indistinguishable by mass ([M+5H]5+ = 
1319.7, [M+6H]6+ = 1099.9, [M+7H]7+ = 942.9, [M+8]8+ = 825.2).  Purified (A-
flagtag2)2B was lyophilized to powder.   
 
Figure 2.99. Semi-preparative HPLC trace of an (A-flagtag2)2B biased library (black = 
214 nm, blue = 254 nm).
 rac-(A-flagtag2)2B  
   meso-(A-flagtag2)2B  
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CHAPTER III 
PHOTOSWITCHABLE DYNAMIC COMBINATORIAL LIBRARIES 
 
(Reproduced, in part, with permission from Ingerman, L. A.; Waters, M. L.  J. Org. 
Chem. 2009, 74, 111 – 117.) 
 
A. Background and Significance 
 With the establishment of DCC as an effective method for the identification of novel 
receptors based on simple building blocks, there is much interest in expanding the scope 
of receptors than can be generated in such dynamic libraries.  In particular, incorporating 
building blocks with new features and potentially interesting recognition elements is 
desirable in order to expand the present applications of DCC.  We have focused our 
efforts in this area on the development of multilevel dynamic libraries by combining two 
reversible processes, hydrazone exchange and photoinduced isomerization. 
 i.  Doubly dynamic libraries.  To further increase library diversity several groups 
have developed doubly dynamic DCLs through the incorporation of two orthogonal 
reversible reactions which can be triggered independently, demonstrating the benefit of 
incorporating multiple equilibria in a single system.1  Having two or more reversible 
chemistries that can be switched on and off independently allows for enhanced control of 
the system, while allowing for new potential applications by alternating use of different 
chemistries.  Otto and co-workers have prepared DCLs which feature two simultaneous 
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covalent exchange reactions, disulfide and thioester exchange.2  In this system the two 
reversible reactions are addressed sequentially.  First, library equilibration occurs based 
on thioester exchange only, and then in the presence of atmospheric oxygen both 
reactions occur simultaneously.  They later report the combination of hydrazone and 
disulfide exchange in a single system, which can be either operated fully orthogonally or 
occur simultaneously at any point depending on the pH of the solution.3   
 Eliseev and co-workers have explored doubly dynamic libraries as well by combining 
non-covalent metal coordination with imine exchange, which can be used as independent 
equilibrium processes controlled by different types of external intervention, 
oxidation/reduction of the metal template and change in the pH and temperature of the 
medium.4   Others have since taken advantage of this methodology incorporating metal-
ligand coordination and reversible covalent exchange for the development of 
hierarchically self-assembled systems including iron(II) and copper(I) complexes,5 as 
well as zinc(II) grid complexes.6  Furthermore, a system has been reported in which three 
dynamic linkages, disulfide, imine, and coordinative bonds, were shown to be capable of 
simultaneous reversible exchange.7  Although the three types of dynamic linkages were 
demonstrated to be mutually compatible, both transmetallation and covalent imine 
exchange were used to alter the equilibrium between disulfides, allowing for greater 
control over the degree of self-sorting.  The parallel utilization of three different 
reversible reactions has also been shown in the assembly of boronic acid based 
macrocycles and cages of unprecedented size in one-pot reactions.8  In this case, 
aldehyde-amine condensation reactions and metal-ligand interactions are combined with 
the reversible formation of boronic esters from boronic acids and diols. 
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 ii.  Azobenzene as an optical trigger.  Despite its extensive use in other applications, 
particularly in the field of molecular recognition, photochemistry has yet to be widely 
employed in the design of dynamic combinatorial libraries.  However light offers many 
advantages as a means of manipulating systems with extreme spatial and temporal 
resolution, often reversibly.  Eliseev and coworkers reported an early example which 
integrated photoisomerization into DCC, making use of an unsaturated dicarboxylate 
monomer in the development of anionic receptors for arginine.9 
 Azobenzene has been widely used as an optical trigger for various photoresponsive 
systems due to its pronounced changes in geometry and polarity upon light-induced 
isomerization.  Azobenzene is an attractive photoswitch due to its high photo stability, 
facile isomerization resulting in good quantum yields, and extremely fast and reversible 
isomerization processes (picosecond time scale).10  At thermal equilibrium the trans 
isomer is dominant, but irradiation to the photostationary state converts the trans isomer 
to its corresponding cis form (Figure 3.1).  The reverse process is also feasible 
photochemically (at 450 nm) or thermally, although thermal relaxation to the trans state is 
a slow process (hour-to-day time scale).11 
N
N
360 nm
450 nm or !
N N
R
R'
R R'  
Figure 3.1.  Cis-trans isomerization of azobenzene derivatives. 
 The conformational change that is induced upon isomerization of azobenzene 
derivatives has been successfully exploited to control the biological properties of various 
systems, such as folded peptides12 and helical polymers,13 by either disrupting, changing, 
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or enhancing secondary structure.  Recently, progress has been made in the development 
of photoswitches that covalently modify target proteins and reversibly present and 
withdraw a ligand from its binding site as a result of photoisomerization of an 
azobenzene linker, allowing for rapid and selective manipulation of protein function.14  
The photoswitchable properties of azobenzenes have also been utilized to manipulate the 
properties of host-guest systems involving crown ethers15 and cyclodextrins,16 while also 
finding applications as small molecule inhibitors.17  
 iii.  Hydrazone exchange in dynamic combinatorial libraries.  Hydrazone 
exchange is well suited for DCC, as much success has been met with this reversible 
reaction in the preparation of DCLs.18 The required hydrazide and aldehyde functionality 
can be incorporated in a straightforward manner, and the hydrazone linkage can be 
subsequently formed under acidic conditions (Figure 3.2).  While acid catalyzes both the 
initial formation and the interconversion of an assembly of macrocycles, neutralization 
yields stable, isolable products.19  The hydrazone exchange reaction is chemoselective 
and thus compatible with a wide range of solvents and functional groups.  DCLs based on 
hydrazone exchange have been reported using metal ions, carbohydrates, nucleic acids, or 
peptides as either building blocks or templates without observing any interference.20 
O
NHNH2MeO
MeO
H+
O
NHNH2MeO
MeO
O
NHNH
O
O
NHNH2
 
Figure 3.2.  Hydrazone formation from hydrazine monomers. 
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 iv.  Goal of this work.  In this work we aimed to both investigate the incorporation of 
a photochemical switch in a dynamic combinatorial library in attempt to develop novel 
molecular receptors, while also expanding the field of doubly dynamic libraries by 
combining hydrazone exchange and photoinduced isomerization in a single system.  The 
two exchange processes involved in our double-level DCLs is advantageous in that it 
offers a higher degree of control over the library composition in the investigation of 
potential targets.  While hydrazone exchange facilitates the traditional formation and 
interconversion of an assembly of macrocycles under acidic conditions, photoinduced 
isomerization can be applied for the development of switchable receptors.  We aimed to 
develop a DCL from which we could identify switchable receptors with which one could 
photomodulate molecular recognition processes as a direct result of the distinct 
conformational changes of azobenzene.  
 
B.  Results and Discussion 
 i.  Azobenzene monomer design and synthesis.  Building block 1 was designed 
containing the desired azobenzene chromophore, appended with the necessary hydrazide 
and protected aldehyde functionality to facilitate hydrazone exchange (Figure 3.3).  The 
formation of an acyl hydrazone was desired, for without an acyl or similar electron 
withdrawing group hydrazones tend to be too stable for use in dynamic libraries.  
Furthermore, an aromatic acetal was chosen, as it has been observed that the equilibrium 
constant of hydrazone formation is several times higher with an aromatic aldehyde than 
with an aliphatic one.21 
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N
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H2N
O
OMe
OMe
1  
Figure 3.3.  Azobenzene building block 1 functionalized with a hydrazide (red) and 
protected aldehyde (blue) to facilitate hydrazone exchange. 
 
 Monomer 1 was synthesized based on the corresponding fully protected azobenzene 
amino acid 4.  The preparation of 4 (Scheme 3.1) relies on the reaction of a 
nitrosobenzene with an aniline as previously described by Hilvert and coworkers.22  The 
nitrosobenzene was prepared in two steps by esterification of commercially available m-
nitrophenylacetic acid under Mukaiyama conditions, followed by reduction of the nitro 
group to the hydroxylamine and immediate reoxidation to the nitroso compound.  The 
aniline was prepared in two steps from commercially available 3-nitrobenzylamine 
hydrochloride, involving introduction of an Fmoc protecting group followed by reduction 
of the nitro group.  Coupling the nitrosobenzene and aniline in glacial acetic acid resulted 
in the reported protected amino acid 4. 
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Scheme 3.1.  Preparation of precursor 4.22 
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 Tert-butyl ester 4 was transesterified to the corresponding methyl ester 5 because we 
were unable to prepare 5 directly due to the instability of the required 3-
nitrosophenylacetic acid methyl ester precursor (Scheme 3.2).23  Fmoc deprotection under 
basic conditions yielded the free amine 6.  The coupling of 6 with 3-
carboxybenzaldehyde dimethoxyacetal via standard HOBt/HBTU coupling to yield 7, 
followed by hydrazinolysis of the methyl ester afforded the desired building block 1 as a 
mixture of cis and trans isomers. 
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Scheme 3.2.  Synthesis of building block 1. 
 
 ii.  Library formation under thermodynamic conditions.  Deprotection and 
subsequent cyclization of 1 (4 mM) was accomplished using an excess of TFA (100 
mM).  Because we were met with solubility problems upon cyclization in most solvents, 
libraries prepared with building block 1 only were generated in DMSO.  In this case the 
entire library remained soluble throughout the time of analysis.  Reactions were 
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monitored daily by LC-MS for 4-5 days, although thermodynamic equilibrium was 
reached after 4 days.  Most cyclization occurred within 24 hours and the initial library 
distribution did not change drastically after the first day.  Although linear species were 
observed within hours of monomer deprotection, the libraries were composed of entirely 
cyclic macrocycles upon reaching equilibrium.  This DCL gave relatively simple 
distributions dominated by macrocyclic monomers and dimers, along with smaller trimer 
peaks (Figure 3.4).  
 
 
Figure 3.4.  HPLC traces at 280 nm of a DCL of 1 at equilibrium. 
 
At lower monomer concentrations (1 mM) the library generated is primarily composed 
of monomeric species.  Each library member was observed in both the cis and trans 
conformations and the isomers were easily identified due to different retention times and 
a large difference in absorbance of trans and cis-azobenzene at 320 nm (Figure 3.5).24  
The cyclic hydrazones were found in a cis to trans ratio of about 20:80 at thermodynamic 
equilibrium.  To ascertain the reversible nature of the library and confirm that the 
reaction mixture had reached equilibrium, the library was also generated from pure cyclic 
trans monomer.  As expected, the final product distribution was the same. 
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Figure 3.5.  UV-Vis spectra of monomer 1 (0.022 µM) in the thermal state 
(approximately 80:20 (E):(Z); blue) and in the photostationary state after irradiation at 
365 nm (approximately 15:85 (E):(Z); green).  Spectra were taken in CHCl3 at room 
temperature with a scan speed of 120 nm/min.   
 
 iii.  Library diversification with proline based hydrazine monomers.  To increase 
the structural diversity of the library and expand upon the number of host macrocycles 
generated, we chose to synthesize and investigate other hydrazine functionalized 
monomers, specifically proline based monomers 2 and 3 (Figure 3.6).25  The rigid proline 
based building blocks 2 and 3 differ only in the position of the dimethoxyacetal 
substituent (meta and para, respectively).  The necessary functional groups for hydrazone 
exchange were similarly installed in these monomers, following modified literature 
procedures.19,25  The flexible azobenzene building block 1 was then reacted with either 
monomer 2 or 3, as the mass degeneracy of monomers 2 and 3 prevented them from 
being combined in single DCL.  
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Figure 3.6.  Proline building blocks 2 and 3 functionalized with a hydrazide (red) and 
protected aldehyde (blue), and the synthesis of 2. 
 
 The DCLs were prepared (4 mM in each monomer) in a CHCl3-DMSO (85:15 v/v) 
solution, as the proline monomer was found to assist with solubility and CHCl3 is a more 
amenable solvent for further templation studies.  After equilibration, these multi-building 
block DCLs generated complex library distributions with upward of twenty identifiable 
species and up to pentameric cyclic oligomers in some cases (Figures 3.7 and 3.8).  
 
Figure 3.7.  HPLC trace at 280 nm of a DCL of 1 and 2 at equilibrium. 
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Figure 3.8.  HPLC trace at 280 nm of a DCL of 1 and 2 (top) and 1 and 3 (bottom) at 
equilibrium. 
 
 
 The distinct differences between the distribution of species in the libraries generated 
with 2 versus 3 portray the sensitivity of DCLs to slight structural changes in the building 
blocks.  Particularly in studying the fundamental aspects of molecular recognition, DCC 
can serve as an ideal system due to the changes in library composition that result from 
subtle variations in monomer structure.  In this case, meta-substituted proline monomer 2 
is found to self-sort to a much larger extent than 3, giving rise to the proline homo-dimer 
(2·2) as the dominant library member in DCLs generated from 1 and 2, whereas the 
hetero-dimer (1·3) is found to be the major species in DCLs generated from 1 and 3.  
 iv.  Effect of photoisomerization on library distribution.  To investigate the dual 
nature of our libraries and their application in the development of photoswitchable hosts, 
we examined the effect of light-induced isomerization on the composition of our 
libraries.  Upon irradiation of equilibrated DCLs at 365 nm for 5 minutes, each library 
distribution is shifted significantly in favor of the cis isomers.  This assisted in 
confirming our assignments of the different isomers.  Further isomerization does not 
occur with longer light exposure.  After irradiation of the single building block library, 
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the azobenzene cyclic monomer species is present in a cis:trans ratio of 87:13 as observed 
by LC-MS (Figure 3.9).  In this library a similar large increase of the cis/cis azobenzene 
homo-dimer (1c·1c) is observed, accompanied by a significant decrease of the trans/trans 
azobenzene homo-dimer (1t·1t) and a minor decrease in the cis/trans hetero-dimer (1c·1t).  
Comparable changes are also observed with the trimer macrocycles (1·1·1), as well as 
with oligomers containing one or more proline monomer units in the multi-building block 
libraries (Figures 3.10 and 3.11).   
 
Figure 3.9.  HPLC traces at 280 nm of a DCL of 1 (a) at equilibrium and (b) after 
isomerization.  The chromatogram y-axes are on the same scale. 
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Figure 3.10.  HPLC traces at 280 nm of a DCL of 1 and 2 (a) at equilibrium and (b) 
immediately after photoisomerization. The chromatogram y-axes are on the same scale. 
 
 
Figure 3.11.  HPLC traces at 280 nm of a DCL of 1 and 3 (a) at equilibrium and (b) 
immediately after photoisomerization. The chromatogram y-axes are on the same scale. 
 
 Immediately after photoisomerization the libraries are stored in the dark, although 
with time they return to thermal equilibrium.  The rate of conversion back to thermal 
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equilibrium seems to be solvent dependent, taking on the order of a week or less for the 
libraries generated in mostly CHCl3, but longer for those in DMSO only.  Hydrazone 
exchange within the irradiated DCL (Figure 3.12a) and relaxation back to thermal 
equilibrium are competitive processes, occurring simultaneously, and resulting in a DCL 
dominated by trans macrocycles (Figure 3.12b).  In contrast, libraries which are 
equilibrated under photochemical conditions with repetitive irradiation allow for 
hydrazone exchange to occur in the absence of thermal relaxation (Figure 3.12c).  By 
comparing parts a) and c) of Figure 3.12, both in the photostationary state, it is evident 
that the order of equilibration and photoisomerization along with the conditions under 
which the DCLs are equilibrated considerably influence the distribution of macrocycles.  
The integration of these two dynamic reversible processes permits various distributions 
of species to be generated under different conditions within a single DCL.  Such 
versatility within a library may prove to be valuable in expanding the applications of 
DCC, as well as in the identification of photoswitchable receptors in this context. 
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Figure 3.12.  Part of the HPLC traces at 254 nm of a DCL of 1 and 3 (a) immediately 
after irradiation of an equilibrated library (b) six days after irradiation where there has 
been adequate time for thermal relaxation, and (c) equilibrated in the photostationary 
state with repetitive isomerization. The chromatogram y-axes are on the same scale. 
 
 Azobenzene monomeric building blocks which were subjected to photoisomerization 
before cyclization were also investigated.  As expected, upon acid catalysis the irradiated 
monomers underwent simultaneous cyclization and thermal relaxation, which over time 
resulted in DCLs identical to those generated with the thermodynamically favored trans 
monomers. 
 v.  Templation studies with a polyproline peptide. Because photoisomerization 
converts the library to a photostationary state rather than a thermally equilibrated state, if 
a guest binds a specific cis macrocycle, it would be expected to inhibit conversion of that 
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receptor back to its trans conformation due to favorable binding interactions (Figure 
3.13).  Although this is not amplification in the traditional sense, it would nonetheless 
result in an increased amount of the cis receptor in the templated library versus the 
corresponding untemplated DCL.  This is indeed what was observed when the libraries 
were equilibrated in the presence of a pentaproline guest.  
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Figure 3.13.  Illustration of the conformation of an azobenzene receptor controlling 
binding to a specific template, resulting in an observed stabilization of the cis conformer 
via binding. 
 
 We chose to investigate an oligoproline peptide guest due to the role of polyproline 
helices in many important protein-protein interactions.26  A photoswitchable DCL 
consisting of monomers 1 and 2 was thermally equilibrated in the presence of a five-
residue oligoproline peptide (Figure 3.14). 
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b)   
Figure 3.14.  (a) Templation with a 5-residue polyproline peptide.  (b) Side view of a 
polyproline type I right-handed helix, generally the more common conformation in 
organic solvents.27  However, we have no direct evidence that the polyproline in our 
system is taking on a type I turn.   
 
 At thermal equilibrium, the 1c·1t heterodimer is found to be amplified by about 46% 
relative to the untemplated library (Figure 3.15a and 3.15b).  Immediately following 
photoisomerization of the equilibrated library, a small amplification of both 1c·1t and 
1c·1c is observed relative to the untemplated library, yet there has been little time for re-
equilibration of the newly isomerized macrocycles at this point (Figure 3.15c and 3.15d).  
In returning to a state of thermal equilibrium, a slower rate of thermal relaxation of some 
library members was observed in comparison to the untemplated library, indicative of 
favorable binding interactions with the polyproline guest.  This rate difference is most 
apparent with the cyclic cis monomer 1c.  As seen in Figures 3.15e and 3.15f along with 
Figure 3.16, three days after the DCLs were irradiated at 365 nm, host 1c is significantly 
amplified in the polyproline templated DCL.  As expected, this amplification is observed 
in DCLs containing monomer 1 and either proline monomer (2 or 3).  In contrast, 1t is 
not amplified in the thermally equilibrated library, suggesting that the conformation of 
the azobenzene controls binding.  The fact that 1c is only amplified after 
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photoisomerization is likely a result of not only the low concentration of cis-azobenzene 
macrocycles at thermal equilibrium, but also the competitive equilibria at play.  
Presumably at higher concentrations of the cis monomer, the favorable interactions which 
result in templation of 1c out-compete other equilibria.  This type of phenomenon is not 
unprecedented in dynamic combinatorial libraries,28 and reinforces the fact that the 
thermally equilibrated and photoisomerized libraries represent different libraries with 
different behaviors which indeed should be considered independently. 
 
Figure 3.15.  Part of the HPLC trace at 254 nm of a DCL made from 1 and 2 (a) at 
thermal equilibrium without an added template (b) at thermal equilibrium in the presence 
of a pentaproline peptide (25 mM) (c) immediately after irradiation, untemplated, (d) 
immediately after irradiation with a pentaproline peptide, (e) three days after irradiation, 
untemplated, and (f) three days after irradiation with a pentaproline peptide.  Note that 
figures (e) and (f) are not meant to represent DCLs which have returned to thermal 
equilibrium.  Amplified species are indicated with the dashed lines between untemplated 
and templated libraries.  The chromatogram y-axes are on the same scale. 
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Figure 3.16.  Comparison between the extent of amplification of each library member in 
the polyproline templated library (made from 1 and 2) at thermal equilibrium (yellow) 
and 3 days after irradiation (blue).  (Percent amplification = [(% area of library member 
in templated DCL - % area of library member in untemplated DCL) / % area of library 
member in untemplated DCL] * 100). 
 
 Unfortunately, as is often the case with hydrazone libraries, the binding constants of 
the isolated host-guest complex could not be measured because the host is not soluble 
under non-equilibrating (ie non-acidic) conditions, except in DMSO, which disrupts 
binding.29 
 The observed stabilization of a cis-azobenzene via binding is not unprecedented.  
Such stabilization has been previously reported in the context of binding tethered, 
photoswitchable maleimide-azobenzene-glutamate ligands.30  Polyproline peptides and 
other such guests which form more favorable binding interactions with one isomer of a 
specific host are especially attractive due to the potential to photomodulate the binding to 
these receptors, therefore achieving a larger degree of control over such molecular 
recognition processes. 
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 vi.  Other templates investigated and limitations of azobenzene hydrazone DCLs.  
In our search for a template that would perturb the equilibrium, resulting in the 
stabilization and amplification of a specific receptor due to favorable binding 
interactions, a variety of templates were explored, some of which are shown in Figure 
3.17.  Cationic aromatic ammonium groups were investigated due to their potential to 
interact favorably with the designed monomers via interactions such as aromatic-aromatic 
or cation-π interactions, a few of which have already been shown by Sanders and 
coworkers to bind macrocycles composed of proline monomer 2.25  In addition, various 
biologically relevant molecules in addition to the polyproline peptide were considered.   
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Figure 3.17.  Other template molecules investigated in azobenzene hydrazone DCLs. 
 
 In our screens of different guests, there were various factors which limited those 
templates that were compatible with the designed libraries.  First, solubility was a major 
factor, as many biological molecules in particular were not soluble under the conditions 
for equilibration.  Limited solubility was met with both glucose and N-acetyl 
glucosamine, as well as hormones dopamine and serotonin.  Other guests were soluble 
 187 
initially but led to precipitation over time during library equilibration, whereby an 
accurate comparison to the untemplated reaction was no longer possible.  Some amines 
such as 3-methyl adenine became soluble only upon protonation with the addition of 
TFA.   
 In addition, chromatographic separation of the template from the rest of the library is 
required.  Co-elution of the template and library macrocycles prevents analysis of the 
library composition, as the template is present in excess and its absorption generally 
exceeds that of the library members.  This was problematic with hydrophobic guests such 
as naphthalene, whereas more polar guests tended to have a much earlier retention time.  
Furthermore, guests containing functional groups that could participate in hydrazone 
exchange had to be avoided, while photolytic stability of the template was also required.  
Both hormones melatonin and dopamine are light sensitive, preventing analysis of such 
templated libraries upon photolysis.   
 The azobenzene moiety can undergo surprisingly facile reduction to hydrazobenzene 
in the presence of reducing agents, further limiting the scope of templates that could be 
explored.31  This facile reduction of azobenzene to hydrazobenzene was observed in 
various instances when the library was inadvertently exposed to a reducing agent at some 
point during the LC-MS analysis.  This also makes azobenzene isomerization 
incompatible with the commonly used reversible reactions, disulfide and thioester 
exchange. 
 The results of templation studies with other guests, particularly methylisoquinoline 
and benzyltrimethylammonium, although not entirely understood, are also worth noting 
in providing a thorough discussion of the template limitations with these azobenzene 
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libraries.  In a DCL with monomers 1 and 2 in the presence of benzyltrimethylammonium 
chloride, significant amplification of 23 and 1t⋅2 was observed (Figure 3.18).  
Amplification of 23 was anticipated based on literature precedence. 
 
Figure 3.18.  HPLC traces at 280 nm of an untemplated DCL of 1 and 2 (left) and in the 
presence of 100 mM benzyltrimethylammonium chloride (right) at thermal equilibrium.  
The chromatogram y-axes are on the same scale. 
 
 In addition to the template perturbing the library at thermal equilibrium, after 
photolysis, the 1⋅2 cis-heterodimer converts back to the thermodynamically favored trans 
conformation faster than in the untemplated library, reinforcing that there may be a 
favorable binding interaction with the trans-heterodimer (Figure 3.19).   
 
Figure 3.19.  HPLC traces at 280 nm of an untemplated DCL of 1 and 2 (blue) and in the 
presence of 100 mM benzyltrimethylammonium chloride (red) 1 day after photolysis. 
 189 
 Comparable results were also observed with libraries containing monomers 1 and 3, 
where the trans-heterodimer 1⋅3 was amplified at thermodynamic equilibrium, and after 
photolysis underwent a faster rate of thermal relaxation than in the untemplated library as 
well.  It was proposed that the position of the acetal in the proline monomer did not 
invoke specificity in binding benzyltrimethylammonium.  Acetylcholine was also 
investigated with monomers 1 and 3, and similar amplification was observed to that of 
benzyltrimethylammonium, although to a somewhat lesser extent.   
 In the case of templation with methylisoquinoline, the 1⋅2 trans-heterodimer again 
appeared to be amplified at thermal equilibrium.  However, in this case none of the 
macrocycles containing cis-1 were observed (Figure 3.20).  Upon photolysis, there were 
no distinct changes in the methylisoquinoline templated library, and the expected trans to 
cis isomerization was not observed.  Suspect that the methylisoquinoline may have been 
absorbing the 365 nm light, a control experiment was performed where the sequence of 
events was reversed, and methylisoquinoline was added after isomerization as opposed to 
prior experiments where photolysis was performed in the presence of guest.  The end 
result remained unchanged, as no cis macrocycles were observed after addition of 
methylisoquinoline.   
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Figure 3.20.  HPLC traces at 280 nm of a DCL of 1 and 2 untemplated and in the 
presence of 40 mM methylisoquinoline iodide (a) at thermal equilbrium and (b) 
immediately after photolysis. 
 
 To further understand this result and confirm that the amplification was indeed due to 
methylisoquinoline binding, hydrazide monomer 1 was replaced with the corresponding 
Fmoc protected amino acid 8, which lacks the functionality to undergo hydrazone 
exchange and therefore form cyclic macrocycles.  Amino acid 8 was prepared simply by 
subjecting precursor 4 to trifluoroacetic acid.  It was anticipated that the cis:trans ratio of 
8 would not be affected by methylisoquinoline.   
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Figure 3.21.  Control experiments with azobenzene amino acid 8 (X = iodide or triflate 
counterion). 
 
 Solutions of 8 were prepared in 15:85 DMSO:CHCl3 and subjected to photolysis, 
after which methylisoquinoline iodide was added (Figure 3.21).  Prior to the addition of 
TFA, the amino acid in the absence and presence of methylisoquinoline was photolyzed 
as expected, converting to 85% and 83% cis-azobenzene respectively immediately after 
photolysis (as determined by UV integration at 280 nm).  The reactions were allowed to 
thermally relax in the dark, and the rate of thermal relaxation appeared to be the about the 
same in both cases.  After eleven days the ratio of cis-8:trans-8 had converted to about 
45:55.  In order to more directly mimic the equilibration conditions used for exchange, 
100 mM of TFA was added to both solutions.  Immediate LC-MS analysis revealed that 
while the solution without methylisoquinoline remained at a cis-8:trans-8 ratio of 45:55, 
in contrast, the solution with methylisoquinoline had been converted entirely to trans-8.   
 To explore the dependence on the nucleophilic iodide counterion, methylisoquinoline 
was prepared with a non-nucleophilic triflate counterion and the control experiment was 
repeated (with TFA added from the beginning).  Similarly, no cis-8 was observed in the 
presence of methylisoquinoline triflate, indicating that the results appear to be 
independent of the counterion.  In contrast, the same control experiment was performed 
in the presence of tetrabutylammonium with either an iodide, bromide, or fluoride 
counterion.  In this case the rate of thermal relaxation of cis-8 did seem to differ in the 
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presence of different counterions, with the general trend of N(Bu)4+I- > N(Bu)4+Br- > 
N(Bu)4+F-.  The isomerization occurs most rapidly with the nucleophilic iodide 
counterion, whereas the rate of relaxation in the presence of N(Bu)4+F- is close to that of 
the solution of 8 by itself, suggesting the presence of a nucleophile may indeed be 
important in this acid promoted isomerization.  It is evident that the apparent 
amplification in the presence of methylisoquinoline is not the result of binding to the 
azobenzene receptor macrocycles (particularly 1t⋅2), but instead a TFA promoted 
mechanism by which methylisoquinoline facilitates the conversion of all cis-azobenzene 
molecules to their corresponding trans isomers.   
 The same control experiment was performed with amino acid 8 and 
benzyltrimethylammonium chloride, which also showed promising amplification of 
receptor 1t⋅2, both at thermal equilibrium and during thermal relaxation.  The solutions 
were analyzed daily by LC-MS, and although less drastic than with methylisoquinoline, 
there was a noticeably faster rate of thermal relaxation from cis-8 to trans-8 in the 
presence of benzyltrimethylammonium (Figure 3.22).  In the presence of certain cationic 
guests and their corresponding counterions, it is clear that cis-azobenzene isomers are 
rapidly converted to their trans counterparts under the acidic conditions necessary for 
hydrazone exchange.  This clearly perturbs the dynamic equilibria in our libraries, yet is 
unrelated to favorable binding interactions, and limits the range of guests that can be 
studied.  
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Figure 3.22.  Amount of trans-8 present in solution at different time points during 
thermal relaxation, by itself (green) and with benzyltrimethyl ammonium (purple).   
 
C.  Conclusions 
 This work reports the design of an azobenzene based hydrazide monomer that can 
undergo thermodynamically controlled oligomerization and cyclization under acidic 
conditions, either in single or multi-building block libraries.  Although the thermally 
equilibrated DCLs favor the trans isomers, we have shown that we can photochemically 
control the library distribution by irradiating the systems at appropriate wavelengths.  The 
incorporation of these two reversible processes in a single library is advantageous in that 
it offers a higher degree of control over the library composition and its organization in the 
investigation of potential targets.  In exploring the templation of a polyproline peptide, 
we have demonstrated that we can stabilize and amplify an inherently less stable cis 
azobenzene macrocycle through templation with an appropriate guest.   The development 
of hosts for such proline rich sequences via DCC may help to elucidate their role as 
potential protein interaction domains. 
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 Photoresponsive libraries of this type are useful in that, despite the nature of the 
guest, binding can be controlled by irradiation at appropriate wavelengths.  This shows 
the potential to, in one system, both identify and synthesize novel host receptors and take 
advantage of the optical properties of azobenzene to control binding. 
 
D.  Experimental Section 
 i.  Synthesis of azobenzene monomer.  (E)-methyl 2-(3-((3-((((9H-fluoren-9-
yl)methoxy)carbonylamino)methyl)phenyl)diazenyl)phenyl)acetate (5).  In 27 mL of 
methanol containing 0.1M H2SO4, 4 (0.29 g, 0.53 mmol) was dissolved and the solution 
was refluxed for six hours.  After removal of the solvent, water was added to precipitate 
the product and it was extracted three times with EtOAc.  The organic extracts were dried 
over MgSO4 and the solvent was evaporated to obtain an orange solid (94%).  1H NMR 
(CDCl3, 300 MHz): δ 7.83-7.81 (m, 4H), 7.75 (d, J = 7.5 Hz, 2H), 7.59 (d, J = 7.5 Hz, 
2H),  7.50-7.44 (m, 2H), 7.41-7.36 (m, 4H), 7.31-7.26 (m, 2H), 5.26 (t, J = 6.0 Hz, 1H), 
4.47- 4.45 (m, 4H), 4.23 (t, J = 6.8 Hz, 1H), 3.72 (s, 2H), 3.70 (s, 3H).  HRMS-ESI(+) 
m/z [M+H]+ calculated for C31H27N3O4 = 506.2080, found = 506.2062; m/z [M+Na]+ 
calculated for C31H27N3NaO4 = 528.1899, found = 528.1907. 
 (E)-methyl 2-(3-((3-(aminomethyl)phenyl)diazenyl)phenyl)acetate (6).  To a solution 
of 5 (0.26 g, 0.52 mmol) in 5.2 mL dichloromethane, tris(2-aminoethyl)amine (3.9 mL, 
26 mol) was added.  The mixture was stirred for one hour and then washed with saturated 
NaCl followed by phosphate buffer pH 5.5.  The organic extracts were dried over 
MgSO4.  After the solvent was evaporated, the resulting oil was purified by flash 
chromatography (MeOH with 10% NH4OH/CH2Cl2 1:9) to obtain 0.18 g (68%) of a 
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bright orange oil.  The product was isolated as a mixture cis and trans isomers, with the 
cis isomer ranging from 10 to 20% as determined by NMR integrations.  1H NMR 
(CDCl3, 300 MHz): δ 7.85-7.77 (m, 4H), 7.49-7.37 (m, 4H), 3.96 (s, 2H), 3.72 (s, 2H), 
3.70 (s, 3H).  HRMS-ESI(+) [M+H]+ m/z calculated for C16H17N3O2 = 284.1399, found = 
284.1402. 
 (E)-methyl 2-(3-((3-((3-(dimethoxymethyl)benzamido)methyl)phenyl)diazenyl)phenyl) 
acetate (7).  A solution of 0.022 g (0.112 mmol) of 3-carboxybenzaldehyde 
dimethoxyacetal, 0.015 g (0.112 mmol) of HOBt, and 0.042 g (0.112 mmol) of HBTU in 
700 µL of DMF was added to 6 (0.032 g, 0.112 mmol).  To the mixture was added 47 µL 
(0.336 mmol) of triethylamine, and the solution was stirred for four hours.  After the 
addition of brine, the product was extracted with EtOAc.  The organic phase was washed 
with sodium bicarbonate, dried over MgSO4, and the solvent was evaporated.  The 
resulting orange oil was purified by flash chromatography (MeOH with 10% 
NH4OH/CH2Cl2 1:19) to obtain 0.031 g (60%) of a bright orange oil.  The product was 
again isolated as a similar mixture if isomers, with a small amount of the corresponding 
deprotected aldehyde (5-10%) which was carried through without a problem.  1H NMR 
(CDCl3, 300 MHz): δ 7.86-7.80 (m, 6H), 7.57 (d, J = 7.5 Hz, 1H), 7.48-7.37 (m, 5H), 
5.39 (s, 1H), 4.72 (d, J = 5.7 Hz, 2H), 3.71 (s, 2H), 3.69 (s, 3H), 3.29 (s, 6H).  HRMS-
ESI(+) [M+Na]+ m/z calculated for C26H27N3NaO5 = 484.1849, found = 484.1861. 
 (E)-3-(dimethoxymethyl)-N-(3-((3-(2-hydrazinyl-2-oxoethyl)phenyl)diazenyl)benzyl) 
benzamide ((E)-1).  A solution of 7 (0.032 g, 0.069 mmol) in anhydrous methanol (0.8 
mL) was treated with hydrazine monohydrate (33.5 µL, 0.69 mmol).  The reaction was 
left overnight under nitrogen before removal of the solvent under vacuum to give an 
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orange oil which was purified by flash chromatography (MeOH with 10% 
NH4OH/CH2Cl2 gradient, 1:39 to 1:19 to 1:9) to afford the monomer 1 (65%).  1H NMR 
(CDCl3, 300 MHz): δ 7.88-7.77 (m, 6H), 7.58 (d, J = 7.5 Hz, 1H), 7.50-7.36 (m, 5H), 
5.39 (s, 1H), 4.74 (d, J = 5.7 Hz, 2H), 3.63 (s, 2H), 3.30 (s, 6H).  HRMS-ESI(+) [M+Na]+ 
m/z calculated for C25H27N5NaO4 = 484.1961, found = 484.1958. 
 (Z)-3-(dimethoxymethyl)-N-(3-((3-(2-hydrazinyl-2-oxoethyl)phenyl)diazenyl)benzyl) 
benzamide ((Z)-1).   (E)-1 was photolyzed at 365 nm.  1H NMR (CDCl3, 300 MHz): δ 
7.81 (s, 1H), 7.73 (d, J = 7.8 Hz, 1H), 7.53 (d, J = 7.8 Hz, 1H), 7.38 (t, J = 7.8 Hz, 1H), 
7.14-7.01 (m, 3H), 6.75-6.58 (m, 5H), 5.71 (d, J = 12 Hz, 2H, NH2), 5.37 (s, 1H), 4.46 (d, 
J = 5.7 Hz, 2H), 3.34 (s, 2H), 3.28 (s, 6H).   
 ii.  Synthesis of proline monomers.  (S) N-(3-Dimethoxymethyl-benzoyl)-proline 
carboxylic acid hydrazide (2).  Monomer 2 was prepared according to literature 
procedures,20 except the amide bond formation was accomplished with HBTU/HOBt as 
the coupling reagent rather than EDC, as described below.  A solution of 0.059 g (0.302 
mmol) of 3-carboxybenzaldehyde dimethoxyacetal, 0.041 g (0.302 mmol) of HOBt, and 
0.115 g (0.302 mmol) of HBTU in 1.5 mL of DMF was added to .050 g (0.302 mmol) of 
L-Proline methyl ester hydrochloride.  To the mixture was added 126 µL (0.906 mmol) of 
triethylamine, and the solution was stirred for 1.5 hours.  After the addition of brine, the 
product was extracted with EtOAc.  The organic phase was washed with sodium 
bicarbonate, dried over MgSO4, and the solvent was evaporated to give 0.088 g (94%) of 
a colorless oil.  The hydrazinolysis reaction of the methyl ester was carried out as 
previously reported to afford 2.   
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 (S) N-(4-Dimethoxymethyl-benzoyl)-proline carboxylic acid hydrazide (3).  The 
synthesis of (S) N-(4-Dimethoxymethyl-benzoyl)-proline carboxylic acid hydrazide (3) 
was carried out using 4-carboxybenzaldehyde dimethoxyacetal and the same conditions 
as those reported above for monomer 2. 
 iii.  1H NMR spectra.   
 
Figure 3.23.  (E)-methyl 2-(3-((3-((((9H-fluoren-9-yl)methoxy)carbonylamino)methyl) 
phenyl)diazenyl)phenyl)acetate (5): CDCl3, 300MHz. 
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Figure 3.24.  (E)-methyl 2-(3-((3-(aminomethyl)phenyl)diazenyl)phenyl)acetate (6): 
CDCl3, 300MHz. 
 
 
Figure 3.25.  (E)-methyl 2-(3-((3-((3-(dimethoxymethyl)benzamido)methyl)phenyl) 
diazenyl)phenyl)acetate (7): CDCl3, 300MHz. 
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Figure 3.26.  (E)-3-(dimethoxymethyl)-N-(3-((3-(2-hydrazinyl-2-oxoethyl)phenyl) 
diazenyl)benzyl) benzamide ((E)-1)): CDCl3, 300MHz. 
 
 
Figure 3.27.  (Z)-3-(dimethoxymethyl)-N-(3-((3-(2-hydrazinyl-2-oxoethyl)phenyl) 
diazenyl)benzyl) benzamide ((Z)-1)): CDCl3, 300MHz. 
 
N
H
NN
H
N
O
H2N
O
OMe
OMe
N
HN
N
H
N
O
H2N
O
OMe
OMe
 200 
 
Figure 3.28.  (S) N-(3-Dimethoxymethyl-benzoyl)-proline carboxylic acid hydrazide (2): 
CDCl3, 400MHz. 
 
 
Figure 3.29.  (S) N-(4-Dimethoxymethyl-benzoyl)-proline carboxylic acid hydrazide (3): 
CDCl3, 300MHz. 
 
MeO OMe
N
O
H
HN
O
NH2
N
O
H
HN
O
NH2
MeO
OMe
 201 
 iv.  Synthesis of polyproline peptide (Ac-Pro-Pro-Pro-Pro-Pro-NH2).  The peptide 
synthesis was performed on a Tetras Peptide Synthesizer using Applied Biosystems PAL-
PEG amide resin.  The peptide was synthesized on a 0.0215 mmol scale (50 mg resin).  
Coupling reagents were HOBt/HBTU in DMF.  The N-terminus was acylated with a 
solution of 5% acetic anhydride and 6% 2,6-lutidine in DMF.  Cleavage was performed 
by hand with a cocktail of 95% TFA/2.5% triisopropylsilane/2.5% H2O.  The peptide was 
purified by semipreparative reverse phase HPLC on a C18 column at a flow rate of 4 
mL/min.  The purification was achieved using a linear gradient of A and B (A: 95% 
H2O/5% CH3CN with 0.1% TFA; B: 95% CH3CN/5% H2O with 0.1% TFA) and elution 
was monitored at 214 nm.  Once purified, the peptide was lyophilized and characterized 
by ESI-MS.  ESI-MS (+) m/z [M+H]+ calculated for C27H40N6O6 = 545.30, found = 
545.3. 
 v.  Synthesis of N-methylisoquinoline triflate.  To a flame dried flask purged with 
nitrogen, 300 µl (2.53 mmol) of isoquinoline and 2.5 mL of dry dichloromethane was 
added and the solution was cooled to 0°C.  To a second flame dried flask purged with 
nitrogen, 2.5 mL of dry dichloromethane was added followed by careful addition of 286 
µl (2.53 mmol) of methyltriflate.  The methyltriflate solution was transferred via 
cannulation to the cold isoquinoline solution, and the reaction was stirred overnight under 
nitrogen, gradually warming up to room temperature.  To the solution, 20 mL of ether 
was added, resulting in a precipitate which was filtered to obtain 0.704 g (95%) of a tan 
solid.  The product appeared pure enough for most purposes, but can be recrystallized 
from acetonitrile/ethanol.   
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 vi.  Dynamic Combinatorial Chemistry and LC-MS analysis.  (a) DCL with 
monomer 1.  The single component library was prepared by making a 4 mM building 
block solution of 1 in DMSO containing 100 mM of TFA.  The resulting solution 
equilibrated at room temperature for at least 4 days.  The reaction was monitored daily by 
LC-MS (3 µL injections).  Separations were performed using H2O-acetonitrile gradients 
with 0.2% formic acid (t=0 min: 100% water, flow rate 1.0 mL/min; t=2 min: 75% water, 
flow rate 1.0 mL/min; t=3.5 min: 66% water, flow rate 1.0 mL/min; t=6.5 min: 57% 
water, flow rate 1.5 mL/min; t=11 min: 30% water, flow rate 1.5 mL/min), with the left 
column temperature set to 40°C and the right column temperature set to 50°C to optimize 
separation.  Multiple wavelengths were used for analysis (220 nm, 254 nm, 280 nm, and 
320 nm).  The cis and trans isomers were assigned based on the strong absorbance of 
trans azobenzene at 320 nm, along with the shift in the distribution of isomers upon 
isomerization. 
 (b) DCL with monomers 1 and 2 or 1 and 3.  The mixed library was prepared by 
making a 1:1 solution of the building blocks (4 mM each) in CHCl3-DMSO (85:15 v/v) 
containing 100 mM of TFA.  The resulting solution was stirred at room temperature for at 
least four days for equilibration.  The reactions were monitored daily by LC-MS as 
described above for the single component library.  In the case of templation studies, a 
second library was equilibrated in the presence of 25 mM of a five-residue polyproline 
peptide. 
 vii.  Photoisomerization.  Libraries were irradiated at 365 nm for five minutes in the 
dark with a Spectroline long wave UV pencil lamp (1,000 µW/cm2 of 365 nm radiation at 
1”).  Once irradiated, solutions were continually stored in the dark at room temperature.  
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LC-MS analysis was continued on a daily basis and light exposure was minimized during 
analysis.   
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CHAPTER IV 
DYANMIC CYCLIC THIODEPSIPEPTIDE LIBRARIES FROM THIOL-THIOESTER 
EXCHANGE 
 
(Reproduced, in part, with permission from Ghosh, S.; Ingerman, L. A.; Frye, A. G.; Lee, 
S. J.; Gagné, M. R.; Waters, M. L. Org. Lett. 2010, 12, 1860-1863.) 
 
A. Background and Significance 
 Since so many natural and synthetic cyclic peptides exhibit biological activity, cyclic 
peptides have gained much attention and are often viewed as ideal structures in the field 
of drug design.1,2,3  For example, cyclosporin is a cyclic nonribosomal peptide that is 
widely used as an immunosuppressant, revolutionizing organ transplants.1  In addition, 
both natural and synthetic cyclic peptides have recently been identified as HDAC 
inhibitors, which hold promise in the treatment of cancer.4  As drug scaffolds, cyclic 
peptides are advantageous because they mimic native protein structures, exhibit enhanced 
metabolic stability, and are structurally preorganized, which reduces the entropic cost of 
binding. 
 Despite their therapeutic potential, the options for synthesizing structurally diverse 
libraries of cyclic peptides in a high throughput format are limiting.3  For example, phage 
display has been used to generate and screen large libraries of disulfide-linked cyclic 
peptides as potential inhibitors.5  However disulfides are not stable within the cellular 
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environment and there is no straightforward synthetic replacement for a disulfide linkage, 
limiting their practicality.  Split-and-pool synthesis is also a popular method of 
generating libraries of cyclic peptides, however it requires orthogonal protecting group 
strategies for on-bead cyclizations and it can result in mixtures of both cyclic and linear 
peptides.3     
 Herein, we describe a strategy to use thioester exchange for generating solution-phase 
cyclic thiodepsipeptide libraries via dynamic combinatorial chemistry.6  DCC allows for 
the in situ generation of complex mixtures of peptide macrocycles from smaller building 
blocks.  The generation of cyclic peptide libraries via DCC is not unprecedented.  A 
proline-phenylalanine dipeptide (Figure 4.1a) has been used to generate a series of 
peptidic macrocycles of varying sizes via hydrazone exchange, one of which has been 
demonstrated as an effective receptor for the neurotransmitter, acetylcholine.7  Two 
different peptide macrocycles of this hydrazone DCL have also been shown to effectively 
recognize the diastereomeric templates quinine and quinidine.8   Furthermore, a greater 
degree of diversity has been introduced into such peptide-based libraries through the 
investigation of monomers with the general building block structure shown in Figure 
4.1b, where the residues in positions AA1 and AA2 are varied.9   
MeO
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NHNH2O
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Figure 4.1.  a) Proline-phenylalanine dipeptide monomer and b) the general building 
block structure used to investigate the relationship between peptide structure and library 
diversity through variation of positions AA1 and AA2. 
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 While such reports of peptidic DCL libraries remain interesting, their relevance in the 
investigation of effective peptide receptors for biological targets of interest is debatable, 
as the peptide macrocycles are generated in a combination of organic solvents under very 
acidic conditions and contain an unnatural hydrazone linkage.  A more desirable scenario 
for the investigation of potential drug scaffolds would be the generation of diverse 
libraries of cyclic peptides under close to physiological conditions.  Recent reports 
suggest that thiol-thioester exchange is a promising reversible reaction for DCC since it is 
rapid in aqueous solution at neutral pH,10,11 and it provides a native-like thioester linkage 
(Figure 4.2).  The thioester moiety can also be subsequently replaced by more robust 
amide or ester functionalities, enhancing the potential utility of such macrocycles.  
However, commonly reports of thioester exchange of peptide based molecules make use 
of thioesters that are unsubstituted at the α-position, which significantly limits the 
structural diversity of the peptides that can be generated.  As a result, we have 
investigated the reactivity of peptidic thiol-thioester monomers to determine the scope 
and limitations for their application to DCC. 
HS
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SR'
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O
SR
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+   SR'
pH 7
H2O
 
Figure 4.2. Reversible thioester exchange.   
 
B. Results and Discussion 
 i. Design and synthesis.  Each peptide monomer used to investigate thiol-thioester 
exchange in the context of DCC libraries was designed as a four-residue peptide with the 
appropriate thiol and thioester functionality required to facilitate exchange, and the 
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general structure shown in Scheme 4.1.  The peptides were prepared with a C-terminal 
thioester and a cysteine residue at position AA2 to introduce the thiol functionality.  The 
peptide monomers were synthesized using a modification of the method reported by 
Gellman and coworkers,11 which provided all monomers in approximately 70 – 80% 
yield with no observable epimerization.  This on-bead synthesis of the peptide monomers 
is also advantageous in that it allows for the facile generation of an array of monomers 
containing diverse functionality at various positions.   
 
Scheme 4.1.  Synthesis of thioester peptide monomers. 
 
 To introduce structural diversity into the DCLs, various amino acids were included at 
the AA4 position to both investigate the effect on macrocyclization of having different 
side chains at the C-terminus, and to incorporate a variety of functional groups as 
potential recognition elements.  Amino acids incorporated at the AA4 position included 
positively charged amino acids (Lys, Arg), a negatively charged amino acid (Glu), a 
hydrogen bonding and neutral amino acid (Gln), and hydrophobic and sterically bulky 
amino acids (Phe, Val).  Residues AA2-AA3-AA4 were designed to form the peptide 
macrocycle, with AA1 remaining exo-cyclic.  Charged amino acids (Lys, Arg, Glu) were 
incorporated at position AA1 to enhance water solubility of the macrocycles, as well as 
prevent aggregation.  Similar to the previously developed hydrazone peptide monomers, 
a hydroxyproline turn residue was initially included at the AA3 position to enforce a 
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degree of curvature and favor the formation of macrocycles, while the remainder of the 
structure provides flexibility.12  Hydroxyproline was initially included to enhance water 
solubility, however proline was later investigated at the AA3 position as well.   
 ii. Preliminary DCLs: optimization and initial observations.  Multi-building block 
libraries were initially investigated to gauge the level of structural diversity that could be 
achieved in these DCLs and to probe the reactivity of these monomers.  Early studies 
were focused on optimizing the reaction conditions for these libraries, such as the pH and 
buffer concentration.  One principal advantage of thioester exchange is that exchange is 
generally complete within a few hours, in comparison to disulfide exchange which often 
requires weeks before equilibration is reached.  However, if thioester equilibration is not 
reached within this time frame, the hydrolysis of both linear and cyclic thioesters 
becomes a competitive, irreversible process (Figure 4.3b).  Therefore the reaction 
conditions must be optimized to ensure complete equilibration prior to the accumulation 
of hydrolyzed peptides. 
 Dynamic combinatorial libraries were prepared by mixing equimolar amounts of 
monomers 3, 6, and 7 with the general sequence Ac-Glu-Cys-Hyp-X-SR where X = Phe, 
Glu, and Val respectively (Table 4.1).  Systematic studies were performed to investigate 
the monomer reactivity in a range of buffer concentrations including 10, 50, and 200 
mM, while the pH of the buffer was also varied from 7 to 9.  These studies were also 
performed in the presence of tris(2-carboxyethyl)phosphine (TCEP) to prevent 
competitive disulfide formation.  In each case, the monomers underwent thiol-thioester 
exchange to form a mixture of peptide macrocycles (Figure 4.3a).  The library 
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compositions were analyzed by LC-MS at various time points and all of the library 
members were easily identified.  
 
Figure 4.3.  a) General design of monomers and the major cyclic product of the DCLs.  
b) Sequence of events toward dimeric cyclic thiodepsipeptides. 
 
 The monomer reactivity was found to be dependant on both the concentration and the 
pH of the buffer.  Specifically, as both the buffer concentration and the pH increased, the 
rate of monomer disappearance increased as well.  Very slow reactivity was observed 
with a buffer concentration of 10 mM, and after over a week significant amounts of 
unreacted starting material were still present in solution.  While increasing the pH above 
neutral resulted in faster monomer reactivity, the rate of hydrolysis was seen to increase 
simultaneously, preventing library equilibration prior to the formation of significant 
concentrations of hydrolyzed products.  It was therefore concluded that optimal thioester 
reactivity was achieved at a high buffer concentration (100 mM or greater), yet at a close 
to neutral pH.  While the presence of a high concentration of TCEP successfully 
prevented the formation of disulfides, it also served to decrease the pH of the solutions 
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due to its multiple carboxylic acids, in turn resulting in a somewhat decreased rate of 
reactivity.  As a result, TCEP was not included in later investigations of monomer 
reactivity, and degassing the buffer solutions was found to be equally effective in 
preventing disulfide formation. 
 While these early investigations did not thoroughly probe the potential structural 
diversity that could be achieved in these DCLs due to the presence of either unreacted 
starting material or hydrolyzed products, some interesting observations were made which 
may have otherwise gone unnoticed.  For example, the analysis of a DCL containing 
monomers 3, 6, and 7 (Table 4.1) in 50 mM sodium phosphate buffer at pH 7.0 in the 
presence of an excess of TCEP revealed significantly different rates of disappearance of 
the three starting materials 1.5 hours after the library was generated (Figure 4.4).  
Monomers 3, 6 and 7 were found to exist in a ratio of 1:1.7:2.5 at this time point, 
respectively, indicating the fastest reactivity for the N-terminal Phe monomer and the 
slowest reactivity for the C-terminal Val monomer.  This reveals that the side chain of the 
residue at AA4 appears to influence the rate at which the monomers undergo thioester 
exchange.   
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Figure 4.4.  Analytical HPLC trace at 214 nm of a DCL consisting of monomers 3, 6, 
and 7 (2.5 mM each, in 50 mM sodium phosphate buffer with TCEP, pH 7.0) after 1.5 
hours of equilibration, with the major species labeled.  The three starting materials are 
labeled in black, the cyclic macrocycles are labeled in red, and the linear species are 
labeled in orange.  
 
 In addition, a mixture of both linear oligomer species and cyclic peptides were 
observed with this slow rate of reactivity.  A simple two-step mechanism is proposed, 
where first the two monomers react to form a linear oligodimer, followed by a ring 
closing intramolecular transthioesterification reaction.  Alternatively, if the oligodimer 
reacts with a third monomer prior to ring closing, a significant mount of larger 
macrocycles should be observed.  However the library composition is dominated by 
dimeric species, indicating that the intermolecular step is likely rate limiting.  While it 
appears that there has not been adequate time for cyclization of all of the oligodimers 
present in solution, monomer 3, which appears to be disappearing the fastest, exists as 
one of the two components in each cyclic dimer formed, indicating that 3 indeed does 
appear to have a higher rate of macrocycle formation.   
 To probe this observation further, monomer 1 (Table 4.1) with an C-terminal glycine 
residue was investigated under identical conditions for a direct comparison, despite the 
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known slower reactivity under these conditions.  If the side chain of AA4 significantly 
influences the monomer reactivity, it would be expected that 1 would react just as fast if 
not faster than any other residue at this position.  The analysis of this single building 
block library at various time points revealed that 1 in fact does react at a much faster rate 
than the monomers investigated previously.  After a day 1 was almost completely 
consumed (Figure 4.5), whereas significant amounts of 3, 6, and 7 still remained 
unreacted.  In addition, the library composition was limited to almost exclusively the 
dimeric 20-atom macrocyclic hexapeptide in this case, with only a trace amount of 
trimer.  The lack of formation of an oligodimer in this case supports the observation that 
this monomer has a faster rate of macrocycle formation than 3, and that the 
intermolecular step is rate limiting.   
1
2
1
1
3
1 hr
4.5 hrs
9.5 hrs
1 day
 
Figure 4.5.  Analytical HPLC trace at 214 nm of a DCL consisting of monomer 1 only 
(2.5 mM 1 in 50 mM sodium phosphate buffer with TCEP, pH 7.0) after 1 hour 
(magenta), 4.5 hours (green), 9.5 hours (red), and 1 day (blue).   
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 iii. Systematic investigation of monomer reactivity.  To perform a thorough 
investigation of the influence of the C-terminal residue in the designed system on the rate 
of thiol-thioester exchange for the generation of peptide libraries, peptides 1 – 15 (Table 
4.1) were investigated as single building block libraries under identical, optimal 
conditions.  This rate study was largely conducted by Dr. Soumyadip Ghosh, but for 
completeness, will be included in this thesis.  In addition, the effect of making subtle 
changes at the AA1 and AA3 positions on both the library composition and rate of 
reaction was considered.  Since the intermolecular reaction is thought to be rate 
determining, the overall reaction rate was determined by monitoring the disappearance of 
monomer over time, as measured by a decrease in the monomer peak area in the HPLC 
trace (Figure 4.6).  Since several monomers reacted too fast to accurately measure at pH 
7, the reactivity was instead followed at pH 6.75.  Importantly, at this pH, with the 
exception of monomers 7 and 15 containing Val at the C-terminus, equilibrium was 
always reached prior to the detection of hydrolyzed peptides.   
 
Figure 4.6.  Overlay of analytical HPLC traces showing the consumption of monomer 5 
(Ac-ECHypQ-COSR’) and the appearance of cyclic macrocycles over time. 
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Table 4.1. Monomer sequences, half-lives of reactions, and libraries generated with 1 – 
15 (100 mM NH4Ac Buffer pH 6.75, 25° C). 
compound sequence t1/2 product 
1 Ac-ECHypG-COSR’ ~ 12 min dimer 
2 Ac-ECPH-COSR’ ~ 12 min dimer, trimer 
3 Ac-ECHypF-COSR’ ~ 1½ h dimer,  
4 Ac-ECPF-COSR’ ~ 1½ h dimer 
5 Ac-ECHypQ-COSR’ ~ 1½ h dimer, trimer, tetramer 
6 Ac-ECHypE-COSR’ ~ 5½ h dimer 
7 Ac-ECHypV-COSR’ ND* oligodimer 
8 Ac-ECWE-COSR’ ~ 3½ h dimer 
9 Ac-EC(D-P)Q-COSR’ ~ 10 min dimer, trimer 
10 Ac-KCPR-COSR’ ~ 15 min dimer 
11 Ac-RCPK-COSR’ ~ 15 min dimer 
12 Ac-KCPK-COSR’ ~ 15 min dimer 
13 Ac-KCPQ-COSR’ ~ 20 min dimer, trimer  
14 Ac-KCWR-COSR’ ~ 15 min dimer  
15 Ac-KCPV-COSR’ ~ 10 h dimer, trimer 
*  Not determined. Monomers were hydrolyzed before complete reaction. 
 
 The C-terminal amino acid (AA4) was varied systematically while holding the rest of 
the molecule constant (Table 4.1, compounds 1 – 3 and 5 – 7).  The observed reactivity 
trend, 1 ~ 2 < 3 ~ 5 < 6 < 7, corresponds generally to differences in steric bulk at the C-
terminal amino acid, with the reactivity decreasing with increasing steric bulk; however, 
in some cases, the differences in rate are more subtle (Figure 4.7).  As expected, this 
trend is fairly consistent with the reactivity trends observed for native chemical ligation 
reactions of peptides and sugar-assisted ligation reactions of glycopeptides, which are 
initiated by the same first step involving attack of a thiolate anion.13,14   
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Figure 4.7.  Plot of the disappearance of monomers 1 – 3 and 5 – 7 over time (100 mM 
NH4Ac buffer, pH 6.75, 25 °C). 
 
 It was observed that His reacts as rapidly as Gly, despite its larger size,13 suggesting 
that the imidazole group of the C-terminal His stabilizes the transition state of the trans-
thioesterification reaction.  In contrast, β-branched amino acids such as Val react 
significantly more slowly (Figure 4.7), resulting in measurable hydrolysis prior to 
complete cyclization.  Monomer 6, which contains Glu at AA4, reacts more slowly than 
its neutral Gln analog, while also forming multiple mass degenerate isomers with 
different retention times in the LC-MS analysis.  On the basis of the MS analysis of 
individual peaks as well as literature precedent, it appears that the Glu γ-carboxyl 
cyclizes onto the thioester to form an anhydride, and ultimately 6-isom (Figure 4.8).15 
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Figure 4.8.  Reaction of the C-terminal Glu peptide 6 over time (left) and a proposed 
mechanism for the formation of side product 6-isom, leading to multiple mass degenerate 
products. 
 
 To further explore the monomer reactivity, substitutions were made at positions AA1 
and AA3 as well.  Replacement of the Hyp in 3 with Pro resulted in identical HPLC traces 
and rate profiles for 3 and 4, indicating that the OH group on hydroxyproline does not 
significantly affect the rate of exchange.  The Hyp was also substituted with a more 
flexible Trp residue in 8 to determine if a turn residue is necessary to facilitate rapid 
cyclization.  In fact, it was found that 8 reacts faster than its Hyp analog, and thus the 
rigidity of the proline turn may indeed impede reactivity.  Stereochemistry was also 
determined to be a factor in the reaction rates, as replacement of L-Hyp (5) with D-Pro (9) 
resulted in considerably faster monomer reactivity.  This result does not reflect 
conformational preferences for cyclization, but instead an influence of chirality on the 
accessibility of the thioester or thiol functional groups. 
 Lastly, the effect of positively charged amino acids (Lys and Arg) at positions AA1 
and AA4 was evaluated.  Interestingly, monomers 10 – 15, which contain either Lys or 
Arg at AA1, and in some cases at position AA4 as well, reacted significantly faster than 
their negatively charged analogs.  This rate enhancement suggests that the positively 
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charged Arg and Lys residues stabilize the build up of negative charge in the transition 
state through hydrogen bonding and/or electrostatic interactions.  Furthermore, the Glu at 
AA1 of the sterically hindered Val monomer 7 was replaced with Lys to give monomer 
15.  Although hydrolysis was still observed before complete cyclization, 15 was found to 
react almost five times faster than 7 (Figure 4.9). 
 
Figure 4.9.  Comparison of the disappearance of monomers 7 and 15 over time, 
containing an N-terminal Glu and Lys, respectively (100 mM NH4Ac buffer, pH 6.75, 25 
°C). 
 
 iv.  Generation of diverse libraries.  Having optimized the reaction conditions for 
rapid thiol-thioester cyclization with minimal hydrolysis, and subsequently evaluated the 
reactivity of a range of peptide monomers, we returned to the goal of generating 
structurally diverse libraries of cyclic peptides.  By generating libraries containing 
multiple peptide monomers, the formation of macrocyclic thiodepsipeptides mixtures 
with homo and heterodimers as the major products were observed.  To confirm 
thermodynamic control of the library composition, experiments were performed adding 1 
to the preformed homodimer 32, and 3 to the preformed homodimer 12.  Nearly 
superimposable HPLC traces were obtained after 18 h at pH 6.75, indicating that 
equilibrium can be reached from any direction.   
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 It is clear that a high level of chemical diversity can be rapidly achieved by simply 
increasing the number of monomers combined in solution, as in this case by mixing 1, 3, 
and 5 – 7 (Figure 4.10).  It is worth noting that monomer 7 was incorporated into the 
library despite its slow reactivity.  In addition to cyclodimers, tripeptide macrocycles 
were also identified.  The library speciation was readily deconvoluted using LC-MS, 
which showed extensive cross-reactivity of monomers and a general lack of self-
sorting.16  It also should be noted, however, that in the generation of even larger libraries 
of macrocyclic peptides, eventually the libraries become too complex and outgrow the 
capabilities of LC-MS analysis.  This highlights the need for new methods of analysis 
which are able to accommodate libraries of great size, so that the potential of generating 
highly diverse and complex peptide libraries via DCC can be realized.    
 
Figure 4.10.  Analytical HPLC trace of a mixture of 1, 3, and 5-7 after equilibration for 1 
hour (100 mM NH4Ac buffer, pH 6.75, 25 °C).  Underlined species represent linear 
oligomers. 
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C. Conclusion 
 In summary, an efficient method for rapidly generating a complex library of 
macrocyclic thiodepsipeptides at neutral pH for high-throughput screening has been 
demonstrated.  Structure-function studies indicate that the thiol-thioester exchange 
reaction is tolerant of a variety of amino acids at the C-terminal position, with the 
exception of β-branched amino acids such as Val, which significantly retard the rate of 
homo-dimerization, and carboxylic acid side chains, which can isomerize through 
anhydride intermediates.  Positively charged amino acids, Lys, Arg, and His, at the C-
terminus were found to enhance the rate of thiol-thioester exchange, suggesting a 
stabilizing effect through hydrogen bonding and/or electrostatic interactions of the 
tetrahedral intermediate.  Interestingly, positively charged amino acids were also found to 
increase reaction rates when incorporated at the N-terminus, suggesting that the transition 
state can be stabilized when flanked by a positively charged amino acid on either side of 
the peptide.  In all cases, the dimer macrocycle is the major product, but the extent of 
formation of larger macrocycles is dependent on the peptide sequence.  Upon mixing two 
or more monomers, we have shown that a complex library of cyclic thiodepsipeptides can 
be generated in situ under thermodynamic control.   
 This study demonstrates the feasibility of using DCC to generate a large number of 
cyclic thiodepsipeptides that can be efficiently screened against a particular target within 
hours.  Since thioesters have transient stability in vivo, a receptor identified via a high-
throughput screen can be easily re-synthesized as a more stable analog by replacing the 
thioester group with either an amide or an ester.  Moreover, upon mixing monomers 
containing a Cys located at different positions, macrocycles of different sizes can in 
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theory be generated, such that the outcome is not limited to only cyclic hexapeptides.  
This idea of using cyclic peptide libraries generated via DCC for high throughput screens 
can be employed for a variety of applications, including the development of inhibitors, 
the disruption of protein-protein interactions, and the binding of nucleic acids. 
 
D. Experimental Section 
 i. Peptide synthesis.  All peptides were synthesized by automated solid-phase 
synthesis in a Thuramed Tetras peptide synthesizer (version X94) using standard Fmoc 
chemistry on a 2-chlorotrityl resin (150 mg, apx. 0.09 mmol depending on resin loading).  
In each case, the resin was purchased with the C-terminal residue (AA4) preloaded onto 
the resin.  All amino acids with side chain functionality were protected during synthesis.  
Activation of amino acids was performed with HBTU and HOBT in the presence of 
DIEPA in DMF.  Double coupling cycles (60 min each) were used for each amino acid 
coupling step.  Fmoc deprotections were carried out in 2% DBU (1,8 diazabicyclo[5.4.0] 
undec-7-ene) and 2% piperidine in DMF.  All peptide monomers were acetylated at the 
N-terminus with 5% acetic anhydride and 6% lutidine in DMF for 30 min.  Cleavage of 
the peptide from the resin was performed in 8 mL of a 8:1:1 ratio of dry dichloromethane 
(DCM) : trifluoroethanol (TFE) : acetic acid (AcOH) for 1.5 h.  The filtrate was 
concentrated by rotary evaporation to obtain the peptide product as a yellow oil.  The 
product was dried under high vacuum and then dissolved in 3.6 mL of dry DMF.  To that 
solution was added 32 µL of N,N-diisopropylethylamine (DIPEA), 18 µL methyl 
thioglycolate, and 86 mg PyBOP and the reaction was stirred under N2 at room 
temperature for 1 h.  DMF was removed under high vacuum to obtain a yellow oil.  The 
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amino acid side chain protecting groups were removed in a solution of 18:1:1 
trifluoroacetic acid (TFA) : triisopropylsilane (TIPS) : water for 4 hours.  The TFA was 
evaporated and the cleavage products were precipitated with cold ether.  The peptides 
were extracted into water, lyophilized to solid, and then purified by reverse-phase HPLC 
using a Vydac C-18 semipreparative column and a gradient of 0 to 80% B over 40 min, 
where solvent A was 95:5 water:acetonitrile, 0.1% TFA and solvent B was 95:5 
acetonitrile:water, 0.1% TFA.  After purification, the peptides were lyophilized to 
powder and characterized by +ESI-MS.   
 ii. Thioester libraries.  The relevant building block solution(s) was first prepared at a 
higher concentration in water and diluted accordingly in buffer to give the desired final 
monomer concentration.  Similarly, 50 – 250 mM buffer stock solutions were prepared 
and diluted accordingly to give the final desired buffer concentration.  Any remaining 
volume was made up with water.  The initial three component libraries (3, 6, and 7; 2.5 
mM each) were prepared in sodium phosphate buffer with concentrations ranging from 
10 – 200 mM at pH 7, 8, and 9, and 5 mM TCEP was included in each case.  The single 
component libraries were prepared by making 1 mM monomer solutions in 100 mM 
NH4Ac buffer at pH 6.75.  The buffer was degassed prior to use.  The multicomponent 
libraries (> 3 monomers) were prepared by mixing equimolar amount of monomers (1 
mM each) in 100 mM NH4Ac buffer at pH 6.75.  The vials were capped and analyzed at 
various time points. 
 iii. Analytical LC/MS.  LC-MS was carried out on an Agilent Rapid Resolution LC-
MS system, equipped with an online degasser, binary pump, autosampler, heated column 
compartment, and diode array detector.  Separations were performed on a Zorbax Eclipse 
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XDB-C18 column (4.6 × 50 mm, 1.8 micron).  Separations were performed using either 
water-methanol gradients with 0.2% formic acid (t = 0 min: 90% water, t = 10 min: 0% 
water; flow rate = 1 mL/min) or water-acetonitrile gradients with 0.2% formic acid (t = 0 
min: 95% water, t = 15 min: 62% water; flow rate = 1 mL/min), with the column 
temperature set to 45 ˚C to optimize the separation.  Multiple wavelengths were 
monitored for analysis (214 nm, 230 nm, 254 nm, and 280 nm).   
 iv. Monomer rate studies.  The reaction rate of each monomer was measured by 
analyzing the library composition at multiple time points.  A 50 µl reaction aliquot was 
removed from the reaction in each case, and the reversible thiol-thioester exchange was 
quenched by adding it to a 50 µl solution of 9:1 water:TFA.  The amount of monomer in 
each HPLC trace was determined by manual integration of the area under the monomer 
peak.   
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Figure 4.11.  Plot of the decrease in concentration of 6 (1 mM) over time in100 mM 
NH4Ac buffer pH 6.75, RT (blue) and 100 mM K-Phosphate buffer pH 7.5, RT.  
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Figure 4.12.  Plot of the decrease in concentration of monomers 6 (magenta) and 8 (blue) 
versus time.  The monomer concentration is 1 mM (100 mM NH4Ac buffer pH 6.75, RT). 
 
Figure 4.13.  Plot of the decrease in concentration of monomers 7 (pink), 10 (green), 14 
(red), and 15 (blue) over time (100 mM NH4Ac buffer pH 6.75, RT). 
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Figure 4.14.  Plot of the decrease in concentration of monomers 3 (blue) and 4 (magenta) 
over time. The monomer concentration is 1 mM (100 mM NH4Ac buffer pH 6.75, RT). 
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Figure 4.15.  Plot of the decrease in concentration of monomers 5 (magenta) and 9 (blue) 
over time.  The monomer concentration is 1 mM (100 mM NH4Ac buffer pH 6.75, RT). 
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Figure 4.16.  Molecular models of (a) 5 and (b) 9.  Hydrogen atoms are removed for 
clarity.  Color coding: C, grey; N, blue; O, red; and S, yellow. 
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CHAPTER V 
SELECTIVE RECOGNITION OF 7-METHYL GMP BY MACROCYCLIC PEPTIDE 
RECEPTORS IDENTIFIED BY DYNAMIC COMBINATORIAL CHEMISTRY
 
A. Background and Significance 
 i. β-Hairpin model systems for the recognition of GTP.  Short peptide sequences 
that adopt a specific secondary structure are often used as model systems to mimic a 
certain protein fold and study the factors that contribute to protein folding and protein 
recognition.  Motivated by the prevalence of β-sheet motifs throughout protein structures 
and the desire to better understand the factors contributing to their stability, short, 
monomeric β-hairpin peptides have been studied as models for antiparallel β-sheets.1  
These β-sheet mimics contain two antiparallel β-strands connected by a turn sequence 
which nucleates the hairpin structure.2  This two amino acid sequence imparts a twist to 
the β-turn, which in combination with the right-handed twist of the strands, results in a 
stable β-sheet. 
 Much of the work in this field has been focused on determining the factors that 
contribute to the stability of the hairpin fold, such as the β-turn sequence, sidechain-
sidechain interactions, and individual amino acid β-sheet propensities.3  These model 
systems serve largely as a framework for studying the non-covalent interactions that 
guide protein folding, ranging from hydrogen bonding to the formation of salt-bridges,4 
as well as aromatic5 and cation-π interactions.6 
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 It has also been found that β-hairpin peptides can serve as novel molecular receptors 
for biologically relevant aromatic compounds, such as nucleotides.  Hairpins are quite 
valuable receptors for molecular recognition, as they mimic native protein binding 
motifs, have a large surface area, are well folded without covalent constraints, and allow 
for the incorporation of a wide range of functional groups.  The binding sites of 
nucleotides, such as adenosine 5’-triphosphate (ATP), in proteins generally consist of 
aromatic, aliphatic, cationic, and hydrogen bonding residues.7  The adenine moiety of 
ATP is typically found stacked with aromatic side chains, while the phosphates interact 
with the side chains of lysine or arginine.   
 These interactions were demonstrated in the β-hairpin peptide WKWK (Figure 5.1) 
that binds a molecule of ATP strongly in water via aromatic and electrostatic interactions 
on one face of the β-hairpin.8  The diagonal Trp-Trp pair in the non-hydrogen bonding 
sites of the hairpin provides a binding cleft for aromatic intercalation (Figure 5.2).  In 
addition, the lysine side chains on the same face of the hairpin provide electrostatic 
interactions with the ATP phosphate groups.  ATP was found to bind the β-hairpin with a 
dissociation constant of 170 µM by fluorescence quenching, and a total binding energy of 
approximately -5 kcal/mol.  By NMR titration, the dissociation constant was measured to 
be 1.4 mM as determined by the upfield shifting of the Trp protons upon binding.  This 8-
fold decrease in affinity is presumably due to the presence of 10 mM sodium chloride, 
which screens for favorable electrostatic interactions.   
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Figure 5.1.  Structure of peptide WKWK with the sequence Ac-RWVKVNGOWIKQ-
NH2.  
 
 
Figure 5.2.  NMR structure of the adenine ring of ATP (green) bound to the β-hairpin 
WKWK (yellow) through intercalation of the two Trp residues which create an aromatic 
cleft for binding. 
  
 When nucleotide selectivity was evaluated by NMR, binding saturation was apparent 
at lower concentrations of GTP as compared to ATP, resulting in a Kd of 0.45 mM and 
demonstrating a modestly higher affinity for this substrate.  This selectivity could be 
related to the carbonyl in the guanine base, which has the potential to hydrogen bond with 
the flanking Lys residues (Figure 5.3).  In both cases, upfield shifting of the ribose 
protons suggests that CH-π interactions with the ribose ring may also contribute to 
binding.  These observations enhance the general understanding of protein-nucleic acid 
 232 
interactions that occur with β-sheet proteins, while the observed selectivity for GTP 
shows promise for the development of protein receptors that are selective for guanosine-
rich DNA sequences.   
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Figure 5.3.  Structures of nucleotide substrates ATP and GTP. 
 
 ii. Significance of 7-methyl GTP.  In addition to the natural bases, DNA is also 
known to contain methylated bases, and the biological implications of nucleic acid 
methylation is most commonly related to the control of gene expression.9  In particular, 
eukaryotic mRNA is modified by the addition of the 7-methylguanosine ‘cap’ to the first 
transcribed nucleotide, and this modification is necessary for efficient gene expression 
and cell viability (Figure 5.4).  The 7-methylguanosine cap is required for translation of 
the majority of mRNAs, and it has also been reported to stabilize mRNA against attack 
by exonucleases, as well as promote transcription, splicing, polyadenylation, and nuclear 
export of mRNA.10  Formation of 7-methylguanosine occurs as the substrate mRNA is 
being transcribed, and it is catalyzed by enzymes which are recruited to RNA polymerase 
II.  Furthermore, cellular proteins which regulate mRNA cap methylation are likely to 
function either by regulating the recruitment of the cap methyltransferase to RNA 
polymerase II, or by regulating the cap methyltransferase activity.11   
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Figure 5.4.  Structure of 7-methylguanosine triphosphate. 
 
 During the initiation of translation, the cap is specifically recognized by eukaryotic 
Initiation Factor 4E (eIF4E), which participates in the recruitment of ribosomes to 
mRNA.12  This protein plays a crucial role in the translational control of gene expression, 
and it is known to be overexpressed in many types of tumor cells.13  The critical role of 
translation initiation in cell growth and malignant transformation, coupled with the 
presence of abnormally high levels of eIF4E in several human cancers, suggests that the 
eIF4E-cap interaction could be a potential target for the development of anti-cancer 
drugs.14  Consequently, gaining a greater understanding of this nucleotide-protein 
interaction would be quite valuable. 
 The specific recognition of the cap by eIF4E is thought to be largely mediated by the 
formation of a stacked configuration between the 7-methylguanine and two tryptophan 
indole rings, allowing for discrimination of the methylated cap over other unmethylated 
nucleotides.  This association has been demonstrated in model systems between 
analogues of the mRNA cap and both indole derivatives and tryptophan-containing 
peptides.15  It has also been proposed that a positive charge localization at the N7 position 
of the guanine ring is the primary reason for the enhanced stacking with the cap binding 
site of the protein, and leads to a closer analogy between this cation-π stacking 
interaction and the interaction common in protein structures between an aromatic ring of 
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one residue and a positively charged side chain of another.16,17  This stacking between 
cationic 7-methylguanosine and the Trp side chains is necessary to effectively stabilize 
the base moiety, which in turn facilitates the formation of hydrogen bonds at the cap 
binding site.18  Furthermore, aromatic stacking of the 7-methylguanine ring with two 
aromatic side chains seems to be a general mode of recognition of the mRNA 5’ cap by 
various proteins.   
 iii. Goal of this work.   While the recognition of nucleotides by β-hairpin model 
systems has been demonstrated, a system that exhibits an even greater affinity for such 
nucleotides would be desirable for the broader goal of DNA recognition.  This could 
potentially be achieved by increasing the complexity of the hairpin receptor by various 
means, such as adding a third peptide strand to increase the number of contacts with the 
nucleotide, introducing unnatural amino acids with superior recognition properties, or by 
converting the hairpin binding cleft into a tighter binding pocket.  In this work, we 
investigate dynamic combinatorial chemistry as a method for identifying novel peptide 
receptors for nucleotides.  By introducing a covalent tether between the two antiparallel 
strands of the known receptor, WKWK, a tighter nucleotide binding pocket may be 
formed while increasing the potential number of favorable interactions.  Furthermore, 
DCC allows for the identification and optimization of such peptide receptors in a facile 
and high-throughput manner.  This system also facilitates an interesting investigation of 
the interplay between nucleotide binding and peptide folding, as a covalent modification 
of the hairpin to reinforce binding has the potential to disturb the hairpin fold.   
 In addition, due to the need for a greater understanding of the recognition of the 7-
methylguanoisine mRNA cap by protein receptors, 7-methyl GMP will also be 
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investigated in this system, particularly in comparison to its unmethylated GMP 
counterpart.  The presence of two Trp residues in the native WKWK sequence, as well as 
the potential to introduce further aromatic recognition elements via DCC, provides an 
opportunity to closely mimic native 7-methylguanosine protein receptors in this model 
system.  In addition to highlighting the identification of novel nucleotide peptide 
receptors, these studies also allowed for preliminary investigations of the use of hairpin 
peptides as monomers in dynamic combinatorial libraries. 
 
B. Results and Discussion 
 i. General library design.  In order to facilitate the formation of a tighter binding 
pocket for nucleotide recognition via DCC, two types of monomers were designed for 
reversible exchange: hairpin peptide monomers and small molecule monomers intended 
to bridge the two antiparallel strands of the peptide.  These building blocks can be 
reversibly linked under thermodynamic control to produce an equilibrium mixture of 
potential nucleotide receptors.  While the reaction of peptide monomers with small 
molecule monomers is desired for these purposes, the formation of hairpin dimers or 
larger peptide oligomers is also possible, which have the potential to serve as equally 
valuable nucleotide receptors.   
 Disulfide exchange has become one of the most widely used reactions in dynamic 
combinatorial libraries, and it is particularly suited for this biological application as it 
occurs in aqueous solution at close to neutral pH.  Disulfide exchange is advantageous in 
that disulfides form readily from thiols in the presence of oxygen and small amounts of 
base, it takes place under mild conditions in the presence of a catalytic amount of thiol, it 
 236 
can be quenched under acidic conditions, and disulfides are stable toward many different 
functional groups.19  During oxidation the mixture contains both disulfides and thiols, 
allowing for equilibration through nucleophilic attack of thiolate anions on the disulfides, 
displacing a new thiolate anion in the process (Figure 2.8).  The primary downside to 
disulfide exchange is that it occurs relatively slowly, sometimes requiring on the order of 
weeks for equilibration to be reached. 
 The incorporation of thiols into the hairpin structure was easily facilitated by the 
replacement of two residues of the native WKWK sequence with cysteine residues.  Two 
variants of the dithiol hairpin were synthesized, peptides 1 and 2, with two of the non-
hydrogen bonding residues replaced with cysteines in each case (Figure 5.5).  Non-
hydrogen bonding residues were chosen so that exchange with the small aromatic 
monomers would occur on the same face of the hairpin as the Trp and Lys residues.  
While this results in the loss of one Trp and one Lys residue in each case which were 
shown previously to assist in nucleotide recognition, it is anticipated that new interactions 
will be generated to compensate for such losses.  Despite their similarities, it is possible 
that the two hairpin monomers will function quite differently, as the introduction of an 
unnatural bridge located further from the turn in 2 is less likely to disrupt the hairpin 
structure than when introduced closer to the turn in 1.  Both peptides were synthesized by 
Fmoc solid phases peptide synthesis. 
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Figure 5.5.  Hairpin dithiol monomers 1 and 2, containing two Cys residues (green) in 
place of Trp and Lys residues of the native WKWK sequence.  The remaining Trp 
residue is shown in blue, and the lysine in red. 
 
 Small molecule dithiols B and C were chosen as potential bridging groups for the 
designed dithiol hairpins, both of which have been discussed previously in chapter two 
(Figure 5.6).  They include an aromatic surface to allow for aromatic and hydrophobic 
interactions with nucleotide bases, as well as potential cation-π interactions with 7-
methylguanosine.  The carboxylates are required to induce water solubility, although they 
also have the potential to participate in favorable electrostatic interactions or hydrogen 
bonds with the nucleotides.  It should also be noted that the carboxylates have the 
potential to create repulsive interactions with the phosphate tails, if placed in close 
enough proximity.  As the optimal length required to favorably bridge the two peptide 
strands in the designed positions is unknown, the distance between the thiols in B and C 
was varied, with monomer C containing two extra methylene groups in comparison to B, 
as well as an increased degree of flexibility.  Both molecules also contain some degree of 
curvature, which should encourage the formation of cycles macrocycles with 1 or 2. 
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Figure 5.6.  Structures of small aromatic dithiols, B and C. 
 
 Initial investigations of peptides 1a and 2a containing an N-terminal arginine in 
combination with B and C under the basic conditions required for disulfide exchange led 
to significant amounts of precipitation during equilibration.  Insoluble macrocycles in a 
DCL act as a thermodynamic trap, shifting the equilibrium for reasons other than 
favorable binding.  As both 1a and 2a in solution alone show no signs of insolubility over 
extended periods of time, this precipitation was clearly the result of interactions, either 
covalent or non-covalent, between the hairpin peptide and small aromatic monomers.  
Complete solubility could be regained with the addition of organic cosolvents, however it 
was anticipated that the use of co-solvents would prove to be limiting in the pursuit of 
future templation studies.   
 With an N-terminal arginine, each peptide has 3 basic residues.  While an increase in 
the number of charged residues generally enhances peptide solubility, in combination 
with various equivalents of B and C, each of which contains a negative carboxylate, the 
charge of the library as a whole is close to neutral.  By mutating the arginine, which is far 
removed from the intended binding site, to a glutamic acid (1b and 2b), decreasing the 
overall peptide charge to one, these peptides no longer exhibited solubility problems in 
untemplated DCLs with monomers B and C at millimolar concentrations.  
 ii. Hairpin monomer generation 2: DPro-Gly turn.  Initial investigations of 
untemplated DCLs containing either 1b or 2b as well as B and C resulted in a diverse 
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library of species as determined by HPLC.  Interestingly, in the identification of the 
library members by LC-MS, it was found that various species were present in solution 
that were identified to be 1 mass unit greater than expected (Table 5.1), which is outside 
the error of the mass spectrometer.  In each case, the presence of a peak at a different 
retention time with the expected mass indicated that this extra mass unit was indeed the 
result of a chemical change.   
   
Table 5.1.  Expected and observed masses for representative cyclic macrocycles in the 
DCL. 
Identity Actual [M+H]+ Observed [M+H]+ 
1b or 2b 1433.7 -- 
cyclic 1b or 2b (internal S-S) 1431.7 1431.7 and 1432.7 
(1b or 2b) + B 1615.7 1615.7 and 1616.7 
(1b or 2b) + C 1643.7 1643.7 and 1644.7 
 
 It was proposed that deamidation of the asparagine turn residue was occurring, which 
results in an overall mass increase of 1 Da due to the conversion of asparagine to aspartic 
acid (Figure 5.7).  This most commonly occurs with solvent accessible Asn-Gly 
sequences, such as the turn sequence of 1 and 2, as exposure to alkaline pH results in an 
increased rate of deamidation due to the greater nucleophilicity of the backbone nitrogen 
adjacent to the Asn residue.20   As these peptides are required to stir in alkaline solution 
for days and even weeks at a time to reach equilibrium, this side reaction is not unlikely. 
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Figure 5.7.  Deamidation of hairpin 2b via attack of the carbonyl of the asparagine side 
chain (orange) by the backbone amide nitrogen. 
  
 While some peptide structures can tolerate such a slight modification, deamidation is 
viewed as an undesirable side reaction at the turn of a β-hairpin due to the fact that it 
disrupts the hairpin conformation.  The conversion of asparagine to aspartic acid through 
a succinimide intermediate also allows for the conversion of asparagine to isoaspartic 
acid, which results in an even larger structural change of the hairpin peptide (Scheme 
5.1).21  IsoAsp is found to be the dominant of the two products, formed in a ratio of about 
4:1 in basic solution.   
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 Deamidation of the hairpin turn was confirmed by NMR studies.  Peptide 3 was 
synthesized (Figure 5.8), where the cysteine residues of 2b were replaced with serine 
residues to avoid spectra complicated by the formation of multiple species via 
intermolecular and intramolecular disulfide bonds.  The peptide was analyzed by NMR 
prior to and after being stirred in aqueous solution at pH 8-9 for three days.  To assess the 
extent of peptide deamidation, the ratio of the asparagine side chain amide proton to the 
C-terminal glutamine side chain amide proton was evaluated.  As the Gln side chain is 
unaffected by deamidation, the ratio should remain constant if this process is not 
occurring.  However, the ratio of the Asn NH proton to the Gln NH proton decreased 
from 1.24:1 to 0.39:1 upon exposure to basic solution as determined by integration, 
suggesting the hairpin was indeed undergoing deamidation.  The glycine splitting was 
also examined in each case, as the separation of the Gly Hα resonances have been shown 
to correlate with the extent of folding in β-hairpins.6  While the glycine protons revealed 
a splitting pattern characteristic of a well folded system in the initial peptide NMR, 
following exposure to base, new proton signals were observed in the region of the glycine 
protons (3.5 – 4.0 ppm) indicating the presence of new splitting patterns and therefore a 
change in structure.   
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Figure 5.8.  SKWS hairpin peptide 3 used to investigate asparagine deamidation by 
NMR.  The ratio of the Gln and Asn side chain amide protons was investigated 
(highlighted in yellow). 
 
 Deamidation was easily prevented in future studies through the synthesis and use of 
peptides 4 and 5, where the original Asn-Gly turn was replaced with a similar type I’ 
DPro-Gly turn (Figure 5.9).  The DPro-Gly turn has been shown to be equally, if not more 
effective in nucleating the formation of β-hairpins, and therefore should not affect the 
overall peptide stability.22 
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implemented in place of the Asn-Gly turn of 1b and 2b. 
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 iii. Hairpin monomer generation 3: WCWC.  Dithiol hairpin monomers 4 or 5 
were each combined in solution with monomers B and C at varying concentrations and 
ratios, however the major peptide-containing product in each case was the hairpin 
cyclized by an intramolecular disulfide.  It is likely that upon initiation of disulfide 
exchange, the intramolecular peptide disulfides formed rapidly due to the close proximity 
of the cysteine residues in each case, and that the entropic cost to break these disulfide 
bonds was too great, resulting in a quite limited DCL.  Furthermore, attempts to diversify 
the library via templation did not succeed in shifting the library composition, indicating 
that either there was no recognition of the nucleotides evaluated, or that binding was not 
strong enough to overcome the entropic cost of reducing either cyclic 4 or 5 to form a 
more effective receptor. 
 The hairpins were thus redesigned with the Cys residues further apart from each other 
in attempt to generate a more diverse, useful DCL for future templation studies.  A single 
β-hairpin was synthesized with diagonal Cys residues in positions 4 and 11, in place of 
the two lysine residues of WKWK (Figure 5.10).  While the intrinsic right-handed twist 
of the β-hairpin brings the diagonal Trps closer together than expected from a flat 
projection, the diagonal Lys residues are positioned further apart.23  The preservation of 
the diagonal Trp residues of WKWK was also expected to aid in nucleotide recognition.  
The necessity of an acidic residue to achieve total solubility in a DCL with B and C 
became increasingly apparent, as significant solubility problems resulted when the N-
terminal residue was synthesized as a neutral glutamine in attempt to maintain the same 
overall peptide charge as 4 and 5.    
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Figure 5.10.  Structure of hairpin monomer 6 with diagonal Trp residues (blue), and two 
cysteine residues (green) in place of the Lys residues of WKWK. The peptide also 
contains an N-terminal Glu for solubility and a DPro-Gly turn (orange). 
 
 iv. Nucleotide templation studies.  To further investigate the recognition of 
nucleotides, DCC screens were performed with the optimized β-hairpin monomer 6 and 
the small molecule dithiols B and C.  Efforts were focused on the screening of guanosine 
5’-monophosphate (GMP), largely due to the known higher affinity of WKWK for 
guanosine bases.  In addition, this provides an appropriate comparison in evaluating the 
selective recognition of the methylated analogue, 7-methyl GMP, as the forced positive 
charge can be expected to enhance recognition.  7-methyl GMP was prepared directly 
from GMP with dimethyl sulfate (Scheme 5.2).24  The monophosphate nucleotides were 
primarily investigated as opposed to the triphosphate nucleotides to minimize any 
potential charge repulsion between the phosphate tails and the negatively charged 
aromatic monomers, however this is not expected to drastically influence the results of 
the DCL screens.   
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Scheme 5.2.  Synthesis of 7Me-GMP. 
 
 Preliminary dynamic combinatorial libraries were prepared by mixing equimolar 
amounts of dithiols 6, B, and C (0.3 mM each) in basic solution (Figure 5.11).  Each 
small molecule dithiol building block was dispersed in water and dissolved upon addition 
of NaOH, while a stock solution of 6 was prepared in water.  The three building blocks 
were combined to achieve the desired concentrations, and in two of the three DCLs, 
either GMP or 7Me-GMP was added at a concentration of 0.3 mM.  The pH of each 
reaction was then adjusted to approximately 8 with NaOH, and the libraries were allowed 
to oxidized in capped HPLC vials at room temperature.  All libraries remained 
completely soluble with no visible precipitation.  The library compositions were analyzed 
by analytical HPLC daily, and chromatographic separation was optimized for the hairpin-
containing macrocycles. 
CO2H
HS SH
CO2H
SHHS
CB
SH
SHW
W
+
+
S
SW
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7Me-GMP7Me-GMP
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6
 
Figure 5.11.  Dynamic combinatorial library screens containing dithiol monomers 6, B, 
and C, templated with both GMP and 7Me-GMP. 
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 After four days of equilibration, the amplification of two species was observed in the 
templated libraries, both of which were amplified more significantly in the presence of 
7Me-GMP (Figure 5.12).  Purification of the two peaks at 8 and 12.5 minutes followed 
by direct infusion mass spectrometry analysis, led to the identification of these two 
macrocycles as 6B and 6B2, respectively (Figure 5.13).  While 6B clearly exists in a 
higher concentration than 6B2 in all cases, the extent of amplification of 6B2 appears to be 
greater due to the lower thermodynamic stability of this macrocycle in the untemplated 
reaction.  The apparent enhanced selectivity of both macrocycles for 7Me-GMP is likely 
due to a combination of cation-π interactions and additional hydrophobic interactions 
with the two Trp residues and/or the aromatic ring(s) of B.  It is evident that the diagonal 
placement of the cysteine residues in 6 facilitates greater library diversity than with 4 or 
5, reducing the extent of intramolecular disulfide formation.     
 
Figure 5.12.  The analytical HPLC traces at 280 nm of DCLs containing monomers 6, B, 
and C (0.3 mM each), untemplated (top) and in the presence of GMP (0.3 mM, middle) 
and 7Me-GMP (0.3 mM, bottom) after 4 days of equilibration. 
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Figure 5.13.  Cyclic hairpin structures amplified most significantly in the presence of 
7Me-GMP. 
 
 To further pursue this recognition of 7Me-GMP by the identified macrocycles, 
subsequent screens were evaluated containing only monomers 6 and B, as monomer C 
was not included in either of the amplified macrocycles.   In the first screen, the same 
monomer concentrations were used as in the previous DCLs (0.3 mM each), however the 
nucleotide concentration was increased to 0.6 mM.  The DCLs were investigated by LC-
MS in this case to allow for a better understanding of the composition of the entire 
library, and they were monitored for longer equilibration times.  After two days, a 150% 
increase in the concentration of the 6B macrocycle was observed in the presence of GMP 
(as determined by the change in the absolute peak area), in comparison to a 300% 
increase in the 7Me-GMP templated library (Figure 5.14).  The amplification of the 6B2 
receptor was slightly greater in each case, resulting in a 200% and 430% change via GMP 
and 7Me-GMP recognition, respectively.  This again illustrates the selectivity for the 
cationic 7Me-GMP nucleotide.  The observed amplification was also found to be highly 
concentration dependant, as a similar degree of amplification was not observed in a 
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second screen containing both monomers at higher concentrations (1 mM each).  This 
concentration dependence is not unprecedented in DCC libraries.   
 
Figure 5.14.  Part of the analytical HPLC traces at 280 nm of DCLs consisting of 
monomers 6 and B (0.3 mM each), untemplated (red) and in the presence of GMP (0.6 
mM, green) and 7Me-GMP (0.6 mM, purple) after 2 days of equilibration. 
 
 Analysis of the DCLs at longer time points did not reveal library equilibration as 
expected, but instead a significant amount of decomposition, preventing a full evaluation 
of the extent of amplification, and therefore the degree of recognition.  This is possibly 
due to the tendency of peptides to degrade in solution over time, particularly in basic 
media.  It is feasible to envision that the peptide backbone bonds get cleaved over time, 
resulting in a complete breakdown of the libraries, while other side reactions such as the 
oxidation of the indole rings of Trp are also feasible.  While the basic conditions required 
for disulfide exchange do not appear to be ideal for the equilibration of hairpin peptide 
monomers, the initial amplification of 6B and 6B2 is still promising in the identification 
of novel peptide receptors for nucleotides 
No Guest 
GMP 
7Me-GMP 
6 + B 
6 + 2B 
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 v. Stability of 7-methyl GMP.  In addition, the amplification of both 6B and 6B2 in 
the 7Me-GMP templated library appeared to be short-lived, which prompted an 
investigation of the stability of the nucleotide templates themselves under the conditions 
required for equilibration.  Although such fleeting peak enhancement is often the result of 
kinetic amplification prior to reaching the overall lowest energy state of the library, in 
this case it appeared to be due to the instability of the 7Me-GMP template under the 
equilibration conditions.  From the first time point through day 6 of equilibration of the 
DCL, little change in the size of the HPLC peak corresponding to GMP was observed, 
which suggests the nucleotide is stable throughout this analysis (Figure 5.15).  In 
contrast, the HPLC peak corresponding to the 7Me-GMP template decreased 
substantially after only one day and was entirely gone after 6 days (Figure 5.16).  The 
rate of degradation also appeared to be pH dependant, increasing with an increase in pH, 
which is precedented in the literature.  As the concentration of 7Me-GMP decreased, it is 
likely that the formation of 6B and 6B2 was no longer energetically favorable, causing re-
equilibration of the library and thus a decrease in the concentration of the receptors.  
Since the 7Me-GMP decomposition begins well before equilibrium of the DCL is 
reached, both the level of affinity and extent of selectivity for 7Me-GMP over GMP are 
difficult to fully ascertain. 
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Figure 5.15.  The GMP template peak in the analytical HPLC traces of the GMP 
templated library at time 0 (red) and after 1 day (orange), 2 days (green), and six days 
(blue). 
 
 
Figure 5.16.  The 7Me-GMP template peak in the analytical HPLC traces of the 7Me-
GMP templated library at time 0 (red) and after 1 day (orange), 2 days (green), and six 
days (blue). 
 
 The source of this apparent instability of 7Me-GMP is believed to be due to the basic 
solution required for disulfide exchange as opposed to the presence of thiolate anions, as 
indicated by various control experiments.  The decomposition is likely initiated by the 
irreversible nucleophilic attack of a hydroxide ion on the CH adjacent to the methylated 
nitrogen to give the ring-opened product 7 (Scheme 5.3).25  This is a viable mechanism 
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for the decomposition observed in the DCL, as a new mass 17 Da greater than that 
expected for 7Me-GMP is observed.  
NH
N
N
O
NH2
N
O
OHOH
OPHO
O
OH
H3C
7Me-GMP
NH
N
O
NH2
HN
O
OHOH
OPHO
O
OH
OH-
NO
H
7  
Scheme 5.3.  Possible pathway of decomposition of 7Me-GMP.  
 
 vi. Isolation of hairpin receptors.  To purse further investigations of the cyclic 
peptide receptors as potential 7Me-GMP receptors, the preparation and isolation of these 
molecules was required.  This is achieved via DCC in a fairly straightforward manner.  A 
library was prepared with a 1:2 ratio of 6 to B and a total concentration of 3 mM.  Due to 
the stability of GMP in solution, the library was templated with GMP (2 mM); however, 
amplification of 6B and 6B2 is minimal at these concentrations as described previously.  
The solution was stirred in a capped vial for 4-5 days before purifying both 6B and 6B2 
and on an analytical HPLC, yielding only a few milligrams or less in each case.  The 
identity and purity of the compounds were confirmed by analytical LC-MS. 
 vii. NMR characterization of hairpin receptors.  To investigate the structural 
differences between the isolated receptors and the linear β-hairpin 6, NMR was used to 
characterize the peptides.  Initial attempts to dissolve 6B in a purely aqueous solution 
proved difficult, but complete solubility of the peptide was achieved in a 40% MeOD 
solution.  Peptide 6 was first investigated under identical conditions, revealing a very 
well folded β-hairpin.  This was demonstrated by a glycine splitting of 0.65 ppm, 
indicating different chemical environments of the diastereotopic Hα protons, which is 
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characteristic of a β-hairpin confirmation.  Furthermore, distinct shifts of the Hα protons 
of various residues relative to what would be expected for an unfolded system further 
confirmed a high overall degree of hairpin structure.  While it should also be noted that 
the degree of β-hairpin folding is known to increase in methanol, this solvent system was 
used for an accurate comparison to the cyclic receptors. 
 In contrast, the degree of folding of 6B should be less affected in methanol as a result 
of the preformed covalent tether linking the two strands of the peptide.  However, both 
1D and 2D TOSCY experiments of 6B revealed a substantially less hairpin-like structure 
in 40% MeOD.  Little to no splitting of the glycine protons was observed, while the 
upfield shifting of the Hα protons of various residues such as Ile, Val, and Orn further 
confirmed the non-hairpin like structure.  It is clear that by bridging the two strands at the 
diagonal cysteine residues via a single B monomer, the peptide structure is significantly 
distorted from that of 6.  Due to this apparent structural change, it is likely that the 
binding of both nucleotides by the 6B receptor is quite different than the binding of GMP 
by WKWK.  Although the structure of 6B in the presence of GMP or 7Me-GMP was not 
evaluated, little change in folding is expected due to the fixed nature of the cyclic 
peptide.  While a comparison to 6B2 would have been interesting to determine if hairpin 
structure can be restored with a longer bridge between the two peptide strands, this 
receptor proved to be substantially less soluble under these conditions, resulting in 
concentrations of peptide in solution that were too low for detection by NMR.   
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C. Conclusion 
 In conclusion, this study illustrates the use of structured β-hairpin peptides in the 
context of a dynamic combinatorial library, for the identification of selective peptide 
receptors for GMP and 7Me-GMP.  Peptide 6 was designed based on the known 
nucleotide hairpin receptor, WKWK, with two cysteine residues to allow for disulfide 
exchange of the peptide with the small aromatic dithiol monomers, B and C.  However, 
obtaining complete solubility with such a system containing monomers with quite 
different structures, polarities, and hydrophobicities is not trivial. 
 Library screens in the presence of GMP and 7Me-GMP revealed the amplification of 
two cyclic structures, 6B and 6B2, each of which is modestly amplified in the presence of 
GMP, and more significantly in the presence of 7Me-GMP.  It appears that by covalently 
bridging the two peptide strands of 6 and potentially forming a tighter binding pocket, 
more favorable interactions with the nucleotide templates are created.  Furthermore, the 
methyl group on the guanosine base serves to enhance these interactions, either through 
additional hydrophobic contacts and/or through favorable cation-π interactions with the 
Trp side chains of 6 or the aromatic rings of B.   
 Interestingly, the binding of both GMP and 7Me-GMP to the identified peptide 
macrocycles appears to compete with the folding of the linear peptide (Figure 5.17).  
While 6 maintains a well-folded, hairpin-like structure, the structure of 6B is quite 
different, no longer resembling a β-sheet.  It can be concluded that in the presence of both 
GMP and 7Me-GMP, 6B exists in a higher concentration relative to the untemplated 
reaction due to a greater energy gain as a result of the binding of 6B2 versus the folding 
of 6.  While the stability of both the library and the 7Me-GMP template proved to be non-
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ideal under the conditions required for disulfide exchange, this DCC system still proved 
to be effective in demonstrating novel cyclic peptide receptor structures.  Such receptors 
selective for 7Me-GMP may provide greater insight into native nucleotide-protein 
interactions, as well as aid in elucidating the role of such interactions in gene expression.   
S
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W S
SH
SHW
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7Me-GMP
 
Figure 5.17.  The competing equilibria: folding of hairpin 6 and binding of macrocycles 
6B or 6B2. 
 
D. Experimental Section 
 i. Peptide synthesis. All peptide synthesis was performed on an automated Applied 
Biosystems Pioneer Peptide Synthesizer using a PEG-PAL-PS resin.  Peptides were 
synthesized on a 0.1 mmol scale by standard Fmoc solid phase synthesis.  All amino 
acids with functionality were protected during synthesis.  Coupling reagents were 
HOBt/HBTU in DMF.  Fmoc deprotections were carried out in a solution of 2% 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) and 2% piperidine in DMF and, the N-terminus 
was acylated with a solution of 5% acetic anhydride and 6% 2,6-lutidine in DMF.  
Cleavage of the peptide from the resin and of the side chain protecting groups was 
performed by hand with a cocktail of 95% trifluoroacetic acid (TFA)/2.5% ethanedithiol 
(EDT)/1.0% triisopropylsilane/2.5% H2O for all Cys containing peptides, and 95% 
trifluoroacetic acid (TFA)/2.5% triisopropylsilane/2.5% H2O for all other peptides for 3 
hours.  TFA was evaporated and the product was precipitated with cold ether.  The water-
soluble peptides were extracted with water and lyophilized.  Peptides were purified by 
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semipreparative reversed-phase HPLC on a C18 column at a flow rate of 4 mL/min.  
Peptides were purified with a linear gradient of A and B (A: 95% H2O/5% CH3CN with 
0.1% TFA, B: 95% CH3CN/5% H2O with 0.1% TFA) and elution was monitored at 214 
and 280 nm.  Once purified, peptides were lyophilized to powder and characterized by 
+ESI-MS.   
 ii. 7-methyl GMP synthesis.  The disodium salt of guanosine 5’-monophosphate (0.2 
g, 0.49 mmol) was dissolved in 1.6 mL of water rand the pH was adjusted to 
approximately 4.5 with 1 M HCl.  As the pH was lowered, additional volume of water 
was required to maintain adequate solubility.  Dimethyl sulfate (292 mL, 3.1 mmol) was 
added dropwise via syringe pump over a period of 1 hour at room temperature with 
continuous stirring, and then the reaction was allowed to stir for an additional 3 hours.  
During the course of the reaction the pH was maintained between approximately 3.0 and 
4.5 to prevent esterification of the phosphate groups.  The reaction was pass through an 
ion exchange column of Dowex-1 Cl- (50-100 mesh, 11 × 2 cm) and eluted with H2O.  
The product eluted quickly and 14 fractions were collected, the first 7 of which showed a 
major ultraviolet fluorescent spot.  Fractions 1 – 7 were pooled and the product was 
lyophilized to powder, to obtain pure product.  Further purification via re-precipitation of 
the product with the addition of ethanol has been reported, however this not found to be 
necessary.19  1H NMR (D2O, 300 MHz): δ = 8.97 (s, 1H), 5.90 (d, 1H),  4.48 (t, 1H), 4.28 
(t, 1H), 4.22 (m, 1H), 4.06 (m, 1H), 3.94 (m, 1H), 3.92 (s, 3H). 
 iii. Dynamic combinatorial library screens.  Building block B and C stock 
solutions were each prepared in water, adding sufficient 1.0 M aqueous NaOH to fully 
dissolve the monomers, using sonication when necessary.  Peptide stocks were prepared 
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in water and the concentrations were determined by UV-Vis in 5M guanidine 
hydrochloride, using the absorbance of the tryptophan residues at 280 nm (ε = 5,690 M-1 
cm-1 per Trp).26  Similarly, nucleotide solutions were prepared in water and their 
concentrations were determined by UV-Vis (GMP: ε at 253 nm = 13,700 M-1 cm-1; 7Me-
GMP: ε at 297 nm = 3,537 M-1 cm-1).  The relevant building blocks were combined to 
achieve a 1 mL solution of the desired concentrations (300 µM each, unless indicated 
otherwise), and when necessary, aliquots of nucleotides guests were added to the 
reactions to reach the desired final concentration.  Any remaining volume was made up 
with water, and the pH of each solution was adjusted to approximately 8 using 1.0 M 
NaOH.  The vials were capped and analyzed at various time points, and the pH of each 
solution was monitored over time.   
 iv. Analytical HPLC and LC/MS.  The analytical HPLC was carried out daily (until 
significant library decomposition was observed) on an Agilent Rapid Resolution LC 
system, equipped with an online degasser, binary bump, autosampler, heated column 
compartment, and diode array detector.  HPLC separations were performed using a 
water/acetonitrile solvent system (A: 95% H2O/5% CH3CN with 0.1% TFA, B: 95% 
CH3CN/5% H2O with 0.1% TFA; gradient: 0-30% B, 0-4 minutes / 30-35% B, 4-12 
minutes / 35-45% B, 12-20 minutes) with a column temperature of 55 °C, a flow rate of 
2.0 mL/min, and 5 µL injection volumes.  Reactions were monitored at 214, 280, and 320 
nm.  LC-MSD was performed on a Waters Acquity LC-MSD system with an in-line 
single quadrupole mass spectrometer. LC-MS separations were performed using a 
water/acetonitrile solvent system (A: 95% H2O/5% CH3CN with 0.2% formic acid, B: 
95% CH3CN/5% H2O with 0.2% formic acid; gradient: 0-25% B, 0-2 minutes / 25-30% 
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B, 2-3 minutes / isocratic at 30% B, 3-5 minutes / 30-32% B, 5-7 minutes / 32-75% B, 7-
13 minutes) with a column temperature of 55 °C, a flow rate of 0.6 mL/min, and 2 µL 
injection volumes.  Positive electrospray ionization was used to determine the peak 
masses, however it should be noted that the masses of macrocycles consisting of only B 
and C could not be identified via positive ionization.  The peak areas were integrated at 
280 nm. 
 v. Synthesis and isolation of hairpin receptors.  Libraries were prepared as 
described above on a 1-3 mL scale containing 1 mM 6 and 2 mM B and templated with 
GMP (2 mM), despite the lack of significant amplification at these millimolar 
concentrations.  After approximately four days the libraries were purified on a Waters 
Alliance analytical HPLC with an Atlantis C18 column (4.6 × 150 mm, 5 µm).  The 
libraries were chromatographed (50 – 100 µL automated injections) using standard 
water/acetonitrile peptide synthesis mobile phases (A: 95% H2O/5% CH3CN with 0.1% 
TFA, B: 95% CH3CN/5% H2O with 0.1% TFA; gradient: 0-25% B, 0-8 minutes / 25-30% 
B, 8-12 minutes / isocratic at 30% B, 12-20 minutes / 30-32% B, 20-28 minutes / 32-57% 
B, 28-42 minutes) with a column temperature of 50 °C and a flow rate of 1.0 mL/min.  
Reactions were monitored at 280 nm (Figure 5.18).  Purified 6B and 6B2 were analyzed 
for purity by +ESI (Figure 5.19) and lyophilized to powder. 
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Figure 5.18.  Purification of peptides 6B and 6B2 on an analytical HPLC (280 nm). 
 
 
Figure 5.19.  Representative mass spectra: purified 6B (+ESI, [M+H]+ = 1656.9) 
 
 vi. NMR spectroscopy.  Peptide NMR samples were analyzed on a Varian Inova 
600-MHz instrument at 25 °C.  1D NMR spectra were collected using 32K data points 
and 32 scans using a 1-3 second presaturation.  All 2D NMR experiments used pulse 
sequences from the Chempack software.  2D TOSCY experiments were taken with 32 
scans in the first dimension and 128 scans in the second dimension.  All spectra were 
analyzed using standard window functions (sinbell and Gaussian with shifting).  
6B 
6B2 
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Presaturation was used to suppress the water resonance.  Peptide proton assignments 
were made following standard methods.27 
 To investigate deamidation of the hairpin turn, peptide 3 was dissolved in 50% H2O 
and 50% D2O and analyzed by 1D NMR (Figure 5.20).  A second sample of 3 was 
dissolved in H2O at pH 8-9 and allowed to stir for 3 days.  The peptide was purified by 
HPLC and then analyzed similarly by 1D NMR (Figure 5.21).  The signals corresponding 
to a single Asn NH proton and a single Gln NH proton were identified and integrated in 
each case (Figure 5.22).   
 
Figure 5.20.  Full 1H NMR of 3 at 25 °C. 
 
H2O/D2O 
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Figure 5.21.  Full 1H NMR of 3 at 25 °C after exposure to basic solution for 3 days, 
resulting in a mixture of intact peptide and peptide that has undergone deamidation. 
 
H2O/D2O 
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Figure 5.22.  Asn and Gln NH 1H NMR signals of 3 at 25 °C before (top) and after 
(bottom) exposure to basic solution. 
 
 Samples of 6 and 6B were prepared in 40% MeOD and 60% D2O with 0.5 mM DSS.  
1D spectra were taken of each, as well as 2D TOSCY spectra allowing for the assignment 
and comparison of amino acid Hα protons (Table 2.6).   
Asn NH 
Gln NH 
Asn NH 
Gln NH 
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Figure 5.23. 1H NMR of 6 at 25 °C. 
 
Table 5.2.  Proton Hα chemical shift assignments for 6 (EW1V1C1V2DPGOW2IC2Q) and 
6B at 25 °C. 
Residue 6 Hα 6 + B Hα 
Glu 4.35 or 4.42 4.15 or 4.28 
Trp1 5.19 or 5.32 4.67 or 4.80 
Val1 4.56 4.28 
Cys1 4.42 4.63 or 5.37 
Val2 4.09 4.28 
DPro 4.28 or 3.83 4.42 
Gly 4.02 and 3.37 3.80 
Orn 4.66 3.94 
Trp2 5.19 or 5.32 4.67 or 4.80 
Ile 4.64 4.12 
Cys2 4.42 4.63 or 5.37 
Gln 4.35 or 4.42 4.15 or 4.28 
H2O/D2O 
 
DSS 
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CHAPTER VI 
BINDING INDUCED FOLDING OF A PHOTOCONTROLLED β-HAIRPIN PEPTIDE 
 
A. Background and Significance 
 i. β-Hairpin model systems for the recognition of nucleotides.  Short peptide 
sequences that adopt a specific secondary structure are often used as model systems to 
mimic a certain protein fold and study the factors that contribute to protein folding and 
protein recognition.  Motivated by the prevalence of β-sheet motifs throughout protein 
structures and the desire to better understand the factors contributing to their stability, 
short, monomeric β-hairpin peptides have been studied as models for antiparallel β-
sheets.1  These β-sheet mimics contain two antiparallel β-strands connected by a turn 
sequence, such as an Asn-Gly type I’ turn motif, which nucleates the hairpin structure.2   
 As discussed previously in chapter five, it has been found that β-hairpin peptides can 
serve as novel molecular receptors for biologically relevant aromatic compounds, such as 
nucleotides.  Specifically, the WKWK hairpin (Figure 5.1) has been shown to be a quite 
effective receptor for adenosine 5’-triphosphate (ATP), as the diagonal tryptophan-
tryptophan pair in the non-hydrogen bonding sites of the hairpin provides a binding cleft 
for aromatic intercalation, while the lysine side chains provide favorable electrostatic 
interactions with the phosphate groups.3  ATP was found to bind the β-hairpin with a 
dissociation constant of 170 µM, and a total binding energy of approximately -5 
kcal/mol.  
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 ii. Photoswitchable β-hairpins.  The turn sequence of the β-hairpin has been found 
to be crucial in ensuring proper nucleation of the β-sheet structure.  While WKWK 
contains an Asn-Gly turn, it has also been shown that the D-Pro-Gly segment is a very 
strong promoter of β-hairpin formation, and superior to the L-Asn-Gly segment in this 
regard.4  The utility of the D-Pro-Gly turn sequence for fundamental β-sheet analysis is 
particularly enhanced due to the fact that swapping L-proline for D-proline destroys 
hairpin structure, as L-proline negates formation of β-hairpin loops.  While it is useful to 
be able to prepare and study β-hairpin sequences in both the folded and unfolded state 
based on the implementation of either a D-Pro-Gly or L-Pro-Gly turn respectively, it 
would be equally interesting to study a structure that is able to easily convert between the 
folded and unfolded state in response to an external stimuli.   
 The use of light to initiate the reversible conformational control of β-hairpin 
formation is one way in which this can be achieved.  Azobenzene moieties are ideally 
suited for this application as they give rise to large changes in the distance between 
moieties appended to the aryl rings upon interconversion of the trans and 
thermodynamically less favored cis-azobenzene isomers.  While irradiation at the 
wavelength of the π→π* transition converts the trans isomer to the corresponding cis 
isomer, the reverse process can also be facilitated either thermally or by irradiation of the 
wavelength of the n→π* transition.5  Incorporating azobenzene photoswitches into small 
protein motifs has been demonstrated in the amino acid side chains,6 in the backbone,7 
and even as a β-turn mimic when in its cis form.8  Specifically, monomeric soluble β-
hairpin peptides whose structure is reversibly photocontrolled by an azobenzene-based 
chromophore that acts as a turn mimetic at the tip of the hairpin have been presented.9  
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Such azobenzene moieties have provided excellent conformational control while 
allowing for time-resolved folding studies of β-sheet structures with unprecedented 
temporal resolution.   
 In one case a photocontrolled hairpin peptide has been demonstrated in the context of 
a tryptophan zipper-like β-hairpin.9b  While the original sequence is fully folded at room 
temperature,10 substitution of the Asn-Gly turn residue by an azobenzene chromophore 
considerably destabilizes the hairpin, resulting in an estimated 50% β-hairpin content at 5 
°C for the cis-azo photostationary state as determined by CD.  In comparison, at 30 °C 
the extent of folding of the cis-isomer decreases to 25%, and a two-state transition with a 
melting temperature of 25 °C has been proposed.  In both cases, the hairpin fold is 
significantly diminished upon isomerization to the trans-azo isomer.  NMR structures 
revealed close structural agreement between the cis-azo peptide and the native TrpZip 
peptide for the antiparallel β-strands as well as the tryptophan side chains, whereas the 
trans-azo isomer displays a quite different alignment of the two peptide strands (Figure 
6.1).   
 
Figure 6.1.  Backbone superimposition of the lowest energy NMR structure of the cis-
azo peptide isomer (green ribbons) on the original tryptophan zipper (blue ribbons, PDB 
code 1LE1).  The azobenzene chromophore (orange) and side chains of the tryptophan 
residues are displayed. 
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 The use of a photoinducible azobenzene turn element to control the folding of β-
sheets has also been shown in a 12-residue peptide derived from the GB1 protein.9a  In its 
cis configuration the azobenzene moiety mimics the native D-Pro-Gly dipeptide turn; 
however, it was observed that in this case the cis-azo peptide takes on a different fold 
than the parent peptide.  The backbones of the N- and C-strand segments are both flipped 
by about 180° in the cis-azo hairpin, so that the Hα protons which face the opposing 
strand in one peptide are directed toward the solvent in the other.  Although clearly this 
turn mimic serves to preorganize two peptide strands as a β-hairpin, the more flexible 
nature of the azobenzene turn favors a different set of intramolecular interactions, leading 
to significant structural differences from the parent peptide.  Furthermore this system was 
met with extensive aggregation and precipitation of the trans conformation of the hairpin, 
likely due to intermolecular association of the molecules through hydrophobic 
interactions and stacking of the azobenzene units, which is not unprecedented.11    
 iii. Goal of this work.  In this work we set out to investigate the effect of introducing 
a photoswitchable azobenzene turn moiety into the peptide, WKWK, which is a known 
receptor for nucleotides.  No prior studies have examined a photoinducible β-hairpin in 
relation to its binding capabilities.  We sought to evaluate the impact of the azobenzene 
turn on the recognition of ATP in both the cis and trans conformation.  Furthermore, the 
correlation between folding and binding was investigated, as well as the potential 
influence of binding on the ratio of cis and trans peptide isomers.  The relationship 
between binding and hairpin folding is a unique one, and this provides an ideal 
opportunity to examine both of these elements in a simple system.  All prior studies of 
nucleotide recognition by β-hairpins have made use of well-folded systems, and therefore 
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it is not known to what degree of preorganization is required to facilitate binding.  
Furthermore, the photoswitchable nature of this system provides an opportunity to 
achieve a greater degree of control over both hairpin folding and recognition through the 
use of an external light source.   
 
B. Results and Discussion 
 i. Design of a photoswitchable hairpin.  The 12-residue WKWK peptide has been 
shown to have a high propensity to form a β-hairpin, and has been characterized by NMR 
to be about 95% folded in an aqueous environment.  The type I’ Asn-Gly turn segment at 
positions 6 and 7 nucleates hairpin formation, and was sought to be replaced with an 
azobenzene-containing turn mimetic.  Favorable interactions between the hydrophobic 
pocket formed by the Trp side chains and the turn element in its cis configuration were 
expected to favor a β-hairpin structure.   
 An azobenzene based Fmoc protected amino acid was used for the facile 
incorporation of this moiety via solid phase synthesis.  It has previously been suggested 
that an amino acid with meta-substituted aryl rings was a more promising turn mimetic 
than ortho- or para-substituted aryl rings. 12  Similarly, a single methylene group has been 
found as a more ideal spacer than multiple methylenes between the functional groups and 
the aryl rings in order to accommodate interstrand interactions between the appended 
peptides.12  The synthesis of the Fmoc amino acid 8 relies on the reaction of a 
nitrosobenzene 3 with an aniline 6 (Scheme 6.1).9a  Compound 3 was prepared by 
esterification of commercially available m-nitrophenylacetic acid 1 under Mukaiyama 
conditions, followed by reduction of the nitro group to hydroxylamine with Zn dust in 
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NH4Cl solution and immediate reoxidation with FeCl3 to the nitroso compound.  Aniline 
6 was obtained from commercially available 3-nitrobenzylamine hydrochloride 4 via a 
two-step sequence, involving introduction of an Fmoc protecting group followed by 
reduction of the nitro group.  Coupling of 3 and 6 in acetic acid afforded the fully 
protected azobenzene amino acid 7, and subsequent cleavage of the tert-butyl ester group 
with TFA gave the turn mimetic amino acid 8.   
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Scheme 6.1.  Synthesis of azobenzene amino acid 8. 
 
 Compound 8 was well suited for standard Fmoc-solid phase peptide synthesis.  In the 
synthesis of the full hairpin, the WKWK sequence was left unaltered other than the two 
Asn-Gly turn residues, which were both replaced with the single azobenzene amino acid 
8 (Figure 6.2). 
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Figure 6.2. Structure of the WKWK β-hairpin peptide 9 containing a cis-azobenzene turn 
structure. 
 
 ii. Biophysical characterization of a photoswitchable WKWK peptide.  The 
peptide was first examined to determine the percent composition of trans-9 and cis-9 at 
thermodynamic equilibrium.  A peptide solution was prepared, and as judged by LC/MS 
at 220 nm, it was determined that approximately 75% of the peptide existed in the trans 
configuration, whereas 25% adopted the cis configuration.  The two isomers were well 
resolved and easily identified, as the trans isomer is known to be thermodynamically 
favored and present in higher concentrations.  The expected strong absorbance of trans-9 
at 320 nm in comparison to cis-9 was also observed, as the peptide appears to have 
almost exclusively a trans configuration at this wavelength.   
 Conversion of the hairpin to its photostationary state was then investigated upon 
exposure to 365 nm light.  The length of exposure required for complete conversion to 
the photostationary state was first evaluated by UV-Vis.  After one minute of exposure, a 
significant decrease in absorbance at 320 nm was observed, corresponding to a decrease 
in the amount of trans-9 present in solution (Figure 6.3).  Similarly, a more subtle 
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increase in absorbance at 420 nm was observed, indicative of an increase in concentration 
of cis-9.  To determine if the hairpin was fully converted to the photostationary state, the 
peptide solution was exposed to 365 nm light for another 5 minutes and again the 
composition was assessed by UV-Vis.  An even further drop in the absorbance at 320 nm 
was observed, indicating that 1 min of light exposure was not sufficient to reach the 
photostationary state.  After yet a third isomerization of an additional 5 minutes, no 
further change in the UV spectra was observed, and it was concluded that about 5 
minutes of photolysis was required for the peptide to achieve its photostationary state.  
LC/MS analysis indicated that the hairpin had been converted to a ratio of about 85% cis-
9 to 15% trans-9 at 220 nm.     
 
Figure 6.3.  UV-Vis spectra of hairpin 9 at thermodynamic equilibrium (blue), after 
photolysis for one minute (red), 6 minutes (green) and 11 minutes (purple). 
 
 To confirm the successful isomerization of the hairpin, the peptide was characterized 
by NMR in both the thermodynamic and photostationary state at room temperature.  
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Despite overlap with the aromatic tryptophan residues, distinct differences were observed 
in the aromatic regions of the spectra.  The ratio of cis-9:trans-9 in each spectra, prior to 
and after photolysis, agree well with the corresponding ratios determined by LC/MS.  
Furthermore, the cis-azobenzene protons were upfield shifted from those of the trans-
azobenzene moiety, indicating a distinct change in environment of the turn mimetic upon 
photolysis, and potentially some degree of interaction between the two rings when they 
are brought in close proximity.  The tryptophan α-protons (Hα) were also found to be 
slightly downfield shifted in the photostationary state, which is indicative of a higher 
degree of β-sheet structure.13  In conjunction with 2D TOSCY spectra, the cis-
azobenzene peptide was determined to be approximately 20 – 30% folded, while the trans 
conformation showed no signs of folding.  Both Trp residues in trans-9 show identical 
chemical shifts, indicating that they are in near identical environments and thus the 
peptide is likely fully unfolded. 
 After having characterized the isomerization of the azobenzene chromophore within 
the WKWK sequence, the structure of the peptide was investigated in both the 
thermodynamic and photostationary state by circular dichroism.  The peptide was first 
evaluated in the thermodynamic state where the trans isomer is dominant, and a distinct 
minimum at 200 nm was observed which is characteristic of random coil peptides (Figure 
6.4).  This indicates that replacement of the Asn-Gly turn of the native WKWK with a 
trans-azobenzene residue effectively disrupts the hairpin structure.  A comparable sample 
isomerized to the photostationary state, where cis-9 was now the dominant species by 
about 85:15, shows a quite similar spectra.  The minimum at about 200 nm indicates that 
the peptide remains predominantly unfolded when the majority of the peptide takes on a 
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cis-azobenzene β-turn mimic.  However, a slight maximum is now observed at 230 nm, 
which is due to the contribution of Trp-Trp exciton coupling, or stacking of the cross-
strand tryptophan residues.  This provides evidence that there is a small degree of folding 
initiated by photolysis.  While this may not seem significant, it does not seem extremely 
dissimilar from the corresponding photoswitchable TrpZip system, which exhibits only a 
25% hairpin content of the cis-azo isomer at 30 °C as determined by CD.   
 
Figure 6.4.  Circular dichroism spectra for azobenzene peptide 9 at thermodynamic 
equilibrium (red) and in the photostationary state (orange).  Studies were performed in 10 
mM sodium phosphate buffer pH 5.5 at 25 °C.   
 
 iii. ATP recognition by a photoswitchable WKWK peptide.  Similar experiments 
to those described above were performed in the presence of ATP, in both the thermal and 
photostationary state, to determine the effect of possible ATP recognition on both the 
peptide’s structure and function.  While the native WKWK sequence effectively 
recognizes ATP with micromolar affinity, it naturally exists in a pre-organized state.  In 
comparison, in the cis conformation 9 is only weakly folded, and entirely unfolded in the 
trans conformation.  We sought to investigate what effect, if any, the presence of ATP 
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had on either the cis:trans ratio of the peptide or the structure of the peptide, and whether 
binding to ATP could indeed be photocontrolled. 
A 3-fold excess of ATP was first added to a low concentration sample of 9 at thermal 
equilibrium.  When directly compared to a corresponding sample without ATP by 
LC/MS, no change in the ratio of cis-9 to trans-9 was observed, and both contained 
trans-9 as the dominant isomer in solution (Figure 6.5).  Similarly, the ratio of cis-9 to 
trans-9 in the photostationary state remained unchanged in the presence of ATP.  
Regardless of whether ATP was added prior to or after the photolysis of 9, the amount of 
peptide in the cis conformation in solution remained at about 85%.   
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photostationary
state
photostationary
state
photostationary
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+ 3 eq ATP 
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Figure 6.5.  HPLC traces at 220 nm of azobenzene containing hairpin 9 at 
thermodynamic equilibrium (blue), at thermodynamic equilibrium with 3 equivalents of 
ATP (red), in the photostationary state (green), in the photostationary state with 3 
equivalents of ATP added prior to photolysis (magenta), in the photostationary state with 
3 equivalents of ATP added after photolysis (gold).  The peak at 3.9 minutes in each trace 
corresponds to a small peptide impurity.  
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 To evaluate if the addition of ATP had any affect on the hairpin structure, CD was 
used to evaluate both the trans and cis peptide conformations in the presence of ATP.  
Surprisingly, the spectra of both samples containing either predominantly cis-9 or trans-9 
were altered significantly by the presence of ATP, and similar changes were observed in 
each case.  When ATP was added to 9 at thermal equilibrium, a distinct new minimum 
around 215 was observed, which is indicative of β-sheet structure (Figure 6.6).  At the 
same time, the signal around 200 nm corresponding to the random coil conformation is 
significantly diminished.  This indicates that some degree of structural rearrangement 
upon the addition of ATP is occurring, however without reconfiguration of the 
azobenzene unit to the cis isomer, which would be expected to facilitate hairpin 
formation.  To confirm that the observed changes were not due simply to the presence of 
ATP, the CD spectra of ATP at the same concentration was investigated in isolation, 
showing a much less pronounced signal at about 215 nm and verifying that the new 
minimum observed is predominately due to a change in the peptide structure. 
 
Figure 6.6.  Circular dichroism spectra for azobenzene peptide 9 at thermodynamic 
equilibrium (red) and in the presence of ATP (blue).  Studies were performed in 10 mM 
sodium phosphate buffer pH 5.5 at 25 °C.   
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 A similar change in the CD spectra is observed when ATP is added to 9 in the 
photostationary state.  The distinct minimum at 215 is again observed with a concomitant 
loss in the 200 nm signal, indicating a conversion of the random coil peptide to a β-sheet 
like structure (Figure 6.7).  In addition, a more noticeable maximum signal around 230 is 
observed, again indicating an interaction between the two cross strand tryptophan 
residues, which is characteristic of such β-hairpin sequences.  A similar CD spectrum is 
observed for the peptide regardless of whether the ATP is added prior to or after 
photolysis.  While the peptide starts out quite weakly folded, it is appears that the 
addition of ATP initiates a binding interaction, which induces a greater degree of peptide 
folding.  As the binding of ATP by the native WKWK sequence is largely a result of the 
diagonal relationship of the two Trp residues on opposite strands which form a binding 
cleft for aromatic recognition, it is likely that upon addition of ATP in this case, the two 
peptide strands are brought in closer proximity resulting in an overall more well folded 
system.  This is in contrast to the native WKWK sequence, where the peptide is pre-
organized for nucleotide recognition.   It is evident that by replacing the well-defined 
type I’ Asn-Gly turn with this more flexible azobenzene unit, a binding induced folding 
of the hairpin is facilitated.   
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Figure 6.7.  Circular dichroism spectra for azobenzene peptide 9 in the photostationary 
state (orange) and in the presence of ATP (green).  Studies were performed in 10 mM 
sodium phosphate buffer pH 5.5 at 25 °C.   
 
 In attempt to gain greater insight as to the structural features of the peptide in both the 
thermal and photostationary state in the presence of ATP, we hoped to perform NMR 
studies to further examine the system.  Upon the addition of excess ATP to 
concentrations of 9 required for NMR studies, a significant amount of precipitation was 
observed, preventing further analysis.  While this could be corrected for with the addition 
of a significant amount of a co-solvent such as deuterated acetonitrile, ATP binding is 
expected to be significantly suppressed in this case, resulting in minimal changes of the 
peptide spectra in the presence of ATP. 
 iv. Peptide mutations.  To evaluate whether the binding induced folding of the 
designed hairpin was indeed specific for this particular system, various mutations were 
made to the hairpin sequence to investigate if similar structural changes were observed 
upon the addition of ATP.  First, the azobenzene turn residue was replaced with two 
glycine residues, which are entirely flexible and have no precedence as a turn sequence.  
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By removing the azobenzene moiety which is capable of mimicking a β-turn, it was 
investigated whether folding could be induced by nucleotide recognition in any unfolded 
system where the sequence of the antiparallel strands was maintained.  Investigation of 
this mutated peptide by CD, both in the absence and presence of ATP, showed identical 
spectra in both cases (Figure 6.8).  This indicated that the azobenzene turn moiety is in 
fact required to induce a structural change in the peptide upon nucleotide recognition.  
 
Figure 6.8.  Circular dichroism spectra for WKWK with a Gly-Gly turn (blue) and in the 
presence of ATP (purple).  Studies were performed in 10 mM sodium phosphate buffer 
pH 5.5 at 25 °C.   
 
 Next, to confirm that ATP is indeed intercalating between the two cross strand Trp 
residues as in the native sequence, both Trp residues were mutated.  The tryptophans 
were replaced with hydrophobic, aliphatic leucine residues, which are also known for 
having a reasonably high β-sheet propensity.  Evaluation of this control peptide also 
ensures that the observed changes with hairpin 9 are not the result of non-specific 
interactions between ATP and the azobenzene group.  Initial investigation of this peptide 
at thermodynamic equilibrium, prior to the addition of ATP, revealed a random coil 
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conformation, and a spectrum similar to that observed previously for 9 with the expected 
minimum at 200 nm (Figure 6.9).  Upon photolysis, a very similar CD spectra was 
obtained, indicating that isomerization of the azobenzene unit to the cis confirmation 
does not result in a well folded peptide.  In contrast to cis-9, no maximum at 230 nm is 
observed due to the lack of tryptophan residues in this sequence.   
 Addition of ATP to the LKLK peptide in both the thermal and photostationary state 
revealed only minor changes in both spectra.  In each case the random coil signal is 
slightly weaker, and only a minor increase in signal is observed around 215 nm.  Despite 
the fact that the tryptophan residues are not present to facilitate ATP binding, both lysine 
residues remain intact, which are known to interact with the phosphate groups of ATP via 
favorable electrostatic interactions.  As a result, it is likely that ATP is still interacting to 
some degree with the LKLK control peptide in this fashion, resulting in a minor change 
in the CD spectra of both the cis and trans peptide.  This confirms that the ATP is in fact 
interacting between the diagonal Trp residues of 9, as removal of these side chains 
significantly weakens the binding induced folding of the β-hairpin.   
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Figure 6.9.  Circular dichroism spectra for the LKLK azobenzene peptide at 
thermodynamic equilibrium (red), at thermodynamic equilibrium with ATP (blue), in the 
photostationary state (orange), and in the photostationary state with ATP (green).  Studies 
were performed in 10 mM sodium phosphate buffer pH 5.5 at 25 °C.   
 
C. Conclusion 
 In conclusion, we have designed a β-hairpin peptide whose secondary structure can 
be induced by its ability to recognize and bind ATP.  The hairpin sequence is based on 
the known nucleotide receptor peptide, WKWK, however the type I’ Asn-Gly turn was 
replaced with a photoswitchable azobenzene moiety.  This allows for photochemical 
control of the peptide structure through photolysis of the azobenzene turn, converting it 
from completely unfolded in the trans confirmation, to only modestly folded in the cis 
conformation.  Upon addition of ATP, the peptide takes on a β-sheet structure in both the 
thermodynamic and photostationary state.  It is possible, as the azobenzene turn in the 
trans conformation is not expected to nucleate hairpin formation, that the β-sheet 
formation in the case of trans-9 is in fact intermolecular, as opposed to intramolecular in 
the case of cis-9.  Both the azobenzene turn and the cross strand tryptophan residues are 
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required to facilitate this binding induced folding phenomenon, as mutation of each 
separately prevents β-sheet formation upon addition of ATP.  Gaining a greater 
understanding of protein folding and being able to control peptide and protein structure 
with the use of an external trigger is quite valuable, as often the change in a protein’s 
secondary structure can result in vastly different functions, which in some cases proves to 
be deleterious.  We have demonstrated a unique system that enables such structural 
control based on the fundamental principles of molecular recognition.   
 
D. Experimental Section 
 i. Peptide synthesis. All peptide synthesis was performed on an Applied Biosystems 
Pioneer Peptide Synthesizer using a PEG-PAL-PS resin.  Peptides were synthesized on a 
0.1 mmol scale by standard Fmoc solid phase synthesis.  All amino acids with 
functionality were protected during synthesis.  Coupling reagents were HOBt/HBTU in 
DMF.  For the coupling of arginine, Fmoc-Arg(Boc)2-OH was used in place of the 
normal Pbf protected residue, as side reactions of unknown nature involving the 
azobenzene moiety have been reported in the acidolytic removal of the Pbf group from 
arginine.14  For the coupling of 8, only 1.5 equivalents were used and the coupling was 
performed for 10-12 hours off of the synthesizer.  Fmoc deprotections were carried out in 
20% piperidine in DMF and, the N-terminus was acylated with a solution of 5% acetic 
anhydride and 6% 2,6-lutidine in DMF.  Cleavage of the peptide from the resin and of the 
side chain protecting groups was performed by hand with a cocktail of 95% TFA/5% 
H2O for 3 hours.  TFA was evaporated and the product was precipitated with cold ether.  
The water-soluble peptides were extracted with water and lyophilized.  Peptides were 
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purified by semipreparative reversed-phase HPLC on a C18 column at a flow rate of 4 
mL/min.  Peptides were purified with a linear gradient of A and B (A: 95% H2O/5% 
CH3CN with 0.1% TFA, B: 95% CH3CN/5% H2O with 0.1% TFA) and elution was 
monitored at 214 nm, as well as 320 nm in the case of 9.  Generally only the trans-9 was 
collected due to its much higher concentration and cis-9 was often found to co-elute with 
other peptide impurities.  Once purified, peptides were lyophilized to powder to give a 
bright orange solid in the case of 9, and characterized by +ESI-MS.   
 ii. Peptide photoisomerization.  Azobenzene containing peptides were irradiated at 
365 nm for five minutes in the dark with a Spectroline long wave UV pencil lamp (1,000 
µW/cm2 of 365 nm radiation at 1”).  Once irradiated, solutions were continually stored in 
the dark at room temperature.  Analysis and characterization of the photolyzed peptides 
was generally carried out immediately after photolysis.  A maximum of cis- to trans-azo 
ratios of about 85:15 are obtained at the photostationary state as determined by LC/MS. 
 iii. UV-Vis measurements.  A sample of hairpin 9 was prepared at a concentration of 
45 µM as determined by mass in NaOAc buffer, pH 3.7.  UV scans were taken over 500 
to 200 nm, both prior to and after photolysis.        
 iv. Analytical LC/MS.  LC-MS was carried out on an Agilent Rapid Resolution LC-
MSD system equipped with an online degasser, binary bump, autosampler, heated 
column compartment, and diode array detector.  All separations were performed using 
H2O-acetonitrile gradients with 0.2% formic acid and a Zorbax Eclipse XDB-C18 
column (4.6 × 50 mm, 1.8 micron).  The MS was performed using a single quad mass 
spectrometer. Mass spectra (ESI+) were acquired in ultrascan mode by using a drying 
temperature of 350°C, a nebulizer pressure of 45 psi, a drying gas flow of 10 L/min, and 
 284 
a capillary voltage of 3000 V.  Injection volumes were varied from 4 µl to 15 µl 
depending on the sample concentration, in order to achieve adequate MS and UV 
detection.  The chromatography of was carried out at 45°C at a flow rate of 1.5 mL/min 
(0-20% B, 0-2 minutes / 20-31% B, 2-6 minutes).  Multiple wavelengths were monitored 
for analysis (220 nm, 280 nm, 320 nm) and the peak areas were integrated at 220 nm.  
The cis and trans isomers were assigned based on a strong absorbance of trans 
azobenzene at 320 nm, along with the shift in the distribution of isomers upon 
isomerization. 
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Figure 6.10.  LC/MS trace of azobenzene containing hairpin 9 at thermodynamic 
equilibrium at 220 nm (top) and 320 nm (bottom).  The cis:trans ratio of the peptide was 
determined to be 25:75 at 220 nm. 
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Figure 6.11.  LC/MS trace of azobenzene containing hairpin 9 in the photostationary 
state at 220 nm (top) and 320 nm (bottom).  The cis:trans ratio of the peptide was 
determined to be 85:15 at 220 nm. 
 
 v. NMR spectroscopy.  Peptide NMR samples were prepared in concentrations of 
0.7 – 1.0 mM and analyzed on a Varian Inova 600-MHz instrument at 25 °C.  Samples 
were dissolved in one third CD3CN and two-thirds D2O buffered to pD 4.0 with 50 mM 
NaOAc and 240 mM AcOD with 0.5 mM DSS.  1D NMR spectra were collected using 
32K data points and 32 scans using a 1-3 second presaturation.  All 2D NMR 
experiments used pulse sequences from the Chempack software.  2D TOSCY 
experiments were taken with 16 scans in the first dimension and 128 scans in the second 
dimension.  All spectra were analyzed using standard window functions (sinbell and 
Gaussian with shifting).  Presaturation was used to suppress the water resonance. 
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Figure 6.12.  1H NMR of 9 at thermodynamic equilibrium (25% cis, 75% trans) in one-
third CD3CN at 25 °C. 
 
 
Figure 6.13.  1H NMR of 9 in the photostationary states (85% cis, 15% trans) in one-
third CD3CN at 25 °C. 
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 vi. Circular dichroism.  CD spectra in the range of 185 to 500 nm were recorded on 
a Pistar-180 spectropolarimeter equipped with a thermostated cell holder.  In the case of 
the control Gly-Gly turn peptide, the spectra were collected on an Aviv Model 62DS CD 
spectrometer.  In each case, spectra were obtained at 25 °C with a 1.0 nm step, a 
bandwidth of 2 nm, and 2.5 seconds per point in a 0.1 cm quartz cell.  Spectra were 
generally taken at peptide concentrations of either 45 µM or 135 µM as determined by 
mass in phosphate buffer (pH 5.5).  The error associated with determining peptide 
concentrations by mass is quite large, resulting in CD signals of varying intensities.  
When appropriate, three equivalents of ATP were added as determined by UV absorption 
at 259 nm (ε = 15,400 M-1cm-1).  A buffer subtraction was performed in each case, and 
the results are reported in terms of molar ellipticity per residue: 
[Θ]R = (Θobs / (10 × l × c)) / r 
where Θobs is the observed signal, l is the pathlength (0.1 cm), c is the peptide 
concentration, and r is the number of residues (11 was used for the azobenzene peptides).  
The CD spectra of the cis-azo isomers were recorded immediately after irradiation at 365 
nm until the photostationary state was reached. 
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